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Summary
Our knowledge of reproductive medicine has expanded rapidly since the birth of Louise 
Brown, the first baby to be conceived by in vitro fertilization (IVF) in 1978. In vitro
maturation (IVM) of oocytes - a culture technique to support maturation of immature oocytes 
in vitro - could offer an interesting adjunct to the classical assisted reproductive treatments. 
From a clinical point of view, it could diminish or avoid the use of superovulation drugs, thus 
reducing treatment length, costs and the risk of severe ovarian hyperstimulation syndrome 
(OHSS) and other adverse side-effects associated with hormonal stimulation. Other potential 
benefits include the provision of a source of oocytes for research in the fields of stem cells 
and cloning, obtaining oocytes for donation and preservation of fertility.  
However, several aspects of the technique are still in the process of optimization. A crucial 
point in this context is the development of new culture strategies for IVM, which is the 
objective of the present thesis. Immature human and mouse oocytes were used as models to 
reach this goal.  
We first analysed retrospectively the clinical benefit of in vitro matured metaphase I (MI) 
oocytes in a selected population of patients undergoing controlled ovarian hyperstimulation 
(COH), but with a low number of mature oocytes ( 6) available for the infertility treatment 
(= ‘rescue IVM’). This study was conducted within the framework of a routine IVF-lab, 
without changing the procedure of ovarian stimulation, ovum pick-up or oocyte culture. 
Although fertilization rates and developmental capacity of these oocytes was reduced 
compared to in vivo matured controls, a normal pregnancy and live birth could be obtained
out of 13 transfers exclusively derived from IVM oocytes. This demonstrated that these 
oocytes could be worthwhile to increase the number of embryos available for transfer. On the 
other hand, the oocytes’ reduced developmental capacity confirmed that current IVM culture 
systems are insufficient to support maturation in vitro properly. 
The next step was trying to modify the existing culture techniques for IVM. One of the major 
problems in IVM is the fact that isolated meiotic-competent oocytes undergo nuclear 
maturation spontaneously before the cytoplasm achieves full maturity. A possible way to 
circumvent this deficiency is to apply a 2-step culture composed of (1) a prematuration 
culture (PMC) to block temporarily spontaneous nuclear maturation, followed by (2) 
conventional IVM.  By inducing meiotic arrest during PMC, oocytes may have the time to 
undergo cytoplasmic changes (mRNA storage, protein accumulation, ultrastructural 
remodelling), needed to enhance the oocytes’ capacity to sustain further embryonic 
development. Oocyte-specific phosphodiesterase type 3-inhibitors (PDE3-Is) are potent 
meiotic inhibitors of the PMC-step. 
Since MI oocytes are already on the process of nuclear maturation, the above described 
hypothesis was applied on germinal vesicle (GV)-stage oocytes. In the second study, mouse 
cumulus-oocytes complexes (COCs) were utilized to optimize the 2-step culture. We could 
identify the most effective concentration of the PDE3-I, cilostamide (1 µM), and analyzed the 
effect of the inhibitor on the kinetics of meiotic progression and aneuploidy rates of the in
vitro matured oocytes. Improved meiotic spindle morphology and developmental competence 
demonstrated the potential of this 2-step culture to increase the quality of in vitro matured 
oocytes.
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Because of these promising results in mouse oocytes, we applied a similar 2-step culture on 
human oocytes. In the third study, cumulus-free GV-stage oocytes retrieved from COH cycles 
were used as source of human experimental material. Temporary nuclear arrest with PDE3-I 
proved to be beneficial for obtaining normal spindle and chromosome configurations after 
IVM, similar to in vivo matured oocytes. We also observed that the GV oocytes underwent 
nuclear configurations during PMC, which were characteristic for preovulatory oocytes. 
However, a clear drawback in the experimental set-up was the fact that the oocytes were 
denuded from surrounding cumulus cells before starting the 2-step culture. It is known that 
the bidirectional communication between the oocyte and its surrounding cumulus cells plays 
an important role in the maturation process. To circumvent this deficiency, we performed the 
PMC step in the next experiment in a three-dimensional (3D) co-culture system of human 
GV oocytes with dissociated cumulus cells, making use of an extra-cellular matrix (ECM; 
collagen). The presence of the cumulus cells and/or the ECM during 3D-PMC improved 
significantly the morphological quality and nuclear constitution of the embryos post-IVM and 
IVF.
Finally, the type of oocytes that are used clinically for ‘true IVM’ are not the denuded ‘left 
over’ GV oocytes that failed to mature in vivo, but the COCs retrieved from small antral 
follicles. When a 2-step culture is applied in this type of oocytes (see second study), we 
observed that the oocytes start to lose their connections with the surrounding cumulus mass, 
which alters the 3D-structure of the COCs. Therefore, the final step in our research project 
was to further optimize the PMC conditions in order to preserve the functional cellular 
connections within the COC. This was realized by embedding COCs in an ECM, the same 
collagen matrix as was tested in the previous study. A mouse model was initially used to test 
this approach. Lucifer Yellow dye coupling assay revealed that oocyte-cumulus cell 
connections stayed intact during 3D-PMC. Upon IVF, this strategy resulted in a significant 
increase in the percentage of mouse 2-cell embryos compared to a 2-step culture in the 
absence of an ECM (= 2D-PMC).  In addition, we evaluated this culture system on human 
COCs derived from small antral follicles donated by patients undergoing COH for IVF/ICSI 
treatment. Applying a 3D-PMC improved maturation rates and developmental competence of 
the oocytes compared to a conventional IVM system.  
In conclusion, the results from the above studies might offer significant applications for 
improving the clinical outcome of IVM technologies. Although the different culture systems 
still remain to be further explored, this work opens exciting new avenues for future research 
in this field.  
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Samenvatting
Onze kennis over reproductieve geneeskunde is snel toegenomen sinds de geboorte van 
Louise Brown, de eerste baby verwekt via in vitro fertilizatie (IVF) in 1978. In vitro maturatie 
(IVM) van eicellen – een cultuurtechniek om maturatie van onrijpe eicellen in vitro te 
ondersteunen – zou een interessante aanvulling kunnen bieden op de klassieke reproductieve 
behandelingen. Vanuit een klinisch oogpunt zou het het gebruik van superovulatie-medicijnen 
kunnen verminderen of vermijden en aldus de behandelingstijd, -kosten, het risico op ovarieel 
hyperstimulatie syndroom (OHSS) en andere ongunstige bijwerkingen geassocieerd met 
hormonale stimulatie kunnen reduceren. Andere potentiële voordelen zijn de voorziening van 
een bron van eicellen voor onderzoek in het domein van stamcellen en klonen, het verwerven 
van eicellen voor donatie en het bewaren van de vruchtbaarheid. 
Verschillende aspecten van de techniek bevinden zich echter nog steeds in een proces van 
optimalisatie. Een cruciaal aspect in deze context is het ontwikkelen van nieuwe 
cultuurstrategieën voor IVM. Dit is het onderwerp van deze thesis. Onrijpe humane en 
muizeneicellen werden aangewend als model om dit doel te realiseren.  
Allereerst analyseerden we, retrospectief, de klinische bruikbaarheid van in vitro
gematureerde metafase I (MI) eicellen in een geselecteerde populatie van patiënten die 
gecontroleerde ovariële hyperstimulatie ondergingen, maar bij wie een laag aantal rijpe 
eicellen ( 6) beschikbaar waren voor de onvruchtbaarheidsbehandeling (= ‘rescue IVM’). 
Deze studie werd uitgevoerd binnen het kader van een routine IVF-labo, zonder de procedures 
van ovariële stimulatie, eicelpunctie of eicelcultuur te veranderen. 
Hoewel de bevruchtingsgraad en ontwikkelingscapaciteit van deze eicellen gereduceerd was 
in vergelijking met in vivo gematureerde controles, kon uit 13 embryotransfers - exclusief 
bestaande uit embryo’s afkomstig van IVM eicellen - een normale zwangerschap en 
levendgeborene verkregen worden. Dit toonde enerzijds aan dat deze eicellen waardevol 
kunnen zijn om het aantal embryo’s beschikbaar voor transfer te verhogen. De verminderde 
ontwikkelingscapaciteit van de eicellen bevestigde, anderzijds, dat de huidige IVM 
cultuursystemen insufficiënt zijn om maturatie in vitro volledig te ondersteunen. 
In de volgende stap probeerden we de bestaande cultuurtechnieken voor IVM te wijzigen. Een 
van de grootste problemen in IVM is het feit dat geïsoleerde meiose-competente eicellen 
spontane nucleaire maturatie ondergaan alvorens het cytoplasma volledige maturatie heeft 
bereikt. Een mogelijke oplossing om deze tekortkoming te omzeilen is het toepassen van een 
2-staps-cultuur bestaande uit (1) een pre-maturatie cultuur (PMC) om spontane nucleaire 
maturatie tijdelijk te blokkeren, gevolgd door (2) conventionele IVM. Door meiotisch arrest te 
induceren tijdens de PMC krijgen de eicellen de tijd om bepaalde cytoplasmatische 
veranderingen te ondergaan (mRNA stockage, accumulatie van proteïnes, ultrastructurele 
modelering). Deze veranderingen kunnen de capaciteit van de eicel verhogen om verdere 
embryonale ontwikkeling te ondersteunen. Eicel-specifieke phosphodiesterase type 3-
inhibitoren (PDE3-I) zijn bruikbare meiose-inhibitoren voor de PMC-stap. 
Gezien MI eicellen zich reeds in het proces van nucleaire maturatie bevinden, werd de 
hierboven beschreven hypothese getest op germinale vesikel (GV) eicellen. Cumulus-eicel 
complexen (CEC-en) van de muis werden gebruikt in de tweede studie om de 2-staps-cultuur 
te optimaliseren. We konden de meest geschikte concentratie van de PDE3-I, cilostamide 
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(1µM), identificeren en analyseerden het effect van de inhibitor op de snelheid van meiotische 
progressie en aneuploidie-graad van de in vitro gematureerde eicellen. Verbeterde morfologie 
van de meiotische spoelfiguur en ontwikkelingscapaciteit toonden het potentieel aan van deze 
2-staps-cultuur om de kwaliteit van in vitro gematureerde eicellen te verhogen. 
Gezien de veelbelovende resultaten op muizeneicellen pasten we een gelijkaardige 2-staps- 
cultuur toe op humane eicellen. Cumulus-gedenudeerde GV eicellen - verkregen na 
gecontroleerde ovariële hyperstimulatie - werden gebruikt als bron van humaan experimenteel 
materiaal in de derde studie. Tijdelijk nucleair arrest met PDE3-I bewees voordelig te zijn om 
normale spoelfiguren en chromosomale configuraties te verkrijgen na IVM, dit in vergelijking 
met in vivo gematureerde eicellen. We observeerden tevens dat GV-eicellen nucleaire 
configuraties ondergingen tijdens de PMC die karakteristiek zijn voor pre-ovulatoire eicellen. 
Niettemin was een duidelijk gebrek in de experimentele set-up het feit dat de eicellen 
gedenudeerd waren van omringende cumuluscellen alvorens de 2-staps-cultuur te starten. Het 
is gekend dat de tweerichtings-communicatie tussen de eicel en de omringende cumuluscellen 
een belangrijke rol speelt tijdens het maturatieproces. Om dit gebrek te omzeilen voerden we 
in het volgende experiment de PMC-stap uit in een drie-dimensioneel (3D) co-cultuur 
systeem van humane GV eicellen met gedissocieerde cumuluscellen. Hierbij maakten we 
gebruik van een extra-cellulaire matrix (ECM; collageen). De aanwezigheid van de 
cumuluscellen en/of de ECM tijdens een 3D-PMC verbeterde significant de morfologie en 
nucleaire samenstelling van embryo’s post-IVM en IVF. 
Uiteindelijk is het type eicellen dat klinisch wordt gebruikt voor ‘echte IVM’ niet de 
gedenudeerde ‘restant’ GV eicellen die faalden om in vivo maturatie te ondergaan, maar de 
CEC-en afkomstig uit kleine antrale follikels. Wanneer we een 2-staps-cultuur toepasten op 
dit type van eicellen (zie tweede studie) observeerden we dat de eicel de connecties met de 
omgevende cumulusmassa begint te verliezen. Dit wijzigt de 3D-structuur van het CEC. 
Daarom bestond de finale stap in ons onderzoeksproject eruit om de PMC condities verder te 
optimaliseren, zodat functionele cellulaire connecties binnen het CEC bewaard bleven.
Dit werd gerealiseerd door de CEC-en in te sluiten in een ECM, dezelfde collageen-matrix die 
was getest in de vorige studie. Een muismodel werd initiëel gebruikt om deze aanpak te 
testen. Lucifer Yellow koppelingsanalyse toonde aan dat eicel-cumuluscel connecties intact 
bleven tijdens de 3D-PMC. Na IVF resulteerde deze strategie in een significante stijging van 
het percentage 2-cellige muizenembryo’s in vergelijking met een 2-staps cultuur zonder ECM 
(= 2D-PMC). Vervolgens evalueerden we dit cultuursysteem op humane CEC-en afkomstig 
van kleine antrale follikels en gedoneerd door patiënten die gecontroleerde ovariële 
hyperstimulatie ondergingen voor IVF/ICSI behandeling. Het toepassen van een 3D-PMC 
verhoogde de maturatiegraad en ontwikkelingscapaciteit van de eicellen in vergelijking met 
een conventioneel IVM cultuursysteem. 
Samenvattend kunnen de resultaten van de bovenvermelde studies significante toepassingen 
bieden om de klinische resultaten van de IVM technologie te verbeteren. Hoewel de 
verschillende cultuursystemen verder moeten geëxploreerd worden, opent dit werk boeiende 
en nieuwe paden voor toekomstig onderzoek in dit domein.  
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1. Introduction 
‘Omne vivum ex ovo’ (Harvey, 1651) ‘all living things come from eggs’ 
1.1. Oocyte maturation 
The mature human oocyte is the key ingredient for fertility, highly specialized and yet 
totipotent at the same time, invested with the unique ability to be fertilized and form new life. 
These characteristics make the oocyte perhaps the most precious cell in the body. However, 
many of the functioning mechanisms of the ooplasm remain ununderstood.  
This part of the thesis will provide a concise review of the origin, growth and maturation of 
the oocyte.  
1.1.1. Biological aspects 
1.1.1.1. Origin and development of the female gamete 
Oogenesis encompasses the differentiation, growth and maturation of the female gamete, in 
preparation for fertilization and subsequent development of the embryo.  
The major milestones in this process are: (a) differentiation of the primordial germ cells 
(PGCs) from the rest of the cellular population; (b) migration from the site of origin to the 
developing gonad; (c) further development characterized by initial mitosis, which gradually 
ceases with the initiation and arrest of meiosis; (d) decline in the number of gametes and (e) 
re-initiation of meiosis following the preovulatory gonadotrophin surge and re-arrest 
preceding ovulation and fertilization. In humans, the phenomena (a) and (b) occur during the 
embryonic period, (c) occurs during the fetal period, (d) starts already before birth and  
together with (e) encompass almost the entire reproductive period of a woman.  
Once oocytes have been formed, they must make connections with somatic cells in order to 
survive (Gosden et al., 1997). Therefore, follicles are the lifeboats of the ovary because they 
nourish and control the development of oocytes.  
Follicles begin their development as primordial structures that consist of an oocyte arrested at 
the diplotene stage of the first meiotic division, surrounded by a single layer of flattened or 
polyhedral granulosa cells (Peters, 1969). Once the pool of primordial follicles has been 
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established, and in response to either stimulatory or the release from inhibitory factors, 
follicles are gradually, irreversibly and continuously recruited to grow (= initial recruitment;
Fig 1) (McGee and Hsueh, 2000). Once this process has started, it continues without halting 
until ovulatory maturity is attained or, in the majority of cases, until the follicle degenerates 
(atresia). The signals regulating the growth initiation of primordial follicles are still unknown, 
but are likely to be an interaction of factors such as anti-Müllerian hormone that inhibit 
initiation (Durlinger et al., 1999) and a range of stimulatory factors such as c-kit and kit-
ligand (Skinner, 2005). Follicles at this early stage of development have been shown to 
express FSH receptors (Bao and Garverick, 1998). However, gonadotrophins do not appear to 
be essential for early follicle growth, because, in their absence, follicles can still develop to 
the early antral stage (Awotwi et al., 1984; Gong et al., 1996).
During this early growth period or ‘basal growth phase’, the oocyte grows and the granulosa 
cells proliferate to form a multi-laminar structure. The follicle is now called a preantral 
follicle. At this stage, theca cells (the third follicular cell type) begin to differentiate from the 
surrounding stroma. Once the follicle reaches a species-specific size, it forms a fluid-filled 
space called an antrum within the granulosa cell layers (Gosden and Telfer, 1987a,b). When 
this stage has been reached, follicles become acutely dependent on gonadotrophins for further 
growth and development (Nayudu and Osborn, 1992) and the oocyte has completed most of 
its growth by that time.  
Increases in circulating FSH during each reproductive cycle, which starts after pubertal onset, 
rescues a cohort of antral follicles from atresia (= cyclic recruitment; Fig 1). Among this 
group of antral follicles, one of the leading follicles grows faster than the rest of the cohort 
and produces higher levels of estrogens and inhibins (Gougeon, 1996). This exerts a negative 
feedback upon gonadotrophin release and, as a result, the remaining growing antral follicles 
are deprived of adequate FSH stimulation required for survival (diZerega and Hodgen, 1981). 
This allows a positive selection of the dominant follicle, thus ensuring its final growth and 
eventually ovulation.
At birth, the human ovary is densely packed with primordial follicles, but a number of 
growing, multi-laminar follicles are usually present (Gosden et al., 1997). During childhood, 
the ovary contains growing follicles at virtually all developmental stages, except the dominant 
ones. Thus, in addition to the preantral stages, few antral follicles (> 2 mm) and atretic forms 
may be found. The follicles in the ovaries become larger as puberty approaches. This stage is 
somewhat akin to that observed in domesticated animals during their non-breeding seasons.
The pool of primordial follicles is progressively reduced throughout life, even during 
pregnancy, anovulation periods and lactation, until the store is exhausted shortly after 
menopause in mid-life (Jones and Krohn, 1961; Gougeon et al., 1994). Less than 1% of 
primordial follicles present at the time of birth will ever proceed to ovulation (Erickson, 
1966), with the majority of follicles degenerating by atresia. For years, it has been assumed 
that there is a fixed non-renewable population of primordial follicles. However, this 
assumption has recently been challenged by the publication of two papers that suggest oocyte 
renewal/regeneration in adult mice and possibly humans (Johnson et al., 2004, 2005), a 
situation which should be consistent with the ovarian biology of lower vertebrates such as 
Xenopus Laevis. This hypothesis has opened a new debate on the existence of germ-line stem 
cells in the mammalian ovary (Gosden, 2004). 
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Figure 1: Duration of follicle recruitment and selection in human and rat ovaries.
Primordial follicles undergo initial recruitment to enter the growing pool of primary follicles. Due to 
its protracted nature, the duration required for this step is unknown. In the human ovary, more than 
120 days are required for the primary follicles to reach the secondary follicle stage, whereas 71 days 
are needed to grow from the secondary to the early antral stage. During cyclic recruitment, increases in 
circulating FSH allow a cohort of antral follicles (2-5 mm in diameter) to escape apoptotic demise. 
Among this cohort, a leading follicle emerges as dominant, thus ensuring its final growth and 
eventually ovulation. After cyclic recruitment, it takes only 2 weeks for an antral follicle to become a 
dominant Graafian follicle. In the rat, the duration of follicle development is much shorter. The time 
required between the initial recruitment of a primordial follicle and its growth to the secondary stage is 
more than 30 days, whereas the time for a secondary follicle to reach the early antral stage is about 28 
days. Once the early antral stage (0.2 – 0.4 mm in diameter) has been reached, follicles are subjected 
to cyclic recruitment and only 2-3 days are needed for them to grow into preovulatory follicles. In 
rodents, multiple follicles become dominant during each estrous cycle (Modified from McGee and 
Hsueh, 2000). 
1.1.1.2. Growth and acquisition of meiotic competence 
Non-growing oocytes within primordial follicles are commonly, and misleadingly, described 
as ‘quiescent’. It is only the state of the nucleus that is resting (i.e. dictyate stage of prophase 
I). The presence of one or more nucleoli, RNA polymerase activity and continuous uptake of 
amino acids and ribonucleosides demonstrate their active state. Since these cells may survive 
for 50 years or more in human ovaries, it is not surprising that they continuously repair and 
replace damaged organelles and macromolecules in order to maintain a status quo (Gosden
and Bownes, 1995).
During the growth phase, the oocytes remain in the same stage of meiosis, but they undergo 
a remarkable increase in volume and alteration in cellular behavior. This is indicated by an 
Primordial 
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AntralInitial
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intense metabolic activity, which in turn is reflected by marked biosynthetic changes and 
changes in the oocytes’ ultrastructure. It is during this time that many of the macromolecules 
essential for further development, both before and after ovulation, are produced and 
stockpiled within the oocyte. Besides accumulating water, ions and lipids, growing oocytes 
display 2- to 3-fold higher rates of RNA synthesis than non-growing or fully-grown oocytes 
(Bachvarova, 1981). The rate of protein synthesis and total protein content rises in parallel 
with expanding cell volume (Schultz and Wassarman, 1977). Transcriptional as well as 
translational products remain stable over a long period of time, principally due to 
polyadenylation control (Gosden, 2002). Posttranslational modifications of proteins through 
phosphorylation are common mechanisms by which proteins are modified for later use (Gould 
and Nurse, 1989).
Accumulation of RNAs and proteins are not the only major changes taking place during 
oocyte growth. Ultrastructural studies have demonstrated that complex organelle hypertrophy 
and reorganization occurs during this accumulative phase (Szollosi, 1972). For example, 
mitochondria, Golgi complexes and rough endoplasmic reticulum (RER) increase numerically 
and become dispersed in the oocyte (Gosden and Bownes, 1995). Increased division of 
mitochondria - from between 50-100 copies to over 200 000 - prepares the oocyte for its 
intensive metabolic activity before, during and after fertilization. Rearrangement of RER and 
Golgi complexes is involved in the synthesis and packaging of cortical granules and in the 
secretion of proteins constituting the zona pellucida (ZP). In addition, the oolemma elaborates 
a microvillar surface concomitant with the formation of the ZP. Modifications of the 
cytoskeleton result in the formation of a cytoplasmic framework where membrane-limited 
organelles translocate and assume defined positions within the growing oocyte (Albertini, 
1992).
The coupling between the oocyte and the granulosa cells becomes much more intimate after 
follicle growth is initiated. Granulosa and theca cells support the oocyte on this journey 
through the provision of essential nutrients, information molecules, metabolic precursors, 
growth factors and hormones (Donahue and Stern, 1968; Brower and Schultz, 1982; Gilchrist 
et al., 2004). However, it is also becoming apparent that the oocyte itself plays an active and 
dominant role in directing follicle growth by synthesizing factors that regulate the 
proliferation, function, survival and differentiation of granulosa cells, the recruitment of theca 
cells and the secretion of extracellular matrix components (Hussein et al., 2005, 2006). In this 
regard, the oocyte manipulates its own microenvironment. 
Near the end of the growth phase, the oocyte will acquire the capability to resume meiosis. 
This important phase during oogenesis is called ‘acquisition of meiotic competence’ 
(Wickramasinghe et al., 1991; Eppig, 1996). It refers to the ability of the oocytes to reinitiate 
meiosis spontaneously when they are isolated from their follicles (Pincus and Enzmann, 1935; 
Edwards, 1965). Expression of meiotic competence has been correlated with a species-
specific minimal oocyte diameter and it generally coincides with follicular antrum formation 
in rodents (Eppig and Schroeder, 1989). In humans, the oocyte has a size dependent ability to 
resume meiosis in vitro (Durinzi et al., 1995), but it also depends on the follicle size and the 
stage of the menstrual cycle. Oocytes retrieved in the follicular phase of the menstrual cycle 
from follicles of 9 to 15 mm complete meiotic maturation at a higher rate than oocytes from 
follicles of 3-4 mm. Oocytes retrieved from follicles in the luteal phase will complete meiosis 
at the same rate irrespective of follicle size (Tsuji et al., 1985). 
A growing body of evidence indicates that meiotic competence is acquired in individual steps. 
First, oocytes exhibit the ability to undergo germinal vesicle breakdown (GVBD) (Eppig and 
Schroeder, 1989; Eppig et al., 1994). Subsequently, they acquire the ability to progress 
through meiosis I and arrest at metaphase of meiosis II (Wickramasinghe and Albertini, 1991, 
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1992). A similar process is observed in domestic species as well (Hyttel et al., 1997). This 
shows that acquisition of meiotic competence corresponds to a point at which the oocyte 
achieves a threshold level of maturation-promoting proteins and/or a correct position of these 
molecules within the oocyte (Mehlmann, 2005). 
In the mouse, the most intensively studied species, it was discovered that critical remodeling 
in nuclear and cytoplasmic structures occurred during the course of meiotic competence 
acquisition. These changes include: 1) the appearance of a rim of heterochromatin around the 
nucleolus; 2) the loss of an interphase array of cytoplasmic microtubules; 3) the appearance of 
phosphorylated centrosomes; 4) the migration of centrosomes and organelles from a 
subcortical position to a perinuclear position (Mattson and Albertini, 1990; Wickramasinghe 
et al., 1991; Wickramasinghe and Albertini, 1992). Since these nuclear and cytoplasmic 
modifications resembled changes that are normally seen in somatic cells when they move 
from G2 to the M-phase, it was suggested that a similar transition in the cell cycle of the 
oocyte occurred during this phase of oogenesis. 
Meiotic competence acquisition does not necessarily imply that the oocyte acquires 
developmental competence. Developmental competence is progressively acquired within the 
preovulatory follicle, prior to and following the LH surge (Eppig et al., 1994). This phase in 
the maturation process is called ‘cytoplasmic maturation’. 
1.1.1.3. Cytoplasmic maturation 
Cytoplasmic maturation can be defined as the processes in which the female gamete changes 
from a developmentally incompetent cell to one with the capacity to direct and support the 
events of fertilization and early embryonic development (Eppig, 1996). This imprecise term 
covers, for example, the appropriate processing of mRNAs and proteins - previously 
accumulated during oocyte growth - by modifying the transcription and translation machinery 
(nucleolus condensation and vacuolization, ribosome depletion, undulation of the nuclear 
membrane) (Sirard et al., 2006). Other changes are the formation and peripheral arrangement 
of cortical granules together with relocations of other organelles, such as mitochondria. 
Another process that is included as part of cytoplasmic maturation is the accumulation of 
specific molecules - largely unidentified - which prepare the oocyte for post-fertilization 
events. These include the development of calcium signalling mechanisms for oocyte 
activation, the ability for embryo cleavage and mitosis and the ability to unpack the fertilizing 
sperm DNA and enable embryonic genome activation (Eppig, 1996).  
These events take place in the pre-ovulatory follicle when the oocyte awaits the ovulation 
signal and it is only during this phase of development that the oocyte reaches its full 
developmental capacity. Hence, similarly to the process of sperm capacitation, the term 
‘oocyte capacitation’ has been introduced (Hyttel et al., 1997; Hendriksen et al., 2000). 
A critical challenge in the context of in vitro maturation (IVM) is to understand the 
mechanisms that govern this final peri-ovulatory phase during oocyte development.  
1.1.1.4. Regulation of oocyte nuclear maturation
The term ‘nuclear maturation’ generally encompasses the period between the resumption of 
meiosis of an oocyte that was arrested in the dictyate stage of prophase I and the transition to 
the second metaphase stage (MII), when the oocyte undergoes a re-arrest awaiting 
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fertilization. Morphologically, these events are represented by the breakdown of the GV and 
asymmetric cytoplasmic division of the oocyte resulting in the extrusion of the first polar 
body (PB). On fertilization, meiosis is completed by exit from MII and extrusion of the 
second polar body. Consequently, a truly haploid oocyte does not exist in mammals, because 
the final reduction in the chromosome number does not occur until fertilization. 
Before discussing the external triggers and intracellular events that promote oocyte 
maturation, the signals that hold oocytes in meiotic arrest must be described.  
Meiotic arrest
It is well established that meiotic arrest is regulated by cAMP levels within the oocyte (Conti 
et al., 1998, 2002; Eppig et al., 2004). The downstream pathway(s) by which high cAMP 
levels prevent meiotic maturation is incompletely understood and a detailed discussion is 
beyond the scope of this thesis. Ultimately, the cAMP level within the oocyte affects the 
activity of the p34
cdc2
 kinase/cyclin B protein complex, also known as maturation, meiosis or 
mitosis promoting factor (MPF) which is the master orchestrator of the cell cycle. High 
cAMP levels within the oocyte result in the phosphorylation of p34
cdc2
 kinase on Thr14 and 
Tyr15, rendering it inactive (= pre-MPF) (Duckworth et al., 2002) (Fig 2). A decrease in 
oocyte cAMP leads to the dephosphorylation of p34
cdc2
 kinase on Thr14 and Tyr 15, and the 
MPF complex becomes active such that the oocyte can re-enter meiosis. The discrete set of 
steps through which cAMP activates or inactivates MPF are still under investigation. The 
major players are protein kinase A (PKA), which, through an undetermined number of steps, 
regulates the activities of the phosphatase CDC25 and the kinase WEE1/MYT1 (Eppig et al.,
2004). CDC25 dephosphorylates MPF, while WEE1/MYT1 phosphorylates it. Future studies 
are needed to clarify the entire pathway by which cAMP levels affect the activity of MPF. 
cAMP could be produced either by the oocyte (internally generated; Fig 2) or by the follicle 
cells that surround it (externally generated). One long-standing hypothesis is that cAMP is 
produced by follicle cells and diffuses through gap junctions into the oocyte (Anderson and 
Albertini, 1976; Dekel et al., 1981). As an extension of this concept, it has been proposed that 
re-entry into the cell cycle is accompanied by the interruption of the communication between 
the oocyte and the somatic compartment.  However, recent findings on mouse oocytes suggest 
that cAMP diffusion through gap-junctions is not sufficient by itself to maintain meiotic arrest 
(Vaccari et al., 2008). An alternative hypothesis is that the oocyte produces its own cAMP 
through a G-protein-linked receptor, GPR3 (mouse and human), in the oocyte plasma 
membrane that stimulates Gs and, subsequently, adenylyl cyclase (AC) (Mehlmann et al.,
2004; DiLuigi et al., 2008). It is currently not known whether constitutive activity of GPR3 in 
the oocyte is sufficient to produce the amount of cAMP required to maintain meiotic arrest, or 
whether the follicle cells surrounding the oocyte stimulate the intra-oocyte cAMP synthesis 
by producing a ligand that increases the activity of GPR3.  
Alternative possibilities proposed for maintenance of high intracellular cAMP levels are that 
somatic cells produce hypoxanthine and other purines which, via a paracrine way, block 
phosphodiesterase 3A (PDE3A), the enzyme involved in the control of cAMP levels in the 
oocyte (Conti et al., 1998) (Fig 2). 
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Resumption of meiosis
The signals that control resumption of meiosis of mammalian oocytes are poorly understood. 
While it has been difficult to study this phenomenon in situ, two in vitro experimental models 
have provided the framework for much of our insight into this process. In 1935, Pincus and 
Enzmann observed that mammalian oocytes spontaneously undergo resumption of meiosis 
when removed from the follicular environment (Pincus and Enzmann, 1935). This 
observation led to the hypothesis that follicular cells send inhibitory signals to the oocyte to 
maintain the meiotic arrest. In addition, experiments with cultured follicle-enclosed oocytes 
have demonstrated that LH promotes oocyte maturation indirectly via activation of the 
granulosa cells (Tsafriri, et al., 1972; Tsafriri and Dekel, 1994).
In vivo, meiosis resumes in response to a preovulatory surge of luteinising hormone (LH) or 
the exogeneous administration of human chorionic gonadotrophin (hCG). LH receptors are 
most concentrated in the theca cells and the outer layers of the granulosa compartment, i.e. the 
mural granulosa cells. In theca cells, LH elicits the production of aromatizable androgens 
(‘two-cell two-gonadotrophin model’), while in mural granulosa cells, LH triggers ovulation 
by inducing the rupture of the follicular wall, and thereafter it stimulates luteinization and 
progesterone production of the corpus luteum. The cumulus cells surrounding the oocytes 
have relatively few LH receptors (Eppig et al., 1997) and since no functional receptors are 
present on the oocyte (Patsoula et al., 2001), the mechanism(s) by which LH stimulates 
oocyte maturation is indirect. Although much is known about LH signalling in the mural 
granulosa cells (Richards et al., 2002), how the LH signal transmute to the cumulus cells and 
the oocyte itself is not fully understood. Park et al. (2004) has recently characterized a whole 
network of members of the epidermal growth factor family as paracrine mediators that 
propagate the LH signal throughout the follicle. 
Figure 2: Cell signaling leading to the 
maintenance of meiotic arrest. 
GPR3, activated either constitutively or by an 
unknown ligand from the follicle cells (?), 
activates GS, which stimulates AC to cause 
an elevation of cAMP. cAMP activates 
protein kinase A (PKA), which ultimately 
causes the cell cycle regulatory complex, 
P34cdc2/cyclin B, to be phosphorylated (P) 
and thereby inactivated. PKA phosphorylates 
(directly or indirectly) the phosphatase 
CDC25b (CDC25b-P), which inactivates it. 
PKA may also stimulate the activity of the 
WEE1/MYT1 kinase that phosphorylates 
P34cdc2 to keep it inactive and therefore 
prevent meiotic resumption. The activity of 
the cAMP phosphodiesterase, PDE3A, is 
thought to be kept low in the immature 
oocyte, thus preventing the breakdown of 
cAMP and maintaining high levels of cAMP 
within the oocyte (Modified from Mehlmann, 
2005). 
GPR3 GS
AC?
PDE3A cAMP 
PKA 
WEE1/MYT1 CDC25b - P 
“pre-MPF” 
Cyclin B 
P34cdc2
P P P
Meiotic arrest 
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Ultimately, LH action on the mural granulosa cells translates to a change in signalling 
molecules within the oocyte to initiate meiotic resumption. This action could either remove a 
maturation-arresting substance or it could provide a maturation-promoting substance to 
the oocyte. An attractive hypothesis for a maturation-inducing process is that LH stimulation 
leads to the activation of oocyte PDE, which hydrolyzes cAMP (Conti et al., 2002). PDE3A 
activity in cumulus-enclosed mouse oocytes has been shown to increase following the 
stimulation of LH receptors (Richard et al., 2001). 
The role of cAMP 
The mechanisms for activation of oocyte maturation vary from one species to another, but 
what is sure is the fact that cAMP molecules are key regulators of meiosis resumption in 
amphibian, mammalian and some invertebrate oocytes. Upon release of oocytes from their 
follicles (i.e. spontaneous oocyte maturation), it is supposed that a drop of intra-oocyte 
cAMP is enough to cause meiotic arrest release in vitro. However, there is evidence that 
cAMP has both inhibitory and stimulatory actions. Within the follicle (i.e. induced oocyte 
maturation), the gonadotrophin surge leads to opposing changes in cAMP levels in ovarian 
somatic cells and oocytes: a rise in follicular cAMP mediates LH-induced meiotic maturation, 
while a rise in intraoocyte cAMP maintains meiotic arrest (Tsafriri et al., 1972). This 
contradictory observation demonstrates that high levels of cAMP in the cumulus cells may 
induce the release of a signal or signals that trigger meiotic resumption despite the presence of 
high levels of cAMP in the oocyte.
It was hypothesized that this paradoxical effect results from the compartmentalization and 
differential regulation of cAMP levels in the two major compartments of the follicle (i.e. the 
germ cell and the somatic cells). This differential regulation may result from selective 
expression and regulation of phosphodiesterases (PDEs) in the somatic and the germ cell 
compartments of the follicle. These PDEs exist in several isoforms in the ovaries: PDE4 types 
D and B are present in mural granulosa and theca cells, and PDE3 type A is expressed in 
oocytes of several species (Tsafriri et al., 1996; Shitsukawa et al., 2001; Nogueira et al.,
2003a). In addition, the effectors of cAMP are the protein kinases (PKA and PKC), among 
which there is also a compartmentalization of different isoforms. Probably, the magnitude of 
cAMP levels in the different cell compartments may be the mediator of different signals so 
that stimulation of an identical nature may result in different responses (Nogueira, 2005). 
MPF activation 
The common pathways downstream cAMP for both spontaneous and induced (i.e. overriding 
an inhibitory effect) oocyte maturation involve cAMP-dependent protein kinase A (PKA). 
Upon deactivation of PKA, progression from the G2- to M-phase in the oocyte requires the 
activation of MPF. This involves either or both, depending on the species, the synthesis of 
cyclin B, its relocation from the cytoplasm to the nucleus and the formation of the p34
cdc2
kinase/cyclin B protein complex together with the dephosphorylation of Thr 14 and Tyr 15 of 
p34
cdc2
 itself. In meiotic competent mouse oocytes, pre-MPF is already present and de novo 
protein synthesis is not required to undergo GVBD (Fulka et al., 1986; Wickramasinghe and 
Albertini, 1993). In humans and other domestic mammalian species, it seems that GVBD 
requires protein synthesis, because the pattern of proteins is different before and after 
maturation (Schultz and Wassarman, 1977; Pal et al., 1994). 
MPF activity increases until MI and decreases during the anaphase to telophase transition, but 
remains elevated above a certain baseline (Fig 3). This causes the extension of the condensed 
state of the chromatin and prevention of DNA replication. The activity of MPF increases 
again, due to neo-synthesis of cyclin B, until the oocyte reaches MII. At this stage, MPF is 
maintained at a high level by the interaction of cytostatic factor (CSF), which is activated by 
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the gene product of the proto-oncogene c-mos. Sperm penetration and the resultant increase in 
oocyte intracellular Ca
2+
 concentrations upon fertilization induce cyclin degradation and the 
completion of the meiotic cycle.   
MAPK activation 
Another principal pathway-regulator of the cell cycle that functions in interaction with and 
parallel to other protein kinases is MAP kinase (MAPK = microtubule-associated or mitogen- 
activated protein kinase). The activation of the MAPK pathway depends on the conditions in 
which the oocyte is led to resume meiosis. In mammalian species, activation of MAPK in 
cumulus cells is necessary for gonadotrophin-induced meiotic resumption, while MAPK 
activation is not required for spontaneous meiotic resumption (Fan and Sun, 2004). It is 
proposed that, during induced maturation, an interaction between the cAMP-PKA and the 
MAPK pathways takes place, while spontaneous maturation acts only via the cAMP-PKA 
pathway (Leonardsen et al., 2000). The activity of MAPK is associated with a plethora of 
cytoplasmic events including the regulation of microtubule dynamics, spindle assembly and 
chromosome condensation (Verlhac et al., 1993). In most oocytes, high concentrations of 
MAPK are maintained during meiotic progression to MII and concentrations decrease after 
fertilization or parthenogenetic activation (Fig 3). 
Figure 3: Evolution of MPF and MAPK activity during oocyte meiosis. During
anaphase/telophase MPF drops, but remains elevated above baseline (X-axis). This causes the 
extension of the condensed state of chromatin. MAPK activity increases in oocytes during resumption 
of meiosis and remains high throughout progression to MII. After GVBD, this component of 
serine/threonine protein kinase family is involved in microtubule organization and spindle formation 
(Modified from Smitz et al., 2004). 
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1.1.2. Clinical aspects 
1.1.2.1. Definition of oocyte in vitro maturation (IVM) 
In vitro maturation (IVM) involves the practice of intentionally retrieving immature oocytes 
from unstimulated or minimally stimulated ovaries and culturing the obtained cumulus-
enclosed oocytes in appropriate medium until they reach metaphase II. In domestic animals, 
embryo production from unstimulated ovaries using in vitro matured oocytes is routine 
practise. In humans, this technique was employed for the first IVF treatment (Edwards et al.,
1969). However, due to the poor success of embryo development, the technique was 
abandoned to the advantage of in vivo matured oocytes until the first pregnancy after IVM 
was achieved 22 years later (Cha et al., 1991). Since then, IVM has become an interesting 
alternative for the classical assisted reproductive technologies (ARTs).
The main category of patients in whom IVM has been applied initially is constituted by 
women with polycystic ovaries (PCO) or with polycystic ovarian syndrome (PCOS; 
Mikkelsen and Lindenberg, 2001; Child et al., 2002; Chian et al., 2004; Le Du et al., 2005). 
Pregnancy and implantation rates after IVM in these patients are approximately 30-35% and 
10-15%, respectively (Chian et al., 2004). Later on, these methods have been applied for 
patients with regular menstrual cycles and normal appearing ovaries as well. To date, it is 
estimated that approximately 400 children have been born after IVM. Obstetric and perinatal 
outcome of these children appears to be normal (Buckett et al., 2005; Söderström-Anttila et
al., 2006). The available information is unfortunately limited by the young age of IVM 
technology.
This new approach in ART is still in an experimental phase and still needs to be improved 
before routine clinical application, since the outcome measures of IVM (i.e. pregnancy, 
implantation and spontaneous abortion rates) are often not comparable among studies. This is 
likely a result of differences in clinical practices such as the population of patients, follicular 
priming, timing of immature oocyte retrieval, IVM culture conditions and preparation of the 
endometrium rather than the technique itself (Jurema and Nogueira, 2006). Consequently, the 
worldwide acceptance of IVM technology is variable. In Canada, Sweden, Norway and 
Finland, IVM is regarded as a safe technique and is provided as a clinical service to selected 
patients, while in other countries, like Belgium, IVM is considered experimental and 
performed only in a research protocol (Jurema and Nogueira, 2006).  
1.1.2.2. Rationale to perform IVM
Conventional IVF was originally performed with the single dominant ovarian follicle 
produced during a spontaneous menstrual cycle. This was very inefficient and pregnancy rates 
were dismal. Consequently, the ovaries were ‘hyperstimulated’ using exogenous 
gonadotrophins to induce maturation of multiple follicles. This is obtained by FSH injections 
after pituitary desensitization with GnRH agonists of antagonists. Oocyte maturation is then 
induced by hCG administration before transvaginal oocyte retrieval.
Controlled ovarian hyperstimulation (COH) has been shown to be not entirely safe. It can be 
difficult and inconvenient for the patient. One to three per cent of infertile women develop 
ovarian hyperstimulation syndrome (OHSS), a severe life-threatening complication which 
may cause liver dysfunction and thromboembolism (Rizk and Smitz, 1992; Delvigne and 
16
Rozenberg, 2003). Women with PCO or PCOS are more likely to develop OHSS. This 
complication can be avoided when oocytes are obtained at an immature stage out of small or 
medium-sized follicles.  
There is also growing evidence that the ovary resists to ovarian hyperstimulation by 
decreasing the quality of the oocytes it produces (Stouffer and Zelinski-Wooten, 2004; Sirard 
et al., 2006). This brings back in perspective the importance of moderating the hormonal 
stimulation protocols to optimize the yield of high quality embryos (Baart et al., 2007). On 
the other hand, some studies (both on human and animals) were not able to find a negative 
effect of ovarian hyperstimulation on oocyte and/or embryo quality (Caligara et al., 2001; 
Combelles and Albertini, 2003; Xu et al., 2008; Weghofer et al., 2008). Therefore, it is 
important to determine the underlying defects associated with ovarian hyperstimulation. 
Hence, IVM technology offers a simple protocol with decreased or no hormonal stimulation 
before oocyte retrieval, which will result in a more patient-friendly IVF treatment and, 
consequently, lower cost. Furthermore, any other potential short- or long-term adverse effects 
of supraphysiologic concentrations of gonadotrophins on sex steroid hormone-sensitive tissue 
(i.e. ovaries, endometrium and breasts) are minimized. In this respect, IVM might be suitable 
for different subgroups of infertile patients, both PCO/PCOS as well as normo-ovulatory 
women. IVM treatment is also indicated for cancer patients who wish to preserve their 
fertility, since the high levels of estrogen related to gonadotropin stimulation may be 
detrimental to patients with estrogen-dependent cancers, such as breast cancer. The reduced 
costs make IVM to become in clinical demand in developing countries where more than half 
of the cycle expense is related to gonadotrophins and GnRH analogues (Jurema and Nogueira, 
2006). Finally, IVM is fundamentally important to augment our understanding of oocyte 
maturation processes in the human.  
1.1.2.3. Results of IVM in human ART 
The application of IVM is very successful in certain mammals and in the livestock industry 
(Blondin et al., 2002). However, attempts to adopt this technology in human ART have met 
with mixed success. The most important reason for this is the lower pregnancy rate compared 
to conventional IVF/ICSI. Although the clinical pregnancy rate per embryo transfer is 
reasonable, this is still low per oocyte collection (Suikkari and Söderström-Anttila, 2007). 
However, straight conclusions from clinical studies are sometimes difficult to draw as the data 
often come from observational evaluations with different patient populations, stimulation 
regimes and without adequate control groups.  
Studies from Child et al. (2002) and Cha et al. (2000) directly compared the outcome of IVM 
cycles with conventionally IVF cycles in patients with PCO/PCOS. These studies suggest that 
IVM may be comparable to IVF in efficacy regarding the number of MII oocytes obtained, 
fertilization, cleavage and pregnancy rates. In addition, IVM decreased the risk of OHSS 
compared with IVF. However, implantation rates were found to be lower in the IVM cycles. 
The reason for this could be related either to poorer embryo quality or suboptimal endometrial 
preparation (Mikkelsen and Lindeberg, 2001). Lower embryo quality has resulted in the need 
for more embryos to be transferred. Nevertheless, notwithstanding the fact that multiple 
embryos are often transferred, the multiple pregnancy rate appears to be lower after IVM than 
after conventional IVF/ICSI (Cha and Chian, 1998; Chian et al., 2004; Mikkelsen, 2005). 
Furthermore, cryopreservation of embryos derived from IVM oocytes was found to be less 
efficient compared to standard IVF (Suikkari and Söderström-Anttila, 2007). 
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Results from the limited number of experimental studies examining the development of 
human in vitro matured oocytes have shown that several aspects of nuclear and cytoplasmic 
maturation are abnormal in these oocytes (Combelles et al., 2002, Nogueira et al. 2000).  An 
overabundance of transcripts was recently identified in IVM oocytes, which demonstrates a 
dysregulation in gene transcription or post-transcriptional modification of genes (Jones et al.,
2008).
These observations indicate that current maturation systems do not adequately support nuclear 
and/or cytoplasmic maturation, which subsequently affect embryo development. It should be 
mentioned that, due to the lack of research material, the immature oocytes in many of these 
studies came from COH cycles for conventional IVF/ICSI treatment. These oocytes are 
aspirated out of follicles that did not respond to the hCG stimulus and are considered as a 
side-product in ART cycles. Hence, maturing this type of oocytes in vitro is called ‘rescue 
IVM’. The results of these studies needs to be interpreted with caution and should not be 
compared to immature oocytes derived from unstimulated or slightly stimulated cycles. 
It is clear that many variables strongly influence the quality of in vitro matured oocytes (i.e. 
etiology of infertility, follicular priming, follicle size, type of oocytes, method of 
insemination), but a crucial point in the optimization of IVM is the development of new 
strategies for culturing immature oocytes, which is the topic of the present thesis. 
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1.2. Concepts and technologies to improve IVM outcome 
Progress to improve the efficiency of IVM technology has been slow over the past decade. A 
critical challenge is to understand what constitutes oocyte developmental competence and the 
mechanisms governing it. These insights are slowly translated into progressive adaptations of 
standard culture techniques for IVM. The approaches used in the present thesis serve mainly 
three goals: one is to prevent spontaneous maturation by establishing a 2-step culture; the 
other is to preserve functional cellular interactions within the cumulus-oocyte-complex (COC) 
by three-dimensional cultures; the last one is trying to re-establish the natural in situ
environment of the COC by co-culturing cumulus-denuded oocytes with dissociated cumulus 
cells. Each concept is outlined hereafter. 
1.2.1. Two-step cultures
1.2.1.1. Definition and rationale of 2-step cultures 
“The history of the follicle determines the future of its oocyte”
(Hyttel et al., 1997) 
IVM differs from in vivo oocyte maturation in three fundamentally important ways. Firstly, 
COCs are generally collected from small or mid-sized antral follicles (i.e. 6-12 mm diameter 
in humans) that have not completed their final maturation or ‘oocyte capacitation’ and hence 
do not possess the cytoplasmic machinery required to support early embryogenesis. Secondly, 
removing mechanically the COC from the follicle results in loss of the natural meiotic 
inhibiting environment, leading to spontaneous or ‘premature’ meiotic maturation in vitro. In 
this way, nuclear maturation occurs before the cytoplasm has reached full maturity. Thirdly, 
the population of small antral follicles, from which COCs for IVM are collected, is very 
heterogeneous regarding stages of development and atresia. Such varying degrees of maturity 
make it difficult to support IVM of all COCs by using one single culture method and/or 
medium, which may lead to variations in embryo quality. 
Hence, it should be expected that embryos and fetuses generated from IVM have impaired 
developmental potential compared to those generated from in vivo matured oocytes, and 
indeed this is the case. 
A possible strategy to circumvent the above evils and, consequently, to improve IVM 
outcome is to keep oocytes meiotically arrested in vitro for a certain period of time. This may 
promote cytoplasmic maturation by allowing time for the oocyte to undergo structural and 
biochemical changes which normally occur in the preovulatory follicle (Lonergan et al.,
1997). Some examples are the continued transcription of mRNA, post-translational 
modifications of proteins, relocations and modifications of organelles (Hyttel et al., 1997; 
Dieleman et al., 2002; Hendriksen et al., 2000).
In this way, a two-step in vitro culture system is created. In the first step, called the 
‘prematuration culture (PMC)’, oocytes are temporarily exposed to a meiosis-inhibiting 
compound. After the PMC period, the inhibitor is removed and the oocytes are transferred to 
the classical IVM medium to resume nuclear maturation. The philosophy behind this concept 
is to permit i) synchronization between cytoplasmic and nuclear maturity within each 
individual oocyte and ii) synchronization within the mixed population of immature oocytes 
retrieved out of small antral follicles. 
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1.2.1.2. Approaches to inhibit spontaneous oocyte maturation
The mechanisms governing mammalian oocyte meiotic arrest and resumption have been 
studied in great detail and there are a wide variety of approaches to artificially induce nuclear 
arrest in vitro (Fig 4).  
One way is to expose the oocyte to kinase inhibitors (e.g. roscovitine, butyrolactone I, 6-
DMAP) which prevent MPF and/or MAPK activity. Studies in different species showed that 
these inhibitors either adversely affects (Adona and Lima Verde Leal, 2004; Lonergan et al.,
1997; Avery et al., 1998; Anderiesz et al., 2000) or has no positive effect (Adona and Lima 
Verde Leal, 2004; Lonergan et al., 2000; Grupen et al.; 2006) on subsequent oocyte 
developmental potential, although there is one report of an actual improvement in oocyte 
quality (Hashimoto et al., 2002).
Another class of inhibitors are the protein synthesis inhibitors (e.g. Cycloheximide, 
puromycin), which act on proteins that needs to be synthesized in order to activate MPF 
(Motlik et al., 1990; Tatemoto and Terada, 1995). 
A negative aspect of the above mentioned inhibitors is that they are not specific to a singular 
cell type. They can act on the functionality of surrounding cumulus cells, influencing 
mechanisms related to cumulus cell expansion (Lonergan et al., 2003, Vigneron et al., 2003). 
Also, they might interfere with different kinase activities that modify the function of proteins 
related to embryogenesis. Hence, using these inhibitors as PMC additives to promote oocyte 
developmental potential is probably not realistic. 
In contrast, agents that modulate the intra-oocyte concentration of the second messenger 
cAMP show greater potential. It is widely accepted that the cAMP level within the oocyte 
plays a crucial role in the regulation of oocyte maturation. Cyclic AMP levels can be 
increased by exposing the oocyte to: (i) cAMP analogues such as dibutyryl cAMP, (ii) 
activators of adenylate cyclase, such as FSH, forskolin or invasive adenylate cyclase and (iii) 
phosphodiesterase inhibitors (PDE-Is) (Fig 4).  
The use of PDE-Is to control cAMP levels has attracted special attention in the field of 
reproduction in the last decade and is discussed in the next chapter. 
cAMP  
MPF
MAPK
GVBD
Pre-MPF
6-DMAP
Roscovitine
ButyrolactoneI
6-DMAP
Hx
IBMX
Cilostamide
Org9935
Cycloheximide
Puromycin
Protein synthesis
inhibitors
Kinase
inhibitors
PDE
inhibitors
Figure 4: Pharmacological compounds blocking oocyte nuclear maturation in vitro
(Modified from Nogueira, 2005).
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1.2.1.3. Phosphodiesterase inhibitors 
Phosphodiesterases (PDEs) are enzymes that are responsible for the hydrolysis of cAMP 
and/or cGMP. They have a similar structural layout, composed of a conserved catalytic 
domain and a distinct regulatory domain. They are classified into 11 distinct families on the 
basis of their kinetic characteristics, substrate specificity and regulation (Manganiello et al.,
1995; Conti and Jin, 1999). Two of the PDE families, the PDE3 and PDE4, are strongly 
associated with intra-follicular cAMP hydrolysis. The PDE3 family shows high affinity for 
cAMP as a substrate and is inhibited by the presence of cGMP and has at least two different 
gene products: PDE3A and PDE3B. The PDE4 family shows high affinity for cAMP as a 
substrate, but is not inhibited by cGMP. This family has at least four different gene products. 
PDE3 and PDE4 are differentially localized within the follicular somatic and germ cells 
compartments. PDE4D is present in cumulus and mural granulosa cells, PDE4B is localized 
in theca cells and interstitial tissue and PDE3A is expressed in oocytes of several species 
(Richard et al., 2001; Shitsukawa et al., 2001; Conti et al., 2002; Thomas et al., 2002; 
Nogueira et al., 2003a; Sasseville et al., 2006) (Fig 5). However, a recent report has 
established the functional presence of a PDE3A in porcine cumulus cells as well (Sasseville et
al., 2007). 
While non-specific PDE inhibitors (PDE-Is; e.g. 3-isobutyl-1-methylxanthine (IBMX), 
hypoxanthine) inhibit many isoenzymes, specific PDE-Is or ‘second-generation PDE-Is’ 
will exert their action on only a specific type of PDE. Consequently, specific PDE-Is can be 
applied to differentially regulate cAMP levels in the oocyte and the cumulus cells. While 
PDE3 inhibitors (PDE3-Is; e.g. milrinone, cilostamide, Org9935) effectively inhibit oocyte 
maturation, PDE4 inhibitors (PDE4-Is; e.g. rolipram) cause oocyte maturation in follicle 
culture in the absence of gonadotrophin stimulation (Tsafriri et al., 1996; Thomas et al.,
2002). Because PDE3-Is do not affect PDE4 in the granulosa cells, steroidogenesis and 
functionality of surrounding cumulus cells appears not to be affected (Nogueira et al., 2005). 
In addition, the availability and use of target-specific PDE-Is provide a new opportunity for 
more extensive examination of oocyte maturation mechanisms and represent new and 
powerful experimental tools for investigating oocyte-follicular cell interactions during oocyte 
maturation (Thomas et al., 2002).
The importance of PDE3 in the regulation of oocyte meiosis has been studied in several 
species, such as Xenopus (Sadler, 1991), rodent (Tsafriri et al., 1996; Richard et al., 2001, 
Wiersma et al., 1998), bovine (Mayes and Sirard, 2002; Thomas et al.; 2002), monkey 
(Jensen et al., 2002) and human (Nogueira et al., 2003a). Treating oocytes in vitro with 
PDE3-I reversibly prevents meiotic resumption of mouse (Tsafriri et al., 1996; Nogueira et
al., 2003b) and human oocytes (Nogueira et al., 2003a, 2006), but exerts only a transitory 
inhibitory effect on meiotic resumption in bovine oocytes (Thomas et al., 2002, 2004).
Adding PDE3-Is to PMC media often improves or has no detrimental effect on subsequent 
oocyte developmental potential (summarized in Table I). In addition, meiotic arrest in vitro
with PDE3-I allows oocytes the time to transit from a dispersed to compacted chromatin 
configuration and from a non-surrounded to a surrounded nucleoli (Nogueira et al., 2003a, b). 
These changes indicate transition from a transcriptionally active state to an inactive state, 
which characteristically occurs during the final phase of acquisition of developmental 
competence in vivo, just prior to the preovulatory LH surge (Hyttel et al., 1997; Combelles et
al., 2002; Miyara et al., 2003; De La Fuente, 2006).
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As such, these observations suggest that applying a period of PMC in the presence of an 
oocyte-specific PDE3-I is likely to improve synchronization between nuclear and cytoplasmic 
maturation. Hence, our laboratory has taken the approach to set-up a 2-step culture with 
PDE3-I in order to improve the IVM-outcome of human and mouse oocytes.
Figure 5: Intrafollicular localization of PDEs and respective selective inhibitors of PDE isoforms 
schematically represented in an antral follicle (GC: granulosa cells; Modified from Nogueira, 2005).
Table I: Effect of specific PDE3-Is during PMC on subsequent embryo development 
Inhibiting  Species Effect on embryo Reference 
agent    development 
Milrinone Bovine Improved  Thomas et al., 2004 
Org9935 Murine Improved  Nogueira et al., 2003b 
Milrinone Porcine Unchanged  Grupen et al., 2006 
Org9935 Human Improved  Nogueira et al., 2006 
Cilostamide Human Unchanged  Shu et al., 2008 
PDE3-I: 
milrinone 
cilostamide  
Org9935 
Mural GC
PDE 4D 
PDE 4D
PDE 3A
PDE4-I: 
rolipram
Cumulus GC 
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1.2.2. Three-dimensional cultures
“There’s a big difference between a flat layer of cells and a complex, three-dimensional 
tissue. But until recently, many biologists have glossed over this fact”
(Abbott, 2003) 
For biotechnological research in vitro in general and tissue engineering specifically, it is 
essential to mimic the natural condition of the cellular environment as much as possible. Most 
tissues in the body consist of more than one cell type. The three-dimensional (3D) 
organization of these cells and there interactions are vital for the tissue’s normal development, 
homeostasis and repair (Hendriks et al., 2007).
When translating the above paragraph to IVM technology, the ‘tissue’ target for culture is the 
highly specialized cumulus-oocyte complex (COC) - also called the cumulus-enclosed oocyte 
(CEO) - present within the antral follicle. The cumulus cells nurture the oocyte throughout its 
development and maturation, while the oocyte plays an active role in the regulation of ovarian 
somatic cell function (Eppig, 1991; Gilchrist and Thompson, 2007). Hence, maintenance of 
the cellular interactions and the 3D morphology of the COC throughout the period of PMC 
and IVM might be crucial to obtain satisfactory results.  
1.2.2.1. Function of cell communication within the cumulus-oocyte complex 
The association between the germ cell and somatic granulosa or cumulus cells persists 
throughout growth, differentiation, maturation and fertilization of the oocyte. While the 
detailed steps involved in the signalling between these two cell types remain unknown, 
studies from mice bearing targeted deletions in essential ‘communication’ genes reveal 
selective disturbances in oocyte maturation competencies that compromise the oocytes’ 
developmental potential (Carabatsos et al., 1998, 2000).
Cumulus cells have an important function (1) in keeping the oocytes under meiotic arrest, (2) 
in participating in the induction of meiotic resumption and (3) in supporting cytoplasmic 
maturation (Tanghe et al., 2002). While the above sections have documented the role of 
cumulus-oocyte interactions in the regulation of nuclear maturation, the next paragraph will 
focus on the support of cumulus cells during oocyte cytoplasmic maturation.  
From a metabolic perspective, cumulus cells fulfill a role as ‘nurse cells’ through the final 
phases of oocyte development, by providing the oocyte with essential substances (Moor et al.,
1998). They reduce cystine to cysteine and promote the uptake of cysteine in oocytes 
(Takahashi et al., 1993; de Matos et al., 1997). This increases the content of intracellular 
glutathione (GSH), which participates in sperm decondensation and formation of the male 
pronucleus. GSH also plays an important role in protecting the oocyte against oxidative 
injury. Another substrate which is not readily metabolized by the oocyte itself is glucose. 
Cumulus cells metabolize glucose to pyruvate or Krebs cycle intermediates that can pass to 
the oocyte and are oxidatively metabolized for ATP generation in the oocytes’ mitochondria 
(Downs et al., 2002; Tanghe et al., 2002). The efficiency by which oocytes undergo 
metabolic activities of these kinds is clearly compromised in the absence of the cumulus (Liu 
et al., 1997). Maintenance of cumulus contacts throughout the period of maturation is critical 
for the support of oocyte metabolism, not only prior to and following fertilization, but also 
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during pre-implantation development. Any procedure that precociously disrupts this 
metabolic cooperation will compromise oocyte function, even though the consequences of 
such impairments may not be revealed until later stages of embryonic development (Wang et
al., 2008).
Cumulus cells fulfill a protective role as well, since they lower oxygen tension in the 
immediate vicinity of the oocyte. Furthermore, cumulus cells participate in the global 
suppression of transcription in oocytes that occurs before nuclear maturation (De La Fuente 
and Eppig, 2001). In addition, cumulus cells secrete a wide variety of growth factors that 
may either amplify or attenuate gonadotrophin actions within the COC. 
In addition to granulosa cell-to-oocyte communication, it has recently become apparent that 
the oocyte itself plays a key role in directing its own fate through the synthesis and secretion 
of oocyte-secreted factors (OSFs) which act on granulosa cells to modify their proliferation, 
function, differentiation, apoptosis and expansion (Eppig, 2001; Gilchrist et al., 2004, 2008; 
Hussein et al., 2005). The studies of Nalbandov and colleagues were pioneering in this field, 
observing a precocious luteinization of granulosa cells from antral follicles cultured in the 
absence of oocytes (Nekola and Nalbandov, 1971). Nowadays, it is becoming clear that this 
communication axis is mainly regulated by fully grown meiotically competent immature 
oocytes (i.e. oocytes from antral follicles) (Gilchrist et al., 2004). The exact identities of these 
OSFs are unknown, but growth-differentiation factor 9 (GDF-9) and bone-morphogenetic 
protein 15 (BMP-15) are two important examples (Hussein et al., 2005). Recently published 
studies demonstrated that the addition of these native OSFs during IVM culture can 
significantly enhance oocyte developmental competence (Hussein et al. 2006; Yeo et al.,
2008).
The bi-directional communication axis within the COC is summarized in Fig 6.  
Growth 
Metabolism
Meiotic arrest 
Transcription 
Maturation 
Differentiation 
Follicle formation 
Proliferation
Steroidogenesis Cumulus expansion 
Ovulation 
Figure 6: Bi-directional 
communication between 
oocytes and companion 
somatic cells showing the 
influence of granulosa cells 
on oocyte development and 
the processes in granulosa 
cells controlled by oocytes 
(Eppig, 2001). 
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1.2.2.2. Structural basis of oocyte-cumulus cell interactions
In addition to the local production of soluble factors that act in a paracrine fashion, oocytes 
and granulosa cells communicate via direct physical contacts (Fig 7).
Cell junctions of at least two varieties dominate: 
- Gap junctions composed of connexin subunits (Cx) that assemble to form channels 
between the cytoplasm of granulosa and oocytes, which facilitate the transport of 
nutrients and small molecules from cell to cell (Simon and Goodenough, 1998). This 
includes ions, metabolites and amino acids that are necessary for oocyte growth, as 
well as small regulatory molecules that control oocyte development (Gilchrist et al.,
2004).
While homologous gap junctions are found joining adjacent granulosa cells 
(containing predominantly Cx43), heterologous gap junctions are found between the 
oocyte and the granulosa cells. Deletion of the gene for the oocyte-specific gap 
junctional subunit, Cx37, interferes with antral follicle development and causes female 
sterility (Simon et al., 1997; Carabatsos et al., 2000), which emphasizes the 
importance of this interaction.  
- Adhesion junctions exploit the cytoskeleton between apposed granulosa cells and 
oocytes using specialized integral membrane proteins to anchor cells and maintain 
stable and prolonged contact zones between these two cell types. They also connect 
granulosa cells to the oocytes’ ‘personal’ extra-cellular matrix (ECM), the zona 
pellucida.
It has been proposed that these contact sites may serve as active signalling domains for 
the interaction of certain oocyte- (e.g. GDF-9, BMP-15) and granulosa cell- (Kit 
Ligand) derived paracrine growth factors with their appropriate receptor kinases 
(Fagotto and Gumbiner, 1996). However, the exact cellular mechanisms that facilitate 
bi-directional exchange of paracrine signals are unclear (Albertini et al., 2001).
Figure 7:
Oocyte-granulosa cell 
communication.
Communication occurs via 
paracrine signaling (curved 
arrows) and gap-junctional 
exchange of small molecules 
(straight arrow). This is a bi-
directional axis (Gilchrist et
al., 2004). 
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An intriguing feature in the establishment of cell junctions is that the oocyte and cumulus 
cells are physically separated by a considerable distance because of the zona pellucida 
surrounding the oocyte. To overcome this distance and to assemble oocyte-granulosa cell 
(junctional) and/or zona-granulosa cell adhesion, specialized cytoplasmic extensions are 
derived from granulosa cells that breach the zona pellucida and establish contact with the 
oolemma. In bovine COCs, these structures are often referred to as cumulus cell process 
endings (CCPEs) (de Loos et al., 1989; 1991; Hyttel et al., 1997). More generally, they are 
called transzonal projections (TZPs) (Anderson and Albertini, 1976) (Fig 8).
As in the case of neuritic extensions, TZPs have a core of cytoskeletal elements that includes 
microtubules, microfilaments and intermediate filaments (Combelles et al., 2002; Suzuki et
al., 2000). Microtubules within TZPs form tracks for the bi-directional movement of 
organelles like mitochondria, lysosomes or endosomes (Albertini et al., 2001). The abundance 
of mitochondria indicates that the generation of ATP within these structures may be important 
for organelle transport, maintenance of cytoskeleton structural integrity and the provision of 
energy stores required by the oocyte during the metabolically demanding process of oocyte 
maturation. 
An important deficiency in our current knowledge is how TZPs regulate paracrine and gap-
junctional signaling within the COC. A model considering different pathways is schematically 
represented in Fig 8. 
Figure 8: Model proposing different pathways (1-4) of how TZPs regulate paracrine and 
gap-junctional signaling within the COC. (1) Localized uptake of oocyte factors (x), like GDF-
9, by endocytosis at stabilized attachment sites of TZPs at the oolemma; vectorial transport of 
endocytic vesicles (EV) to granulosa cell body occurs along microtubules (MT) in preparation for 
intracellular processing and release of factors after transcytosis. (2) Granulosa- ZP anchoring required 
for TZP orientation. Contact sites may play a signalling role for oocytes and granulosa cells. (3) gap-
junctions that allow direct intercellular communication between oocyte microvilli and granulosa cell 
TZPs. (4) Pathway for delivery of granulosa-derived factors packaged in secretory vesicles (SV) that 
are subsequently endocytosed by receptor-mediated endocytosis at the oocyte surface through coated 
pits (CP). FSH modifies oocyte-cumulus interactions by reducing TZP density (Albertini et al., 2001).
Studies in humans have demonstrated that there is a dynamic alteration in the number and 
form of TZPs at specific stages of follicle development (Motta et al., 1994). In preantral 
follicles TZPs are most numerous forming both adhesive and gap junctional contacts. During 
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peak periods of oocyte growth, TZPs extend as deep invaginations that impinge upon the GV. 
Albertini et al. (2001) demonstrated that after further antral follicle development, TZPs retract 
and maintain fewer terminal connections with the oocyte than in preantral follicles. During 
ovulation, active retraction of TZPs is noted. Typically, all TZPs present in the zona pellucida 
of human oocytes retrieved for IVF showed acetylated microtubules (Albertini et al., 2001), 
indicating that this mechanism for maintaining microtubule stability may persist through the 
latest stages of the follicle development in order to maintain oocyte-granulosa cell 
connections during cumulus expansion. 
1.2.2.3. Use of an extra-cellular matrix to preserve 3D-structures in vitro
The difference between in vitro versus in vivo matured oocytes may originate from the extent 
of the communication between somatic cells and the germ cell. There is a growing sense that 
upon removal of the COC from the follicle, a rapid and irreversible modification in oocyte-
cumulus cell interactions occurs, which affects developmental competence of oocytes, even in 
the presence of the cumulus (Gilchrist et al., 2004). Moreover, during the process of PMC in a 
2-step culture, loss of association between the oocyte and cumulus cells was observed 
(Nogueira et al., 2003a and b, 2006). The COCs attach to the two-dimensional (2D) culture 
surface of the petri-dish and the somatic cells spread out and migrate away from the oocyte 
(Fig 9). In other cases, the cumulus cells loosen completely from the oocyte in form of 
clumps. This spreading or loosening alters the 3D structure of the COC, thereby disrupting the 
cell-cell interactions. Findings from Webb et al. (2002) demonstrate that an intact COC is 
required for normal gap-junctional communication between the oocyte and the cumulus cells. 
In addition, disturbed cell-cell orientation may result in the diffusion of paracrine signals 
away from their target cell-surface receptors.  
         
Figure 9: COCs cultured in a 2D-environment (liquid) adhere and flatten readily. Those cultured in a 
3D environment maintain their in vivo-like architecture. 
One way to preserve 3D structures in vitro and, consequently, to mimic more faithfully the in
vivo environment is to embed tissues within an extra-cellular matrix (ECM) (Abbott, 2003). 
Indeed, in comparison to a 2D environment, a 3D environment results in cell behaviour, 
signalling and gene expression profiles most resembling those observed in living tissues 
(Cukierman et al., 2002).
The ECM is the authentic substrate for most cells in living organisms, which is complex and 
dynamic in molecular composition. In ovarian cells, ECM influences a multitude of cell 
functions, such as cell morphology, aggregation and communication, proliferation, survival 
and steroidogenesis (Berkholtz et al., 2006). The structure of the ECM provides mechanical 
support to the tissue, whereas the biochemical composition can interact directly with cells 
through specific receptors or can bind growth factors that are released upon matrix 
2D 3D
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degradation. In addition, the ECM acts as a barrier that restricts cellular access, thereby 
defining specific cellular compartments and specialization necessary for proper function 
(Rodgers et al., 2003).
The ECM is sensed by cells via integrins, which are membrane-spanning heterodimeric 
receptors that mediate cell-matrix communication. Upon binding, integrins initiate signalling 
cascades involved in cell migration, endocytosis and proliferation (Sheppard D, 2000).
The ECM is composed of a variety of molecules, which include collagens, laminin, 
fibronectin, proteoglycans and polysaccharides. Fibronectin, laminin and certain collagens 
have been localized in the ovaries of many species and their effects on follicle development 
have been examined (Huet et al., 1997; Rodgers et al., 2003). Ovarian follicles contain 
distinct ECMs: the ZP, the antrum, basal lamina and the thecal matrix. The composition of 
these matrix components changes markedly throughout follicle development. During the 
process of ovulation, a new hyaluronan-rich matrix forms within the COC.  
In the field of reproduction, the use of an ECM to preserve 3D morphology in vitro has been 
tested extensively on preantral follicles of different mammalian species, mainly of the mouse 
(Torrance et al., 1989; Carroll et al., 1991; Gomes et al., 1999; Pangas et al., 2003; Kreeger et
al., 2006; Xu et al., 2006). While flat/adhesive cultures led to distortion of follicular 
architecture and frequent follicle disruption, 3D-ECM cultures were able to support normal in
vivo-like follicular morphology, differentiation and growth. The ECM-embedding method has 
also been shown to preserve the integrity of bovine and canine COCs isolated from antral 
follicles (Yamamoto et al., 1999; Alm et al., 2006; Otoi et al., 2006). At the level of 
granulosa cells, many studies showed that cells behave and function in distinct ways when 
cultured in the presence or absence of ECM and in 3D versus 2D dimensions (Ben-Rafael et
al., 1988; Amsterdam et al., 1989; Bussenot et al., 1993).
The composition of the ECM is an essential variable which influences cell behaviour in vitro.
For the 3D in vitro culture of follicles, most researchers used simple gels consisting of 
collagen Type I (Torrance et al., 1989; Carroll et al., 1991; Gomes et al., 1999; Yamamoto et
al., 1999; Alm et al., 2006; Otoi et al., 2006). Others used the commercially available 
Matrigel, which consists of structural proteins such as laminin and collagen, plus growth 
factors and enzymes, all taken from mouse tumours. This approach was tested on human 
follicles (Hovatta et al., 1997). Another option is the use of alginate-based matrices (Pangas 
et al., 2003; Kreeger et al., 2006). Alginate exhibits minimal cellular interactions with 
mammalian cells, and thus likely provides only mechanical support. This synthetic matrix 
can, however, also be modified with intact ECM molecules, as has been tested on mouse 
preantral follicles (West et al., 2007).
Our laboratory has taken the approach to use collagen-gel (Type I) as a 3D matrix for the 
encapsulation of COCs during the first step (i.e. the PMC) of a 2-step culture. This so-called 
‘3D-PMC’ system was tested on mouse and human COCs derived from small antral follicles. 
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1.2.3. Co-cultures
The somatic cells of the follicle, particularly the cumulus cells, play a key role in the 
acquisition of oocyte developmental competence. However, the majority of experimental 
studies on human IVM have utilized immature oocytes denuded of surrounding cumulus cells 
that were obtained after COH for IVF/ICSI treatment. Enzymatic and physical dissociation of 
the cumulus at oocyte retrieval is required to assess oocyte maturity and to perform ICSI. 
Human oocytes with scanty or no cumulus cells show lower maturation rates after IVM than 
oocytes surrounded by an intact cumulus oophorus (Kennedy and Donahue, 1969; Schroeder 
and Eppig, 1984; Ruppert-Lingham et al., 2003; Nogueira et al., 2006). Moreover, cumulus-
free oocytes exhibit accelerated meiotic resumption in vitro, a deficiency in the ability of the 
cytoplasm to maintain M-phase characteristics, a propensity to activate spontaneously after 
M-phase arrest and a lack of coordination between nuclear and cytoplasmic maturation 
(Combelles et al., 2002). Therefore, it is essential to consider ways of restoring the structural 
complexity of COCs in the design and implementation of human ‘rescue’ IVM.
Co-cultures of human denuded oocytes with dissociated cumulus cells, either in suspension or 
monolayer, have been established in an effort to restore support from the surrounding 
cumulus cells to the oocyte and/or to probe interactions between the two cell compartments 
(Häberle et al., 1999; Johnson et al., 2007; Zhu et al., 2007). This approach offers several 
theoretical advantages. Cumulus cells produce pyruvate, glutathione, steroid hormones and 
several growth factors, which may be delivered to the oocyte (Parikh et al., 2006). It is also 
believed that cumulus cells remove toxins from the culture medium. Finally, cumulus cells 
could participate in the preservation of premature cortical granule exocytosis leading to zona 
hardening (Ge et al., 2008). Most of these studies were, however, unable to show a significant 
improvement in IVM outcome.  
An attempt to better mimic the physiological situation of the COC is to create a system that 
permits a tight contact between the dissociated cumulus cells and the oocyte in a three-
dimensional (3D) structure, making use of an extra-cellular matrix (ECM). Until today, only 
two studies on human oocytes investigated this approach (Combelles et al. 2005; Torre et al.
2006).
In the study of Combelles et al. (2005), cumulus cells were embedded into a collagen gel 
matrix with individual immature oocytes added to each gel. The maturation rate of oocytes 
cultured under these co-culture conditions was comparable with the maturation rate of 
denuded oocytes in a conventional culture system (microdroplets under oil; no cumulus cells). 
Nevertheless, co-cultured oocytes exhibited increased activity of MAPK, an important factor 
in the regulation of oocyte maturation. Whether gap junctional communication was restored 
between cumulus cells and oocytes was not determined in this study, but microtubule-rich
processes resembling transzonal projections were observed at the oocyte-cumulus interface. 
In the study of Torre et al. (2006) human oocytes were co-cultured with cumulus cells 
enclosed in the core of a barium alginate capsule, a synthetic ECM product. After 48 h of 
culture, the oocytes appeared to be surrounded by a pseudo-cumulus structure. This culture 
system resulted in a significantly higher maturation rate compared to conventional culture 
techniques in microdroplets.   
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These innovative culture systems afford several advantages, among which are the ability to 
reconstitute direct interactions between isolated cell populations and the use of an ECM-3D 
micro-environment. The positive effect of the ECM on ovarian cell behaviour in vitro has 
been already studied extensively in previous studies. Human mural granulosa cells cultured in 
ECM, such as collagen, maintain a more highly-differentiated morphology, possess an 
increased level of steroidogenic activity (Ben-Rafael et al., 1988; Bussenot et al., 1993), 
produce significantly higher levels of cAMP (Furman et al., 1986) and induce de novo 
formation of gap junctions (Amsterdam et al., 1989).
A superior 2-step ‘rescue IVM’ culture system could be the combination of a 3D co-culture 
system with a period of PMC. In this way, the unhealthy condition of precocious spontaneous 
maturation is circumvented, while the surrounding somatic cells may produce a suitable 
micro-environment to support prematuration events of the cumulus-free oocyte. This 
hypothesis was tested in our research project on human oocytes.  
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2. Aims of the thesis
“It is obvious that while one of the goals of oogenesis is to commence embryogenesis,
an early objective of this phenomenon is the production of a mature egg” 
(Anderson, 1974) 
A crucial point in the optimization of IVM technology is the development of new strategies 
for culturing immature oocytes, which is the aim of the present thesis. 
2.1. Clinical outcome of conventional in vitro maturation (= ‘rescue IVM’) 
To start-up this research project, we analyzed if there exists a clinical benefit for using in vitro
matured metaphase I (MI) oocytes in a selected population of patients with a low number of 
mature oocytes ( 6) available for the infertility treatment (= ‘rescue IVM’) (Article I).  
2.2. Effect of prematuration culture in the presence of a phosphodiesterase 
type 3 inhibitor
In the second study, mouse cumulus-oocyte complexes (COCs) were utilized to set-up a 2-
step culture composed of a prematuration culture (PMC) to block temporarily spontaneous 
nuclear maturation followed by IVM. Oocyte quality was evaluated at the end of IVM 
(Article II). 
In view of the results obtained, we applied a similar 2-step culture on human oocytes. Spare 
cumulus-free GV-stage oocytes retrieved from COH cycles were used as source of human 
experimental material (Article III).   
2.3. Effect of three-dimensional prematuration culture in the presence of a 
phosphodiesterase type 3 inhibitor
A clear drawback in the previous experimental set-up (Article III) was the fact that the human 
GV oocytes were denuded from surrounding cumulus cells before starting the 2-step culture. 
To circumvent this deficiency, the aim of the next study was trying to perform the PMC step 
in a three-dimensional (3D) co-culture system of human GV oocytes with dissociated 
cumulus cells, making use of an extra-cellular matrix (ECM; collagen) (Article IV).  
The final step in our research project was to further optimize the PMC conditions in order to 
preserve intracellular connections within an intact COC. For this purpose, COCs were 
embedded within an ECM, the same collagen matrix as was tested in the previous study 
(Artikel IV). A mouse model was initially used to test this approach. In addition, we evaluated 
this culture system on human COCs derived from small antral follicles donated by patients 
undergoing COH for IVF/ICSI treatment (Article V).
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3. Scientific papers 
3.1. Clinical outcome of conventional in vitro maturation (= ‘rescue IVM’) 
Article I:  Clinical benefit of metaphase I oocytes.
Vanhoutte L, De Sutter P, Van der Elst J, Dhont M  
Reproductive Biology and Endocrinology (2005), 3:71 
33

BioMed Central
Page 1 of 6
(page number not for citation purposes)
Reproductive Biology and 
Endocrinology
Open AccessResearch
Clinical benefit of metaphase I oocytes
Leen Vanhoutte*, Petra De Sutter, Josiane Van der Elst and Marc Dhont
Address: Infertility Centre, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium
Email: Leen Vanhoutte* - leen.vanhoutte@UGent.be; Petra De Sutter - Petra.Desutter@UGent.be; Josiane Van der 
Elst - Josiane.vanderelst@UGent.be; Marc Dhont - Marc.dhont@UGent.be
* Corresponding author    
Abstract
Background: We studied the benefit of using in vitro matured metaphase I (MI) oocytes for ICSI
in patients with a maximum of 6 mature metaphase II (MII) oocytes at retrieval.
Methods: In 2004, 187 ICSI cycles were selected in which maximum 6 MII oocytes and at least
one MI oocyte were retrieved. MI oocytes were put in culture to mature until the moment of ICSI,
which was performed between 2 to 11 hours after oocyte retrieval (day 0). In exceptional cases,
when the patient did not have any mature oocyte at the scheduled time of ICSI, MI oocytes were
left to mature overnight and were injected between 19 to 26 hours after retrieval (day 1). Embryos
from MI oocytes were chosen for transfer only when no other good quality embryos from MII
oocytes were available. Outcome parameters were time period of in vitro maturation (IVM), IVM
and fertilization rates, embryo development, clinical pregnancy rates, implantation rates and total
MI oocyte utilization rate.
Results: The overall IVM rate was 43%. IVM oocytes had lower fertilization rates compared to in
vivo matured sibling oocytes (52% versus 68%, P < 0.05). The proportion of poor quality embryos
was significantly higher in IVM derived oocytes. One pregnancy and live birth was obtained out of
13 transfers of embryos exclusively derived from IVM oocytes. This baby originated from an oocyte
that was injected after 22 hrs of IVM.
Conclusion: Fertilization of in vitro matured MI oocytes can result in normal embryos and
pregnancy, making IVM worthwhile, particularly when few MII oocytes are obtained at retrieval.
Background
A proportion of human oocytes collected during an IVF or
ICSI procedure remains meiotically immature at the ger-
minal vesicle (GV) or metaphase I (MI) stage. Several pub-
lications have shown that this proportion fluctuates
around 15 to 20% [1,2]. It is not exactly known why some
of the oocytes are unresponsive to the maturation trigger
in vivo. Different explanations are possible. When ovarian
hyperstimulation is started, follicles may be at different
stages of development, producing oocytes of varying
degrees of maturity. Since follicles are aspirated prior to
rupture, the collected oocytes come from a heterogeneous
pool of follicles, including luteinizing as well as degener-
ating follicles [3]. It is also possible that smaller antral fol-
licles are aspirated during oocyte retrieval, which can
result in the collection of immature oocytes [4,5]. Eventu-
ally, the proportion of immature oocytes can be depend-
ent on patients' characteristics (such as cause of infertility,
age, ovarian reserve) and the stimulation protocol used.
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Immature oocytes from superovulated cycles can undergo
the final stages of meiotic maturation spontaneously in
vitro. MI oocytes have already undergone the process of
germinal vesicle breakdown (GVBD) and may progress to
the metaphase II (MII) stage within a few hours of in vitro
culture. This allows them to be injected by ICSI at the
same time as their sibling mature MII oocytes. The clinical
use of MI oocytes from stimulated cycles has been studied
by several research groups. It has been reported that these
in vitro matured oocytes yield lower fertilization rates [6-
8], abnormal embryonic development [7-9] and lower
implantation rates [6] than in vivo matured oocytes.
Development to term is limited to rare cases [6,8,9]. As a
consequence, immature oocytes from stimulated cycles
are generally considered to be a side-product and only in
vivo matured MII oocytes are used for ICSI. Nevertheless,
for patients in whom a low number of MII oocytes are
retrieved, the use of in vitro matured MI oocytes may be
worthwhile in order to increase the number of injectable
oocytes at the time of ICSI.
We therefore designed the present study to determine if,
indeed, in vitro matured MI oocytes could have a clinical
application in our IVF-program in a selected population
of patients with a low number of MII oocytes at retrieval.
This was analyzed within the framework of a daily labora-
tory practice, without changing the routine of ovarian
stimulation, oocyte retrieval, ICSI procedure, embryo cul-
ture or transfer.
Methods
Patient selection
The study included all ICSI cycles over a one year period
(2004) in which two inclusion criteria were fulfilled: 1) a
maximum of 6 mature (MII) oocytes and 2) at least one
MI oocyte present at retrieval.
Our ICSI program has been approved as infertility treat-
ment by the Ghent University Hospital Ethical Commit-
tee.
Ovarian stimulation, IVM and oocyte handling for ICSI
All patients underwent controlled ovarian stimulation
after cycle synchronization with a standard contraceptive
pill for 2–6 weeks. A short gonadotrophin-releasing hor-
mone (GnRH) agonist protocol was used, consisting of
0.1 mg of triptorelin (Decapeptyl, Ipsen, France) from day
5 onwards after discontinuation of the oral contraceptive.
This was followed by human menopausal gonadotrophin
(hMG; Menopur, Ferring, Germany) or follicle stimulat-
ing hormone (FSH; either Gonal-F, Serono, Switzerland
or Puregon, Organon, The Netherlands) from day 7 after
discontinuation of the pill onwards. The starting dose was
usually 150 IU, but this dose was adjusted after 7 days of
hMG or FSH administration, according to the individual
response of the patient. Known poor responders were
started on 300 IU of hMG or FSH daily. The follicular
phase was monitored by means of transvaginal ultra-
sound scanning of the ovaries and serum estradiol meas-
urement if judged necessary. An injection of 5,000 or
10,000 IU human chorionic gonadotrophin (hCG; Preg-
nyl, Organon, The Netherlands) was administered when
half of all mature follicles had reached a mean diameter of
at least 20 mm, measured in two planes. Oocyte retrieval
was scheduled 34 to 36 hrs after hCG administration.
Oocytes were denuded enzymatically by a brief exposure
of the cumulus-oocyte complexes to 80 IU/ml hyaluroni-
dase (Type VIII; Sigma Chemical Co., Bornem, Belgium),
followed by mechanical denudation approximately 1 to 2
hrs after oocyte collection. The nuclear status of denuded
oocytes was subsequently recorded. GV oocytes were not
considered for ICSI. MI oocytes were defined as those
oocytes in which no GV and no first polar body were visi-
ble. These oocytes were put in culture to mature. The cul-
Table 1: Comparison of fertilization and embryonic development between in vitro and in vivo matured sibling oocytes
In vitro matured MI oocytes In vivo matured sibling oocytes (control)
Total N° of oocytes injected 129 339
N° (%) of normal fertilized oocytesa 67 (52)* 229 (68)
Embryo development on day 2 (%)b
Excellent 24* 41
Good 27 32
Poor 49* 27
Embryo development on day 3 (%)b
Excellent 22* 38
Good 28 32
Poor 50* 30
* Statistically different between columns (p < 0.05).
a Normal fertilized oocytes were defined as oocytes containing 2 pronuclei en 2 polar bodies.
b The proportions of excellent, good and poor embryos are expressed per total number of embryos obtained on day 2 or day 3.
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ture medium for in vitro maturation (IVM) was either
Sydney IVF Fertilization Medium (Cook, Ltd., Limerick,
Ireland) or Early Cleavage Medium (Irvine Scientific,
Brussels, Belgium).
MI oocytes were left to mature until the time when ICSI
for the particular patient was carried out. This was in a
time-frame of 2 to 11 hrs after oocyte retrieval (day 0). In
exceptional cases, when the patient did not have any
mature oocyte at the scheduled time of ICSI, MI oocytes
were left to mature overnight and, when matured, were
injected between 19 to 26 hrs after oocyte retrieval (day
1).
In vivo and/or in vitro matured oocytes were injected with
patient's sperm. Sperm preparation for ICSI and details
for the microinjection procedure have been described
elsewhere [10]. After injection, oocytes were cultured in
either Sydney IVF Cleavage Medium (Cook) or Early
Cleavage Medium.
Embryo evaluation and transfer
Assessment of fertilization took place between 16 to 20
hrs after ICSI. Embryos were evaluated based on the
number of blastomeres and the degree of fragmentation.
Embryos with less than 10% anucleated fragments were
classified as 'excellent'. Embryos with either 10–20% or
>20% anucleated fragments were classified as 'good' and
'poor' quality embryos, respectively. Embryos with at least
one blastomere with more than one nucleus were classi-
fied as multinucleated embryos and were considered as
'poor' quality embryos as well, regardless of the degree of
fragmentation.
Transfer of embryos was carried out on day 2 or day 3.
Embryos from in vitro matured MI oocytes were chosen
for transfer only when no other good quality embryos
from MII oocytes were available. The number of embryos
transferred was limited by Belgian law based on female
age, cycle number and embryo quality [11].
Pregnancy was diagnosed by the detection of a positive
serum hCG at least 14 days after embryo transfer, fol-
lowed by a rise in hCG levels. All patients received a trans-
vaginal ultrasound scan between 6 and 7 weeks of
pregnancy to differentiate between biochemical and clin-
ical (presence of an intra-uterine gestational sac with fetal
heart beat) pregnancies and to diagnose ectopic implanta-
tions. All pregnancies were monitored further by transvag-
inal ultrasound until 12 weeks of amenorrhoea.
Statistical analysis
For comparison among groups, results were analyzed with
Chi-square and Fisher's exact test when appropriate.
When the P value was <0.05, the difference was consid-
ered significant.
Results
Patient and cycle characteristics
In the year 2004, 180 patients underwent 187 ICSI cycles
in which maximum 6 MII oocytes and at least one MI
oocyte were retrieved. This is 12.7% of the total number
of ICSI cycles performed in our infertility center during
the same year. The mean age of the patients was 35.9 ±
4.67 years (range 25–48).
A total of 1208 oocytes were collected. Three hundred of
these oocytes were at the MI stage at the moment of oocyte
denudation (24.8%; mean of 1.6 MI oocytes/cycle; range
1–6). Hundred thirty-two oocytes were at the GV stage
(10.9%) and 80 oocytes (6.6%) were degenerated or dam-
aged at the moment of denudation.
Comparison between in vitro matured MI oocytes and in 
vivo matured oocytes
Overall, 43% (129/300) of MI oocytes matured to the MII
stage. Maturation and injection of at least one MI oocyte
was achieved in approximately half of the ICSI cycles
(55%; n = 102). In vivo matured sibling MII oocytes,
retrieved in the same treatment cycles, were injected in
parallel and served as the control group. ICSI was per-
formed with fresh ejaculate in 81.4% of the cycles and
with frozen ejaculate in 9.8% of the cycles. Frozen epidi-
Table 2: Comparison of maturation rates, fertilization rates and embryo development between different time periods of IVM
Time interval of 
IVM
N° of MI oocytes N° (%) of in vitro 
matured oocytes
N° (%) of fertilized 
oocytes
N° (%) of excellent 
+ good quality 
embryos on Day 2 
(c)
N° (%) of excellent 
+ good quality 
embryos on Day 3
2 to 4 hrs 147 60 (41) 26 (43)a 15 (58) 14 (61)
>4 to 7 hrs 136 57 (42) 31 (54)a 15 (48) 9 (38)
>7 to 11 hrs 9 6 (67) 6 (100)b 3 (50) 2 (40)
19 to 26 hrs 8 6 (75) 4 (67)ab 1 (25) 2 (100)
a,b Different letters indicate significant differences within columns (p < 0.05).
c Thirteen embryos were transferred on day 2.
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dymal or testicular spermatozoa were used in respectively
1.0% and 7.8% of the cycles.
The results of fertilization and embryo development in
the two groups of oocytes (IVM + control) are presented
in Table 1. The fertilization rate of matured MI oocytes
was significantly lower compared to the fertilization rate
of in vivo matured oocytes (52% versus 68%, P < 0.05).
Also the embryo quality was different between the two
groups. In the in vitro matured group, significantly less
embryos of excellent quality and more embryos of poor
quality were obtained compared to the in vivo matured
group. This was observed on day 2 (p < 0.05) as well as on
day 3 (p < 0.05).
Comparison between different time periods of IVM
A second evaluation of the results was done by splitting
up the period of IVM, between collection of the oocytes
and the time of ICSI, in different time intervals (Table 2).
A number of 147 oocytes, coming from 100 ICSI cycles,
were evaluated for maturity within 2–4 hrs of IVM culture,
136 oocytes (77 ICSI cycles) within >4–7 hrs of culture, 9
oocytes (5 ICSI cycles) within >7–11 hrs of culture, and 8
oocytes (5 ICSI cycles) were left to mature overnight and
were evaluated the day after retrieval, between 19–26 hrs
of culture. A time-dependent increase in the progression
to maturation was noted, ranging from 41% mature
oocytes after 2–4 hrs of IVM to 75% after 19–26 hrs of
IVM, but this trend was not statistically different. The fer-
tilization rate in the group of >7–11 hrs of IVM (100%)
was significantly higher compared to 2–4 hrs of IVM
(43%) and >4–7 hrs of IVM (54%) (p < 0.05), but not to
19–26 hrs of IVM (67%). There was no difference between
the number of excellent and good quality embryos in the
different IVM time interval groups.
Embryo transfer, clinical pregnancy and implantation 
rates
The most important parameter to evaluate whether the
use of in vitro matured MI oocytes has a clinical benefit is
the pregnancy outcome. Table 3 represents the results of
embryo transfer, clinical pregnancy and implantation
rates. A distinction was made between cycles in which at
least one MI oocyte was matured in vitro (n = 102) and
ICSI cycles with no matured MI oocytes (n = 85). The
group of cycles with matured MI oocytes was further split-
up in 3 groups: 1) transfers involving exclusively embryos
derived from in vitro matured MI oocytes, 2) mixed trans-
fers and 3) transfers involving exclusively embryos
derived from in vivo matured MII oocytes. A double
embryo transfer involving embryos exclusively derived
from MI oocytes resulted in a singleton pregnancy and the
birth of a healthy baby girl. This baby originated from an
oocyte that was injected after 22 hrs of IVM. There was no
statistical difference between clinical pregnancy rates and
embryo implantation rates in the three groups. However,
when the numbers of exclusively MI and mixed transfers
were pooled and compared to exclusively MII transfers,
the clinical pregnancy rates (8.8% versus 27.0%) and
embryo implantation rates (5.6% versus 15.1%) were sig-
nificantly lower in the former group (p < 0.05).
Total MI oocyte utilization rate
Forty-two embryos derived from normally fertilized in
vitro matured oocytes were used for transfer and 9
embryos were cryopreserved. This means that 51 out of 67
embryos originating from MI oocytes were used. The total
Table 3: Clinical pregnancy and implantation rates in cycles with maximum 6 MII oocytes
cycles with at least one MI oocyte matured (n = 102) cycles with no MI 
oocyte matured
(n = 85)
Total (n = 187)a
Exclusively 
embryos derived 
from MI oocytes
Mixed transfers Exclusively 
embryos derived 
from sibling MII 
oocytes
N° of transfers 13 21 63 81 178
N° of embryos 
transferred
17 54 119 141 331
N° (%) of clinical 
pregnancies per 
embryo transfer
1 (7.7) 2 (9.5) 17 (27.0) 15 (18.5) 35 (19.7)
N° (%) of implanted 
embryos
1 (5.9) 3 (5.6)b 18 (15.1)b 15 (10.6) 37 (11.2)
No statistical difference between columns.
a In 9 ICSI cycles, no embryo transfer was done.
b A twin pregnancy was obtained in these groups.
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MI oocyte utilization rate (= percentage of embryos trans-
ferred and frozen per fertilized oocyte) was 76%.
Discussion
The present study aimed to analyze, for the first time, the
clinical benefit of MI oocytes in a selected group of
patients with a low number of mature oocytes at retrieval.
To achieve this goal, we selected ICSI cycles in which a
maximum of 6 mature oocytes and at least one MI oocyte
were obtained at oocyte retrieval. The results show that
fertilization rate and developmental capacity of the
embryos was significantly reduced in IVM oocytes com-
pared with control sibling oocytes. One live birth
obtained after transfer of embryos exclusively derived
from IVM oocytes illustrates that the use of MI oocytes is
not of major issue in IVF programs, but may be an option
for patients with low numbers of MII oocytes.
A low number of oocytes at retrieval might be a result of
low ovarian response to gonadotrophin stimulation. Low
response to stimulation occurs in approximately 10% of
the ART population [12]. There is no universally accepted
definition for low response. One of the criteria is the
number of oocytes retrieved. Faber et al. [13] used an
oocyte retrieval rate of ≤ 4 mature oocytes as cut-off limit,
while De Sutter et al. [14] and Moreno et al. [15] catego-
rized < 5 and ≤ 6 oocytes retrieved, respectively, as low
responding patients, without distinguishing mature and
immature oocytes. Based on these different definitions, it
can be concluded that the patients in our study can be cat-
egorized as 'relatively poor responders'. In each cycle of
this study, at least one MI oocyte was present. The propor-
tion of immature oocytes (GV +MI = 35.7%) in this group
of relatively poor responding patients is high compared to
the percentages described in the literature after ovarian
stimulation in a non-selected group of patients (15–20%;
[1,2]) and, as a consequence, the total MI oocyte utiliza-
tion rate of 76% shows that embryos from in vitro
matured MI oocytes were used at high frequency for trans-
fer or cryopreservation.
In the majority of the ICSI cycles, the maturation status of
the MI oocytes was checked between 2 to 7 hours after
oocyte retrieval. Within this time-frame, 41.3% of the col-
lected MI oocytes extruded their polar body. These matu-
ration rates are comparable with those achieved by others
working with MI oocytes retrieved from stimulated cycles.
Chian et al. [16] obtained a maturation rate of 46.1% and
52.0% after 6 hrs of in vitro culture and Strassburger et al.
[8] obtained 45.1% matured oocytes after 4 hrs of culture.
Other studies describe lower maturation rates, like the
study of Devos et al. [6] (26.7% maturation after 4 hrs of
culture) and the study of Chen et al. [9] (16.4% matura-
tion after 9 hrs of culture). Variations in maturation rates
between studies might be explained by different starting
and ending points for in vitro maturation. Also the culture
conditions, the use of more suitable types of media and/
or the addition of serum, growth factors and hormones
might influence maturation rates, subsequent fertilization
and embryo development of in vitro matured oocytes [16-
18]. The group of Balakier et al. [7] performed an exact
time recording of polar body extrusion during IVM of MI
oocytes. They found that the highest fertilization rate and
the lowest incidence of multinucleation were obtained
when injection of the oocytes was performed between 3 to
6 hrs after extrusion of the first polar body. This indicates
that oocyte maturation is not completed upon reaching
the MII stage. In the present study, we did not perform an
accurate kinetic experiment, but proper timing of polar
body extrusion as well as injection may enhance the out-
come of in vitro matured oocytes.
Whatever the conditions of in vitro maturation applied,
our study and the majority of other studies show consist-
ently lower fertilization rates of in vitro matured MI
oocytes compared to sibling in vivo matured oocytes [6-
8]. The proportion of poor quality embryos was higher
after in vitro maturation. This is in accordance with other
publications, which describe more cleavage arrest [7,8], a
higher number of multinucleated blastomeres [7] and a
reduced development to the blastocyst stage [9] after IVM.
On the contrary, the study of Devos et al. [6], performed
on a large group of 896 ICSI cycles, found the same pro-
portions of excellent and fair quality embryos after IVM
compared to in vivo matured oocytes. This might be
explained by the IVM incubation time of maximum 4 hrs
applied in this study. Longer IVM incubation times could
result in oocyte ageing. However, we were not able to find
a statistical difference in fertilization rate and embryo
quality between the different IVM time intervals in the in
vitro matured group, although a larger sample would be
necessary for a more conclusive statement in the IVM time
intervals of >7–11 hrs and 19–26 hrs. Nevertheless, of
special interest was the fact that the live birth we obtained
from exclusively IVM oocytes originated from an oocyte
that was matured in vitro for a period of 22 hrs.
Conclusion
We may conclude that the use of in vitro matured MI
oocytes can be of benefit to obtain pregnancy in patients
with a low number of MII oocytes. IVM culture conditions
and time schedule for ICSI must be refined to achieve
optimum fertilization and development.
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ABSTRACT The present study aimed to ana-
lyze detailed morphological and functional character-
istics of mouse in vitro matured oocytes after a pre-
maturation culture (PMC) by temporary nuclear arrest
with the specific phosphodiesterase 3-inhibitor
(PDE3-I) Cilostamide. In a first experiment the lowest
effective dose of Cilostamide was determined. Cumu-
lus–oocyte complexes (COCs), isolated from small
antral follicles, were exposed to different concentra-
tions of Cilostamide (ranging from 0 (control) to10 mM)
for 24 hr. Afterwards, oocytes were removed from
PDE3-I-containing medium and underwent in vitro
maturation (IVM) for 16–18 hr. A concentration of
1 mM Cilostamide was the lowest effective dose for
maximum level of inhibition and reversibility of meiosis
inhibition. This concentration was used in further
experiments to evaluate oocyte quality following IVM in
relation to different parameters: kinetics of meiotic
progression, metaphase II (MII) spindle morphology,
aneuploidy rate, fertilization, and embryonic devel-
opmental rates. The results were compared to non-
arrested (in vitro control) and in vivo matured oocytes
(in vivo control). Following withdrawal of the inhibitor,
the progression of meiosis was more synchronous and
accelerated in arrested when compared to nonarrested
oocytes. A PMC resulted in a significant increase in the
number of oocytes constituting a MII spindle of normal
morphology. None of the oocytes exposed to PDE3-I
showed numerical chromosome alterations. In addi-
tion, fertilization and embryonic developmental rates
were higher in the PMC group compared to in vitro
controls, but lower than in vivo controls. These results
provide evidence that induced nuclear arrest by PDE3-I
is a safe and reliable method to improve oocyte quality
after IVM. Mol. Reprod. Dev. 75: 1021–1030,
2008.  2007 Wiley-Liss, Inc.
Key Words: aneuploidy; Cilostamide; fertilization;
IVM; meiosis; spindle
INTRODUCTION
In vitro maturation (IVM) of oocytes retrieved from
small antral follicles is an alternative approach to avoid
or reduce the use of superovulatory drugs. Thiswould be
of particular beneﬁt for women who are vulnerable for
ovarian hyperstimulation syndrome (OHSS). However,
the quality and subsequent developmental competence
of in vitro matured oocytes is generally compromised in
most mammals, including the human (Trounson et al.,
2001; Smitz et al., 2004; Jurema and Nogueira, 2006).
This supports the need for improving in vitro culture
conditions.
The process of oocyte maturation is a complex
orchestration of molecular, cytoplasmic, and nuclear
events thatmust occur in a synchronizedmanner.When
fully-grown germinal vesicle (GV)-stage oocytes are
retrieved from antral follicles, they are capable of
spontaneously progressing to metaphase II (MII) before
the cytoplasm has achieved full maturity (Edwards,
1965; Eppig et al., 1994). In addition, GV-stage
oocytes isolated from follicles stimulated by exogenous
gonadotrophins are heterogenous in size, cytoplasmic
microtubule organization, chromatin, and nucleolar
conﬁguration (Mattson and Albertini, 1990; Debey
et al., 1993; Zuccotti et al., 1998; Combelles et al.,
2002;DeLaFuente, 2006). Thisheterogeneity couldalso
account for the overall low developmental competence
after IVM.
Apossible strategy to improve the outcomeof IVMis to
keep oocytesmeiotically arrested in vitro for a prolonged
period of time rather than allowing the oocytes to
undergo germinal vesicle breakdown (GVBD) as soon
as oocytes are retrieved. It is hypothesized that a ‘pre-
maturation’ culture (PMC) gives the oocyte the time to
undergo cytoplasmic changes (e.g. storage of mRNA
and proteins, morphological changes, ultrastructural
remodeling) and might enhance synchronization of the
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starting population of immature oocytes (Anderiesz
et al., 2000; Dieleman et al., 2002; Nogueira et al.,
2003).
The arrest of meiosis can be induced in vitro by
manipulating the intra-oocyte concentrations of the
second messenger cAMP. It is widely accepted that
the cAMP levels within the oocyte plays a crucial role in
the regulation of oocyte maturation (Dekel and Beers,
1978; Downs, 1995; Conti et al., 2002). Inhibition of the
oocyte-speciﬁc phosphodiesterase type 3 (PDE3) keeps
intra-oocyte cAMP levels elevated and, as a conse-
quence, maintains the oocyte arrested at the GV stage
without interfering with the functionality of surround-
ing somatic cells (Tsafriri et al., 1996; Thomas et al.,
2002).
The effect of induced nuclear arrest using speciﬁc
PDE3-inhibitors (PDE3-Is) has been studied in several
species. It was demonstrated that PDE3-I promotes
developmental competence after reversal from in vitro-
induced meiotic arrest in rodent (Nogueira et al., 2003)
and bovine (Thomas et al., 2004) oocytes. Furthermore,
applying a PDE3-I proved to be beneﬁcial for human
IVM by enhancing nuclear maturation rates, without
compromising embryonic developmental quality and
metaphase-II spindle organization (Nogueira et al.,
2006; Vanhoutte et al., 2007).
These observations suggest the potential of speciﬁc
PDE3-Is to improve synchronization between nuclear
and cytoplasmic maturation. Nevertheless, the results
are still suboptimal compared to oocytes that have
been matured in vivo. Further, detailed insights on the
intracellular events during maturation of the oocyte
upon release from PDE3-I could clarify the origin for
this difference in developmental competence and might
be relevant to design new and efﬁcient IVM culture
strategies.
The aim of the present study was, therefore, to inves-
tigate several morphological and functional aspects of
mouse oocytes after temporary exposure to PDE3-I. In
order to mimic the human clinical situation, cumulus–
oocyte complexes (COCs) were collected at an earlier
stage of their development, thus after a short period of
ovarian stimulation. This was achieved by shortening
the standard duration of eCG stimulation from 48 to
24 hr (see ‘Material and Methods’ section).
In a ﬁrst assay, we identiﬁed the lowest effective
working concentration of the PDE3-I Cilostamide. This
concentration was applied in other experiments to
assess the effect of a PMC period on the kinetics of
meiotic progression,MII spindlemorphology and poten-
tial risks of induced aneuploidy. Finally, fertilization
and embryonic developmental capacity was evaluated
as an ultimate assessment for oocyte cytoplasmic
quality.
MATERIALS AND METHODS
Chemicals and Drugs
Unless otherwise indicated, all chemicals were pur-
chased from Sigma Chemical Co. (Bornem, Belgium).
ThespeciﬁcPDE3-ICilostamide (Calbiochem,Bierges,
Belgium; Stock 10 mM in dimethyl sulfoxide (DMSO)
stored at 208C) was used at concentrations of 0.001,
0.01, 0.1, 1, and 10 mM. In preliminary experiments, the
highest concentration of the DMSO carrier (0.1% v/v)
was testedduring an18hr period of IVMandno effect on
maturation, fertilization, and embryonic development
was observed (data not shown).
Animals and Ethics
Mice used in this studywere 7–8-week-old F1 hybrids
(B6D2; Iffa Credo, Brussels, Belgium), housed and bred
according to national legislation for animal care. All
experimental procedures were done after obtaining
written consent from the Animal Ethical Committee of
the Ghent University Hospital (Project No. ECD 06/05).
Collection of Cumulus–Oocyte Complexes
For IVM, mice were primed with intraperitoneal
injection of 5 IU/ml eCG (Folligon; Intervet, Mechelen,
Belgium). The animals were sacriﬁced 24 hr later by
cervical dislocation in order to obtain COCs from small
antral follicles. Ovaries were dissected and collected in
Leibovitz-glutamax medium (Invitrogen, Merelbeke,
Belgium), supplemented with 10% heat-inactivated
fetal calf serum (Invitrogen), 100 mg/ml streptomycin,
100U/mlpenicillin.Toprevent spontaneous resumption
of meiosis, Cilostamide was added to thismedium at the
same ﬁnal concentration as used in the subsequent IVM
medium (see Experimental Design section). COCs were
freed mechanically by puncturing antral follicles with
ﬁne insulin needles (261/2-G; Becton Dickinson, Erem-
bodegem, Belgium). Only COCs that consisted of an
oocyte surrounded by a compact cumulus-cellmasswere
selected for the experiments.
As in vivo controls, oocytes were obtained by priming
mice with 5 IU/ml eCG followed by 5 IU/ml hCG
(Chorulon; Intervet) 48 hr later. Depending on the
Experimental Design, COCs were recovered from pre-
ovulatory follicles (3–10 hr post-hCG) or from the
ampullae (12–18 hr post-hCG).
In Vitro Maturation of Oocytes
The basic culture medium for IVM consisted of
a-minimal essential medium with glutamax (a-MEM;
Invitrogen) supplementedwith 5%FCS, 5 mg/ml insulin,
5 mg/ml transferrin, 5 ng/ml selenium and 10 mIU/ml
recombinant FSH (recFSH; Puregon, kindly donated by
Organon, Oss, The Netherlands).
Nuclear arrest was obtained by adding Cilostamide
to the IVM culture medium at ﬁnal concentrations as
speciﬁed in the Experimental Design section. The
COCs were maintained arrested for 24 hr. Cilostamide
withdrawal was carried out by washing the COCs
three times in inhibitor-free IVM medium.
Stimulation of nuclear maturation was performed by
placing the oocytes in IVMmedium supplemented with
1.5 IU/ml recombinant human chorionic gonadotropins
(rechCG; Pregnyl, Organon) and 5 ng/ml epidermal
growth factor (EGF).
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In all cultures, COCs (groups of 15–20) were placed
in microdroplets of 30 ml covered with oil and incu-
bated under standard conditions (378C in a humidiﬁed
atmosphere of 5% CO2 in air).
Experimental Design
Aschematic diagramof the study is shown inFigure 1.
Experiment 1 was designed to determine the lowest
effective dose of Cilostamide that efﬁciently arrest
oocytes at the GV-stage with full reversibility of the
inhibitory effect. Six different concentrations were
tested: 0 (control), 0.001, 0.01, 0.1, 1 and 10 mM. After
24 hr of inhibitor-culture, half of the oocytes were
denuded of cumulus cells by gentle pipetting to facilitate
visualization of the nuclear stage. Maturation stages in
these oocytes were classiﬁed by light microscopy as GV,
GV breakdown (GVBD) or polar body extrusion (PB).
The remaining COCs were washed out of Cilostamide
and cultured in IVM medium supplemented with hCG/
EGF for 16–18 hr. Maturation stages were analyzed at
the end of IVM to evaluate the reversibility of the
inhibitor. The most effective concentration of Cilosta-
mide was used in Experiments 2–5.
Experiment 2 was designed to assess if a PMC alters
the kinetics of nuclear progression upon release of
meiotic arrest. In the ‘Cilostamide’ group, COCs were
removed from 24 hr PDE3 inhibition and placed in IVM
culture. Thereafter, groups of COCs were denuded and
evaluated at different time-intervals following IVM: at
3, 4, 6, 8, 10, 12, and 16 hr of culture. In the ‘in vitro
control’ group,COCswere denuded and evaluated at the
same IVM time-intervals. For the ‘in vivo control’, COCs
were collected from pre-ovulatory follicles or from the
ampulla at these successive time intervals post-hCG
priming.
The meiotic stages of individual oocytes were classi-
ﬁed on the basis of chromosome conﬁguration and
microtubule organization after immunoﬂuorescence
staining and the kinetics of meiotic progression were
compared between the three groups.
In Experiments 3–5, morphological and functional
characteristics of Cilostamide-exposed oocytes were
examined. Depending on the experiment, PB oocytes
were processed for: (i) immunocytochemistry staining to
analyzeMII spindlemorphology and chromosome align-
ment (Exp 3), (ii) spreading for chromosome counting
(Exp 4), and (iii) fertilization in vitro (Exp 5). The results
were compared to nonarrested, spontaneously matured
oocytes (in vitro control) and in vivo matured oocytes
(in vivo control).
Immunocytochemistry and Confocal Analysis
(Experiment 2 and 3)
PB oocytes were simultaneously ﬁxed and extracted
in a microtubule-stabilizing buffer, as described else-
where (MattsonandAlbertini, 1990). Tovisualizemicro-
tubules, oocytes were incubated in the presence of a 1:1
mixture of mouse monoclonal anti-a,b-tubulin (1:200)
overnight at 48C, followed by Alexa Fluor conjugated
goat-anti-mouse immunoglobulin (Molecular Probes,
Eugene, Oregon; dilution 1:200) for 2 hr at 378C.
Chromatin was stained with Ethidium Homodimer-2
(Molecular Probes; dilution 1:500) for 1 hr at 378C.
Labeled oocytesweremounted onmicroscope slides in
90% glycerol-PBS solution containing 0.2% 1,4-Diaza-
bicyclo[2.2.2]octane (DABCO) as an antifading reagent.
Preparations were observed using a laser scanning
confocal microscope (LSCM; Biorad Radiance 2000
mounted on aNikon invertedmicroscope; Tokyo, Japan)
equipped with a Argon-ion/HeliumNeon (488/543)
laser and selective ﬁlter sets for Alexa Fluor 488 and
Ethidium homodimer-2. Images were obtained using a
100 plan oil immersion objective (numerical aperture
1.3). A three-dimensional image of the microtubular
structure and chromosomes was rendered from the
collected data by using ImageJ software. This allowed
the analysis of spindle size, spindle shape, and chromo-
some alignment.
Spreading of Oocytes for Chromosome
Counts (Experiment 4)
PB extruded oocytes were ﬁxed according to the
method described by Tarkowski (1966) with a few
modiﬁcations. Oocytes were treated with 1.2% hypo-
tonic sodium citrate at room temperature for 2–5 min.
The oocytes were then brieﬂy ﬁxed in ice-cold ﬁxative
(acetic acid: methanol (1:3)), dropped onto a clean,
ice-cold slide, and air dried. The whole process was
monitored under a stereomicroscope. Chromosome
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Fig. 1. Schematic representation of the experimental design.
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preparations were stained with Giemsa and numbers of
chromosomes were counted at 1000 ﬁnal magniﬁca-
tion. Only preparations in which chromosomal numbers
could be counted unambiguously were included for
analysis. Preparations with <17 chromosomes were
considered to be technical artifacts.
In Vitro Fertilization and Embryonic
Development (Experiment 5)
At the end of the IVM culture period, COCs were
fertilized in vitro. The caudae epididymidis were remov-
ed fromadultmales.Epididymal contentswere carefully
squeezed out and the residual caudal tissue was
discarded. Sperm suspensions were preincubated for
2.5 hr to ensure capacitation in KSOM supplemented
with 3% BSA (fraction V). COCs were inseminated into
40 ml droplets and spermwas added at a ﬁnal dilution of
2106/ml and incubated in a humidiﬁed atmosphere of
378C, 5% CO2 in air for 3 hr. At the end of this period,
inseminated oocytes were washed to remove sperm
and cumulus cells by gently pipetting and were then
cultured in 40 ml microdroplets of KSOM supplemented
with 0.5% crystalline BSA (Calbiochem) for 4 days in a
humidiﬁedatmosphere of 378C, 5%CO2, 5%O2, and90%
N2. The percentages of developing embryos to the 2-cell
and blastocyst stages were determined.
Statistical Analyses
All experiments were repeated at least three times.
Variations between replicates are indicated with the
standard deviation (SD in tables and error bars on
graphs). For evaluation of the differences in spindle
morphology, chromosome alignment, aneuploidy rate,
and kinetics of nuclear progression, data were analyzed
with Chi-square test. For evaluation of maturation
rates, spindle measurements, fertilization, and embry-
onic development, data were analyzed with one-way
ANOVA and Tukey-post test. Percentages were ﬁrst
subjected to arcsine transformation. Values with
P<0.05 were considered as statistically signiﬁcant.
RESULTS
Experiment 1: Dose-Deﬁning Experiment
The dose-dependent effect of Cilostamide on nuclear
arrest is summarized in Figure 2A. In the control group
(0 mM Cilostamide) more than 80% of the oocytes
matured spontaneously after 24 hr of culture. This was
not signiﬁcantly different from 0.001 and 0.01 mM
Cilostamide. It was only at concentrations of 0.1 mM
and above that the oocytes were efﬁciently arrested at
the GV stage (>90%).
The reversibility of nuclear arrest following with-
drawal of inhibitor and IVMfor16–18hr is illustrated in
Figure 2B. PB and GVBD rates were not signiﬁcantly
different among the groups. The percentage of GV
oocytes, however, was signiﬁcantly higher at 0.1 mM
Cilostamide compared to 0 and 1 mM Cilostamide
(P<0.05).
As a consequence, 1 mM Cilostamide was chosen in
the other experiments as the lowest optimal working
concentration for efﬁcient inhibition and full reversi-
bility.
Experiment 2: Effect of Cilostamide
on Kinetics of Meiotic Progression
Percentages of oocytes at the GV, diakinesis (DIA),
prometaphase I (PMI), metaphase I (MI), anaphase
I/ telophase I (AI/TI) or MII stage were recorded
(Fig. 3A). Different patterns in both the rate and timing
of meiotic progression were determined in the tempora-
rily arrested, nonarrested, and in vivo matured oocytes
(Fig. 3B).
At 3 hr of IVM, oocytes from the three groups had
undergone GVBD in similar proportions. However, the
progression of meiosis seemed to be accelerated in the
Cilostamide group: 21% of the oocytes had already
progressed to PMI, while only 5% in the in vitro control
and 0% in the in vivo control did so (P<0.05). One hour
later, at 4 hr of IVM, a number of oocytes in the
Cilostamide group progressed to MI (31%), which was
signiﬁcantly higher compared to the in vitro (7%) and in
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Fig. 2. Effect of different concentrations of Cilostamide (0–10 mM)
on nuclear arrest (A) and reversibility of meiotic arrest (B). Values are
expressed as mean %SD (error bars). The total number of oocytes
analyzed (n) is indicated under each group. Different letters within the
same maturation classes represent signiﬁcant differences (P< 0.05).
PB, polar body extrusion; GVBD, germinal vesicle breakdown; GV,
germinal vesicle.
1024 L. VANHOUTTE ET AL.
46
vivo control group (5%; P< 0.05). At 6 hr of IVM,
the in vitro oocytes had the lowest rate of MI (20%),
while these rates were not signiﬁcantly different
between the Cilostamide and the in vivo control group
(55% MI and 36% MI, respectively). The ﬁrst PB
extruded oocytes were detected at 8 hr in the three
groups and the percentage of MII-stages was higher in
Cilostamide-treated oocytes compared to nonarrested
and in vivo matured oocytes (21% vs. 5% and 1%,
P<0.05). At 10 hr of IVM, 44% of the oocytes from the
Cilostamide group were in the process of chromosome
segregation, at AI/TI, and 29% had reached the MII
stage. This pattern of meiotic progression was similar to
the in vivo control. In contrast, the highest proportion of
oocytes in the in vitro control group was still at MI by
that time (52%). However, the proportion of oocytes that
completedmeioticmaturation at 12 and at 16 hrwas the
same in Cilostamide-treated, nonarrested and in vivo
matured oocytes (around 80%).
Of notice was the high degree of synchrony during
meiotic progression in the in vivo control group. This
synchrony was also detectable in the Cilostamide-
exposed oocytes: maximal incidence of DIA, PMI, MI,
and AI/TI were seen at 3, 4, 6, and 10 hr of IVM,
respectively. In contrast, the broader distribution of
maturation stages in spontaneously matured oocytes
indicated a less synchronous pattern of meiotic pro-
gression to MII.
Experiment 3: Effect of Cilostamide on Spindle
Morphology and Chromosome Alignment
Spindle morphology in arrested, nonarrested, and in
vivo matured MII oocytes was analyzed in a qualitative
and a quantitative way (Table 1 and Fig. 4).
For the qualitative analysis (Table 1A), the shape of
the spindlewas classiﬁed as ‘‘normal’’ when itwas barrel
shaped with slightly pointed poles (Fig. 4A,B) or
‘‘abnormal’’ if it was asymmetrical, elongated, round or
disorganized (Fig. 4C). The alignment of the chromo-
somes on the metaphase plate was categorized as
‘‘aligned’’ when all chromosomes were arranged on a
compact metaphase plate at the equator of the spindle
(Fig. 4A0), ‘‘not aligned’’ when one or two chromosome
were displaced from the metaphase plate (Fig. 4B0) and
‘‘chaotic’’ when several chromosomes were dispersed
(Fig. 4C0).
In the Cilostamide group, 89% of the oocytes had a
normal spindle. This percentage was similar to the in
vivo controls, but signiﬁcantly higher than the in vitro
control group (Table 1A; P< 0.05). The percentage of
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Fig. 3. Kinetics of meiotic progression in Cilostamide-exposed,
in vitro and in vivo matured oocytes. (A) Representative confocal
images of differentmeiotic stages.Alfa/beta-tubulin is stained in green,
DNA is stained in red. Original magniﬁcation¼ 400. (B) Percentages
of oocytes at differentmeiotic stages in relation tomaturation time.The
markers on the lines represent the meanSD of results obtained from
30 to120oocytes/time interval (3 replicates). For signiﬁcance difference
between groups: see text. GV, germinal vesicle; DIA, diakinesis; PMI,
prometaphase I; MI, metaphase I; AI/TI, anaphase I/telophase I; MII,
metaphase II.
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oocytes with normal equatorial ‘‘aligned’’ chromosomes
wasnotdifferent between theCilostamidegroupand the
in vitro control, but signiﬁcantly lower than the in vivo
control group (P< 0.05).
For the quantitative analysis (Table 1B), spindle
length, spindle width at the equator and average pole
widthweremeasured. Only imageswith a clear orienta-
tion of the spindleweremeasured. The length andwidth
of the spindles in oocytes cultured in the presence of the
Cilostamide group was signiﬁcantly increased when
compared to those of the in vivo control group (P<0.05).
Thewidth of spindles in oocytes of theCilostamidegroup
was also increased when compared to those of oocytes in
in vitro controls. There was no difference in the average
measurement of spindle poles width between the three
groups.
Experiment 4: Effect of Cilostamide
on Oocyte Aneuploidy Rate
Chromosome preparations of PB oocytes were ana-
lyzed to investigate possible errors that could have
occurredduring chromosomesegregationatMI.Oocytes
with 20 chromosomes were classiﬁed as haploid, 17–
19 chromosomes as hypohaploid, 21–35 chromosomes
as hyperhaploid and 36–40 chromosomes as diploid
(Carrell et al., 2005). The number of oocytes with
aneuploidies in the Cilostamide group was compared
to the in vitro and in vivo control group (Table 2).
The overall level of numerical chromosome aberra-
tions was low. Levels of aneuploidy were not signiﬁ-
cantly different among the treatment groups. Almost all
oocytes (>90%) had a normal haploid set of chromo-
somes (Table 2). Other structural aberrations, such as
the presence of single chromatids, were not observed.
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TABLE 1. (A) Effect of Cilostamide on MII Spindle Morphology and Chromosome Organization: Qualitative
Analysis; (B) Effect of Cilostamide on MII Spindle Dimensions: Quantitative Analysis
A*
Conditions No. of oocytes
No. (%) of oocytes with
normal spindles
No. (%) of oocytes with chromosomes
Aligned Not aligned Chaotic
Cilostamide 56 50 (89)a 26 (46)a 27 (48)a 3 (5)a
In vitro control 31 21 (68)b 15 (48)a 14 (45)a 2 (6)a
In vivo control 50 48 (96)a 48 (96)b 2 (4)b 0a
B**
Conditions
No. of spindles
measured Spindle length (mm)
Spindle width at
equator (mm)
Average pole
width (mm)
Cilostamide 28 23.1 3.0a 13.6 2.8a 6.4 1.5a
In vitro control 17 21.0 2.4a,b 11.1 2.0b 5.6 1.0a
In vivo control 26 20.3 2.5b 11.1 2.5b 5.5 1.7a
*Different superscripts within the same column are signiﬁcantly different (P< 0.05).
**Results are presented as meanSD. Different superscripts within the same column are signiﬁcantly different (P< 0.05).
Fig. 4. Representative confocal images of mouse MII spindles from
Cilostamide-exposed oocytes. Correlative total a/b-tubulin (A–C) and
Ethidium Homodimer-2 (A0–C0) staining patterns. (A, B) Normal
barrel-shaped MII spindle with slightly pointed poles, (C) Complete
disorganization of the spindle, (A0) Aligned chromosome conﬁguration,
(B0) Chromosomes not aligned, (C0) Chaotic chromosome conﬁguration;
Scale bar¼5 mm.
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Experiment 5: Effect of Cilostamide on
Fertilization and Embryonic
Developmental Rates
The percentage of 2-cell embryos on Day 1 and
blastocysts on Day 4 after insemination was signiﬁ-
cantly higher in the Cilostamide group compared to the
in vitro controls, but lower compared to the in vivo
control group (P< 0.05; Table 3). The proportion of 2-cell
embryos reaching theblastocyst stagewas, however, not
different between theCilostamide group and the in vitro
control group, but lower than in the in vivo control group
(Table 3).
DISCUSSION
The fact that oocyte quality is reduced after IVM
remains an intriguing question. Recent results offer a
good perspective for the application of isoenzyme-
speciﬁc or ‘‘second-generation’’ PDE inhibitors to extend
the developmental period of the immature oocyte before
ﬁnal IVM (Nogueira et al., 2003, 2006; Thomas et al.,
2004). Nevertheless, given the apparent differences
with in vivo matured oocytes further studies are
mandatory to clarify precisely the effect of PDE3-I on
thematuration process itself, which is currently largely
unknown. Data on microtubule organization, chromo-
some alignment, and kinetics of meiotic progression are
relevant to study this aspect. In the present study, we
were able to collect qualitative and quantitative data on
this item,which resulted in some important insights and
suggestions for future studies.
Concentration of Cilostamide
The capacity of the speciﬁc PDE3-I Cilostamide to
induce reversal meiotic arrest in the mouse oocyte
has been demonstrated earlier (Tsafriri et al., 1996;
Wiersma et al., 1998). Our dose-dependent experiment
showed that concentrations of 1 mM Cilostamide and
above were efﬁcient for reversal of meiotic arrest,
indicating that reconstitution of PDE3A activity had
occurred upon inhibitor removal. Surprisingly, at a
concentration of 0.1 mM Cilostamide, a signiﬁcant
proportion of oocytes were still blocked at the GV stage
after IVM, while higher concentrations (1 and 10 mM
Cilostamide) resulted inhigherPB rates after IVM.This
is an unexpected but very important observation. It
demonstrates that the concentration of PDE3-I is a
critical factor in the setup of the IVM technique. It is
difﬁcult to explain this phenomenon, since the exact
regulatory mechanism of PDE3A activation is still
unclear. There is enough evidence that this enzyme is
involved in the regulation of meiosis (Masciarelli et al.,
2004). A drop in the intra-oocyte cAMP concentration is
an important trigger to override meiotic arrest (Dekel
and Beers 1978; Downs, 1995; Conti et al., 2002; Horner
et al., 2003). Cyclic AMP can be produced endogenously
by the oocyte (Schultz et al., 1983; Horner et al., 2003)
or can diffuse from granulosa cells to the oocyte via
gap junctions connecting both cellular compartments
(Eppig, 1991;Webbetal., 2002). Themagnitudeof cAMP
levels in thedifferent cell compartments of theCOCmay
result in differential signals. It might be possible that
Cilostamide at a concentration of 0.1 mM is able to raise
inhibitory cAMP levels above a certain threshold, but
has an inﬂuence on the activation of other crucial
factors, downstream of or separate from the cAMP
transduction pathway. A clear demonstration of this
relationship requires further systematic studies in
which PDE3A and/or cAMP levels are measured in
COCs during and after exposure to Cilostamide.
Kinetics of Meiotic Progression
One method to explore possible underlying cell cycle
aberrations during IVM is to observe the kinetics of
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TABLE 2. Cytogenetic Analysis of Arrested (Cilostamide), NonArrested (In Vitro
Control) and In Vivo Matured (In Vivo Control) Oocytes
Conditions No. of oocytes*
Ploidy (n (%))
Hypohaploid Haploid Hyperhaploid Diploid
Cilostamide 53/72 2 (3.8) 49 (92.4) 1 (1.9) 1 (1.9)
In vitro control 48/65 2 (4.2) 43 (89.6) 1 (2.1) 2 (4.2)
In vivo control 45/69 2 (4.4) 43 (95.6) 0 0
*Number of oocytes successfully analyzed/number processed for spreading. No signiﬁcant
difference was observed among the groups.
TABLE 3. Effect of Prematuration Culture in the Presence of Cilostamide on
Fertilization and Embryonic Developmental Rates
Conditions No. of oocytes % 2-cell/total % Blasto/total % Blasto/2-cell
Cilostamide 184 52.3 1.3a 29.8 2.6a 57.3 4.9a
In vitro control 148 20.6 10.3b 11.2 7.9b 50.8 16.6a
In vivo control 177 81.8 4.6c 69.5 8.3c 85.0 9.1b
Results are presented as mean %SD.
Different superscripts within the same column are signiﬁcantly different (P< 0.05).
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meiotic progression upon removal from the inducer of
nuclear arrest. The kinetics of meiosis is a crucial
parameter for further developmental competence of the
oocyte and has been sparsely documented in previous
studies on PDE3-Is.
We found a striking difference in the meiotic pro-
gression of Cilostamide-exposed, spontaneously matur-
ed and in vivo matured oocytes. Of interest was the
higher synchrony in meiotic progression after Cilosta-
mide exposure compared to spontaneously matured
oocytes. This might be attributed to a better synchroni-
zation of the starting population of GV oocytes after the
24 hr period of PMC. A synchronous pattern of meiotic
maturation was found to be a speciﬁc characteristic of
oocytes that have been matured in vivo compared to
in vitro matured oocytes (Sanﬁns et al., 2004). Our
observations indicate that applying a PMC period
mirrors the physiological situation of oocytematuration
by creating amore balanced coordination of nuclear and
cytoplasmic maturation.
We also observed that the timing of meiotic progres-
sion in previously arrested oocytes was initially more
rapid compared to the in vitro and in vivo control
group. Anderiesz et al. (2000) found a similar acceler-
ated pattern of meiosis in 6-dimethylaminopurine
(6-DMAP)-treated mice oocytes. The authors suggested
that during the period of PMC theremight be extra time
for synthesis, translation, and storage of proteins that
are necessary to complete meiosis. Although protein
synthesis is not initially required to re-enter meiosis in
mouse oocytes, it is possible that immediate availability
and participation of signaling proteins and/or other key
components may account for the accelerated meiotic
progression. Alternatively, rapid meiotic progression of
mouse IVM oocytes was observed by Sanﬁns et al.
(2004). This phenomenawas explainedby theauthors as
a precocious liberation of factors from the oocyte cortex
(centrosomes, cytoplasmic microtubules, MPF), leading
to uncontrolled G2 to M cell cycle transition. With this
in mind, our observation offers some inspiration for
future adaptations of the culture technique: adjustment
of the PMC to gradually overcome the inhibitory effect
of the arrester, rather than removing it abruptly by
washing, may recreate a more balanced cell cycle
progression during IVM.
Microtubular Organization
and Chromosome Alignment
Another potential biomarker of oocyte cytoplasmic
quality is the structural normality of the MII spindle
and the integrity of their chromosomes constituent. The
presence of a well-developed spindle is essential for a
correct and balanced distribution of the chromosomes
and other molecular factors to the oocyte and the PB
(Eichenlaub-Ritter, 2002; Albertini, 2003). Several
studies conﬁrmed that IVM conditions can have delete-
rious effects on the phenotypic properties of the spindle
and the organization of the chromosomes. In mice, in
vivo ovulated and IVM oocytes show profound differ-
ences in spindle shape, size, density, stability and
position (Sanﬁns et al., 2003; Moon et al., 2005; Roberts
et al., 2005; Rossi et al., 2006). These differences have
been related to the hormonal conditions to which the
oocytes are exposed (Sanﬁns et al., 2003; Roberts et al.,
2005; Rossi et al., 2006), unbalanced coordination of
nuclear and cytoplasmic maturation (Sanﬁns et al.,
2003), and defects in oocyte-somatic cell communication
during meiotic progression (Hodges et al., 2002). As a
consequence, microtubular organization and chromo-
some alignment has been recognized as an important
checkpoint for assessing the microenvironment sur-
rounding the oocyte.
It was interesting to observe how the use of a PDE3-I
can change the cytoskeletonorganization of the oocyte to
more closely resemble those of in vivo matured oocytes.
Applying a PMC period signiﬁcantly improved the
number of oocyteswith normalMII spindlemorphology.
The vastmajority of PBoocytes in theCilostamide group
possessed a normal barrel-shaped spindle with slightly
pointed poles as seen in vivo. The improved spindle
morphology could be a result of higher nucleation
capacity of the centrosomes, tubulin assembly compe-
tence or microtubule stability. Whether this is due to
cytoplasmic changes induced by a PMC or an indirect
result of the increase in cAMP accumulation in the
immature oocyte needs to be further researched.
Evidence for the latter might be drawn from the study
of Duncan et al. (2006). This group demonstrated that
cAMP-dependent protein kinase (PKA) appears to be
important for appropriate spindle formation. Since an
increase in cAMP stimulates PKA activation (Corbin
et al., 1978), it is possible that elevated cAMP levels due
to PDE3-I exposure are responsible for the improved
spindle morphology observed in our study.
Chromosome alignment was, however, not a param-
eter that improved by applying a PMC period, although
gross disturbances in chromosome positioning were not
detected. Since the spindle appears normal in most of
the arrested oocytes, it seems likely that the defect is not
one of spindle formation itself, but rather of chromosome
movement and attachment to the spindle, which require
kinetochore-ﬁbers (Brunet and Maro, 2005).
The quantitative analysis of the MII spindles in our
study revealed that spindle dimensions differ according
to the maturation conditions. Spindles of in vivo
matured oocytes were clearly shorter and smaller
compared to temporarily arrested oocytes. In contrast,
spindle length and width was equivalent in the two
control groups. Spindle poles tented to be smaller in the
control groups compared to the Cilostamide group,
although the difference was not signiﬁcant. Differences
in spindle dimensions between in vivo and in vitro
matured mouse oocytes have been described by others
(Sanﬁns et al., 2003). It hasbeenproposed that the large,
barrel-shaped spindles formed after IVM results from
the incorporation of multiple microtubule organizing
centers (MTOCs) during spindle assembly, which
reduces the stores of available cytoplasmic gamma-
tubulin necessary for normal embryonic development
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(Combelles and Albertini, 2001; Sanﬁns et al., 2003,
2004; Barrett and Albertini, 2007).
From these results we may conclude that, although a
PMCperiod improved spindlemorphology, the presence
of enlarged spindles and disaligned chromosomes
reﬂects a not yet fully optimized spindle assembly
mechanism.
Aneuploidy
Before any clinical application of PDE3-Is, further
thorough investigations to test the safety of this
compound are surely needed. Moreover, it is important
to verify if the potential beneﬁts of extending the incu-
bation time is not lost through an increased appearance
of chromosomal errors in the meiotic process.
It was previously demonstrated that the majority of
aneuploidies arise during meiosis I, probably due to the
lack of a checkpoint control mechanism at the MI/AI
transition in mammalian oocytes (LeMaire-Adkins
et al., 1997; Hassold and Hunt, 2001; Plachot, 2003).
For this reasons, we investigated the possible risk of
numerical chromosome aberrations during meiosis I by
investigating chromosome preparations of PB extruded
oocytes.
Temporary inhibition of meiosis by Cilostamide did
not increase aneuploidy rates after IVM.Themajority of
the oocytes were haploid with 20 MII chromosomes.
Other structural aberrations, such as the presence of
single chromatids, were not observed. This ﬁnding
demonstrates that the accelerated progression through
meiosis I in Cilostamide-exposed oocytes, as observed in
our kinetic experiment, did not result in a reduction of
the critical period in which chromosome attachment
and alignment on the MI spindle equator takes place
(Eichenlaub-Ritter and Boll, 1989). Hence, the use of
chromosome-speciﬁc probes to analyze the chromo-
some structure more accurately may reveal other
abnormalities.
Fertilization and Embryonic Development
Although the beneﬁcial effect of PDE3-I on fertiliza-
tion rate of mouse in vitro matured oocytes has been
described previously (Nogueira et al., 2003), it is
important to conﬁrm if the same results can be obtained
using another type ofmolecule (i.e., Cilostamide instead
of Org9935). Our results demonstrated that not only the
fertilization, but also the blasotcyst rate was increased
in arrested oocytes. This might indicate that the use of
Cilostamide is preferred above Org9935. It also demon-
strated that 1 mM Cilostamide is sufﬁcient to improve
oocyte development without causing adverse affects.
All together, this study demonstrated that culturing
mouse oocytes for an additional 24 hr in the presence of
PDE3-I alters the cytoplasmic quality into a direction
more closely related to the in vivo situation. Further
improvement of IVMculture techniquesmight require a
combination of a PMC in the presence of an appropriate
in vitro environment.We presume that the latter aspect
needs to be further optimized in our experiments. It was
noticed that cumulus cells started to loose the contact
with the oocyte during the PMC period, a process that is
associated with loss of gap junctional communication
between the two cell types. It is widely recognized that
bi-directional communication between the oocyte and
follicular somatic cells is fundamentally important for
oocyte growth and maturation (Eppig, 2001; Combelles
et al., 2004). Modiﬁcations of the current culture
conditions, aiming for a better oocyte-cumulus contact
during PMC and IVM, may result in a better outcome.
This can be done by replacing recFSH in the culture
medium by forskolin since it was demonstrated that
FSH induces a retraction of transzonal projections
(Combelles et al., 2004; Thomas et al., 2004). Also the
culture of COCs in a synthetic extracellulair matrix
might be a possible strategy to improve oocyte-cell
connections (Combelles et al., 2005; Torre et al., 2006).
Alternatively, co-culturing COCs with oocyte-secreted
factors (OSFs) might be another method to enhance
oocyte developmental competence, as was recently
demonstrated byHussein et al. (2006) on bovine oocytes.
CONCLUSIONS
This is the ﬁrst attempt to characterize in detail the
phenotype of oocytes after release from PDE3-I. The
insights on cytoskeleton organization and meiotic
progressing elucidated some unresolved issues of
PDE3-I exposed oocytes, which are helpful for future
improvement of the IVM culture technique. Although
extrapolations from ﬁndings obtained in the mouse to
the human should be made with caution, these results
could have far-reaching implications for improving the
efﬁciency of IVM in human infertility treatment.
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BACKGROUND: The use of hormones for controlled ovarian stimulation results in follicular heterogeneity, with
oocytes at diverse stages of nuclear and cytoplasmic development. This study evaluated the impact of temporary
nuclear arrest by a speciﬁc phosphodiesterase 3-inhibitor (PDE3-I), cilostamide, on nuclear and cytoplasmic matu-
ration of cumulus-free germinal vesicle (GV) human oocytes from controlled ovarian stimulated cycles.
METHODS: GV oocytes (n 5 234) were cultured in: (i) medium without the inhibitor (control); (ii) medium sup-
plemented with 1 mM cilostamide and (iii) medium supplemented with 10 mM cilostamide. Oocytes in groups (ii)
and (iii) were exposed to cilostamide for 24 h. The PDE3-I was subsequently removed by transfer of oocytes to
fresh in vitro maturation (IVM) medium and the reversibility of GV arrest was assessed during IVM culture for
maximum 48 h. RESULTS: Cilostamide (1 and 10 mM) could maintain >80% of the oocytes at the GV stage,
without affecting subsequent maturation to metaphase II. Oocytes exposed to 1 mM cilostamide were more likely
to have normal bipolar spindles with aligned chromosomes than control oocytes (P < 0.05). When GV chromatin con-
ﬁgurations before and after arrest were compared, a signiﬁcantly higher proportion of oocytes had acquired a nucleo-
lus completely surrounded by a rim of highly condensed chromatin (P < 0.05). CONCLUSIONS: Temporary nuclear
arrest of human GV oocytes with PDE3-I proved to be beneﬁcial for obtaining normal spindle and chromosome con-
ﬁgurations after IVM. It resulted also in synchronization within the population of GV oocytes.
Key words: in vitro maturation/meiosis/oocyte maturation/phosphodiesterases/spindle
Introduction
The application of in vitromaturation (IVM) of human oocytes
as an assisted reproductive technology treatment could offer
several advantages, including lower costs, shorter stimulation
protocols and reduced risks of ovarian stimulation syndrome.
Oocytes matured in vitro, however, do not have the same
developmental potential as in vivo matured oocytes (Cha and
Chian, 1998; Moor et al., 1998; Trounson et al., 2001; Chian
et al., 2004). Currently available evidence indicates that the
culture conditions adequately support nuclear maturation, but
frequently fail to sustain optimal cytoplasmic maturation
(Combelles et al., 2002). The nature of this deﬁciency is still
subject to speculation.
Oocyte developmental competence is gradually acquired
during the long-lasting period of oogenesis. The ﬁnal stage
for optimal development, prior to ovulation, requires synchro-
nization between nuclear and cytoplasmic maturation (Eppig
et al., 1994). Fully grown oocytes from many species can
mature spontaneously following release from the follicle
(Pincus and Enzmann, 1935; Edwards, 1965). It is believed
that extending meiotic arrest in vitro by temporary blockage
of spontaneous nuclear maturation, a so-called ‘prematuration
culture’ (PMC), might improve the synchronization between
nuclear and cytoplasmic maturational status (Anderiesz et al.,
2000; Nogueira et al., 2003a). This allows time for the
oocyte to undergo structural and biochemical changes that
are essential to sustain normal fertilization and further embryo-
nic development, such as the continued transcription of mRNA,
post-translational modiﬁcations of proteins, relocations and
modiﬁcations of organelles (Dieleman et al., 2002).
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Furthermore, the use of hormones for controlled ovarian
stimulation results in follicular heterogeneity and, conse-
quently, in oocytes with diverse stages of nuclear and cyto-
plasmic development (Laufer et al., 1984). Hence, different
chromatin conﬁgurations within the population of fully
grown germinal vesicle (GV) oocytes were reported (Com-
belles et al., 2002; Miyara et al., 2003). A PMC could contrib-
ute to a synchronization of the different types of GV oocytes,
which may result in an overall improved outcome after IVM
(Nogueira et al., 2003b).
The arrest of meiosis can be induced in vitro by manipulat-
ing the intra-oocyte cAMP levels (Conti et al., 2002). Inhi-
bition of the oocyte-speciﬁc phosphodiesterase 3 (PDE3)
keeps intra-oocyte cAMP levels elevated and will maintain
the oocyte arrested at the GV stage (Tsafriri et al., 1996).
This approach has been applied during culture of oocytes
from several species, including human. It was demonstrated
that human cumulus-enclosed oocytes retrieved from small
antral follicles were efﬁciently arrested by the speciﬁc
PDE3-inhibitor (PDE3-I) Org 9935 (Nogueira et al., 2003a,
2006). Ultrastructural analysis of the oocytes showed that
this period of PMC was not deleterious to oocyte morphology
(Nogueira et al., 2003a). Furthermore, applying a PDE3-I
proved to be beneﬁcial for human IVM by enhancing nuclear
maturation rates, without compromising embryonic develop-
ment (Nogueira et al., 2006).
On the basis of these results, the present study was designed
to determine if the use of a PDE3-I could improve IVM of
cumulus-free GV oocytes retrieved from patients stimulated
for ICSI treatment. These oocytes are generally considered to
be a side product of the treatment and the clinical use is
restricted to rare cases (Veeck et al., 1983; Nagy et al., 1996;
Edirisinghe et al., 1997; Chen et al., 2000). Nevertheless,
cumulus-free GV oocytes are a valuable source of research
material to study different effects of PDE3-I on IVM.
The aims of this study were: (i) to evaluate the dose-
dependent effect of cilostamide, a speciﬁc PDE3-I, on the
kinetics and the degree of nuclear maturation; (ii) to assess
cytoplasmic quality of arrested oocytes in terms of spindle
morphology and associated chromosome alignment after
IVM and (iii) ascertain whether a period of PMC could
synchronize the population of GV oocytes by evaluating the
chromatin organization around the nucleolus.
Materials and methods
Source of oocytes
Spare GV oocytes (n ¼ 234) were obtained from 114 consenting
women undergoing controlled ovarian stimulation for ICSI treatment.
Complete institutional review board approval was obtained for this
study (Project N8 EC UZG 2006/168). The stimulation protocol
used in our centre has been described in detail elsewhere (Vanhoutte
et al., 2005). Oocytes were denuded enzymatically by a brief exposure
to 80 IU ml21 hyaluronidase (Type VIII; Sigma Chemical Co.,
Bornem, Belgium), followed by mechanical denudation 1 to 3 h
after oocyte collection. The nuclear status of denuded oocytes was
recorded. Oocytes at metaphase II (MII) were used for the ICSI
cycle of the patients. GV-stage oocytes were distributed among
different culture conditions, according to the experimental design
described later.
In vivomatured MII oocytes (n ¼ 11) were donated in a case where
no sperm was available for ICSI and served as the in vivo control for
assessment of spindle morphology and chromosome alignment.
Products and IVM culture
All products were purchased from Sigma Chemical Co. (Bornem,
Belgium), unless otherwise indicated.
The speciﬁc PDE3-I used was cilostamide (Cat # 231085, Calbio-
chem, Bierges, Belgium; Stock 10 mM in dimethylsulphoxide stored
at 2208C) at ﬁnal concentrations of 1 and 10 mM.
The IVM culture medium consisted of tissue culture medium 199
(TCM 199; M2154) supplemented with 10 ng/ml epidermal growth
factor (E9644), 1 mg/ml estradiol (E4389), 10 mIU/ml recombinant
FSH (Puregon, Organon, Oss, The Netherlands), 0.5 mIU/ml HCG
(Pregnyl, Organon), 1 mM L-glutamine (G7513), 0.3 mM sodium pyr-
uvate (P4562), 0.8% human serum albumin (Red Cross, Brussels,
Belgium), 100 IU/ml penicillin G (P4687) and 100 mg/ml streptomy-
cin sulphate (S1277).
All immature oocytes were cultured singly in 25 ml drops of
medium overlaid with embryo-tested light mineral oil in a humidiﬁed
atmosphere at 5% CO2 in air at 378C.
Experimental design
GV-stage oocytes from each patient were randomly distributed
between three different culture conditions: (i) IVM medium without
inhibitor (in vitro control); (ii) IVM medium supplemented with
1 mM cilostamide and (iii) IVM medium supplemented with 10 mM
cilostamide. This prevented all oocytes from the same patient being
assigned to the same treatment group. Oocytes in groups (ii) and
(iii) were exposed to cilostamide for 24 h (¼PMC). The PDE3-I
was subsequently removed by transferring the oocytes to fresh IVM
medium and the reversibility of inhibition was assessed during IVM
culture for a maximum of 48 h.
The maturational status of the oocytes in the three groups was
examined at 24 h or up to 48 h (from 25 to 48 h) of IVM culture
and was classiﬁed as GV, GV breakdown (GVBD) or polar
body (PB) extrusion. When a PB was identiﬁed at any of these time
points, the oocyte was ﬁxed for immunostaining and confocal
imaging of the spindle and the chromosomes.
For analysis of the GV chromatin conﬁguration, immature oocytes
were ﬁxed and stained immediately after the 24 h PMC period. Only
1 mM of cilostamide was tested, because the previous experiments
in this study proved that this was the optimal concentration (see
Results). The organization of chromatin around the nucleolus in
arrested oocytes was compared to non-arrested, control GV oocytes
that were ﬁxed at time 0 h of culture.
Oocyte ﬁxation, immunostaining and confocal imaging
Oocytes were simultaneously ﬁxed and extracted in a
microtubule-stabilizing buffer, as described elsewhere (Mattson and
Albertini, 1990). To visualize microtubules, oocytes were incubated
in the presence of a mixture of mouse monoclonal anti-a,b-tubulin
(1:200; T9026 and T4026) overnight at 48C, followed by Alexa
Fluor 488 conjugated goat-anti-mouse immunoglobulin G (1:200;
A11001, Molecular Probes, Eugene, Oregon) for 2 h at 378C. Chroma-
tin was stained with ethidium homodimer-2 (1:500; E3599, Molecular
Probes) for 1 h at 378C. Labelled oocytes were mounted on micro-
scope slides in 90% glycerol-phosphate-buffered saline solution con-
taining 0.2% 1,4 diazabicyclo[2.2.2]octane (DABCO; D2522) as an
antifading reagent. Preparations were observed using a laser scanning
L.Vanhoutte et al.
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confocal microscope (LSCM; Biorad Radiance 2000 mounted on a
Nikon inverted microscope; Tokyo, Japan) equipped with an
argon-ion/helium–neon (488/543) laser and selective ﬁlter sets for
Alexa Fluor 488 and ethidium homodimer-2. Images were obtained
using a 100x plan oil immersion objective (numerical aperture 1.3).
Z-axis stacks and 3D reconstructions were obtained by using 0.25 to
0.5 mm steps.
Statistical analysis
Differences between treatment groups were analysed with chi-square
and, when appropriate, two-tailed Fisher’s exact test. When the
P-value was ,0.05, the difference was considered signiﬁcant.
Results
Effect of cilostamide on nuclear maturation
In Table I, the results of the meiotic progression in arrested and
non-arrested oocytes are presented. Of oocytes exposed to 1
and 10 mM cilostamide, 88% and 85% were efﬁciently arrested
at the GV stage, respectively. After removal from PDE3-I,
oocytes were capable of resuming meiosis. The kinetic pro-
gression of PB extrusion was compared with the control
group. Twenty-four hours after withdrawal of inhibitor, PB
rates in the groups of previously arrested oocytes were lower
compared with non-arrested controls (P , 0.05; Table I). By
the maximum time of IVM (48 h), however, the PB rates of
arrested oocytes were not signiﬁcantly different from that of
non-arrested control oocytes. There was no difference in the
proportion and the kinetics of PB extrusion between 1 and
10 mM cilostamide.
Effect of cilostamide on spindle morphology
and chromosome organization
PB oocytes from controls and PMC groups were processed for
LSCM and various stages of microtubule organization and
chromatin conﬁguration could be distinguished. This allowed
us to reclassify 22 IVM oocytes that appeared not to be at
the MII stage of the meiotic cycle, as previously assessed by
PB extrusion with normal light microscopy (Table II). A few
of these oocytes (n ¼ 13) were still at the telophase I stage,
visible by the presence of two discrete bundles of condensed
chromosomes, joined by an attenuated spindle midbody
between the oocyte and the PB (Figure 1A and A0). Some
oocytes (n ¼ 9), present in the two PDE3-I groups, were spon-
taneously activated. This was characterized by the appearance
of a dense and extensive network of interphase microtubules
throughout the oocyte cortex and the formation of a single pro-
nucleus. In contrast, all in vivo matured oocytes (n ¼ 11),
which were ﬁxed immediately after retrieval, were at the MII
stage at the moment of ﬁxation. This was evidenced by the
presence of a MII spindle and one group of condensed
chromosomes arranged on a compact plate at the equator of
the spindle.
Oocytes that reached the MII stage were classiﬁed according
to the structure of the spindle (Figure 1B and C) and the organ-
ization of the chromosomes on the metaphase plate (Figure 1B0
and C0; Table II). The percentage of oocytes displaying a
normal barrel-shaped spindle and well-aligned chromosomes
at the equator was signiﬁcantly higher in the in vivo controls
compared with the in vitro controls and the 10 mM cilostamide
Table I. Progression of meiosis in non-arrested and temporary arrested
germinal vesicle (GV) oocytes, followed by in vitro maturation (IVM) for up
to 48 h
Culture conditions
Control 1 mM
cilostamide
10 mM
cilostamide
No. (%) of GV after inhibition 56/64 (88) 51/60 (85)
No. of GV undergoing IVM 43 56 51
Maturation at 24 h of IVM (%)
GV 26 21 25
GVBD 23a 48b 51b
PB 51a 25b 22b
Maturation up to 48 h of IVM
(between 25 and 48 h) (%)
GV 12 16 24
GVBD 14 13 4
PB 72 63 65
GVBD, germinal vesicle breakdown; PB, polar body.
a,bValues within the same row with different superscripts are statistically
different (P, 0.05). Due to the exclusion of degenerated oocytes, the
different proportions may not add up to 100%.
Table II. Microtubule and chromatin organization of in vivo matured oocytes (in vivo control) and GV oocytes showing a PB after IVM for up to 48 h (in vitro
control, 1 and 10 mM cilostamide)
Culture conditions
In vivo
control
In vitro
control
1 mM
cilostamide
10 mM
cilostamide
No. of PB oocytes analysed 11 27 32 30
No. (%) of oocytes at TI stage 6 (22) 5 (16) 2 (7)
No. (%) of oocytes activated 4 (12) 5 (17)
No. (%) of oocytes at MII stage 11 (100) 21 (78) 23 (72) 23 (77)
Normal spindle shapea 11 (100)b 12 (57)c 18 (78)b,c 14 (61)c
Aligned chromosomesd 10 (91)b 10 (48)c 16 (70)b,c 10 (43)c
TI, Telophase I.
aDeﬁned as a barrel-shaped spindle with slightly pointed, anastral poles. Percentages are calculated over the total number of metaphase II (MII) oocytes.
b,cValues within the same row with different superscripts are statistically different (P, 0.05).
dDeﬁned as condensed chromosomes arranged on a compact plate at the equator of the spindle. Percentages are calculated over the total number of MII oocytes.
Oocyte meiosis inhibition
1241
55
group (P , 0.05; Table II), but similar to the 1 mM cilostamide
group.
On the basis of these results, a concentration of 1 mM cilos-
tamide was chosen in the next experiment.
Effect of cilostamide on chromatin conﬁguration
within the GV
To evaluate if a PMC for 24 h might exert an inﬂuence on
nuclear characteristics of the GV oocytes, the pattern of
chromatin conﬁgurations was evaluated. This was assessed
before (control) and after the period of arrest.
Three different patterns could be distinguished: Pattern ‘1’:
a nucleolus partially surrounded by chromatin and the presence
of ﬁbrillar chromatin distributed throughout the nucleus
(Figure 2A); Pattern ‘2’: a nucleolus completely surrounded
by chromatin and masses of condensed chromatin or threads
of dispersed chromatin occupying a smaller portion of
the nuclear area (Figure 2B) and Pattern ‘3’: a nucleolus com-
pletely surrounded by a rim of highly condensed chromatin and
Figure 1. Immunocytochemical staining of different spindle morphologies (A–C) and correlative chromatin patterns (A0 –C0) in human oocytes.
(A and A0) Telophase I stage: an attenuated spindle midbody is formed between the oocyte and the polar body (PB; arrow in A). Two sets of
condensed chromosomes are visible; (B and B0) Normal metaphase II spindle with aligned chromosomes, orientated perpendicular and in a cor-
tical position in the oocyte. The microtubule and chromatin organization in the PB is visible as well (arrow in B and B0); (C and C0) Abnormal
spindle with disorganized and partially depolymerized microtubules. In addition, several chromosomes are dislocated from the metaphase plate
(arrows in C0). Scale bar ¼ 5 mm.
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no chromatin throughout the remainder of the nucleoplasm
(Figure 2C).
The proportions of GV in which the different patterns
were observed before and after arrest are represented in
Figure 3. In the control group (before meiotic arrest), the
three different patterns of chromatin conﬁguration were visu-
alized, but pattern ‘2’ was the most frequent one (53% of the
total number of GVs analysed). After 24 h of inhibition, there
was a signiﬁcant increase in the proportion of oocytes that
had acquired a pattern ‘3’ conﬁguration, which was signiﬁ-
cantly different from the control group (81% versus 33%;
P , 0.05).
Discussion
The present study demonstrates that supplementation of the
IVM culture medium with the speciﬁc PDE3-I cilostamide
for 24 h resulted in reversible meiotic arrest of denuded GV
oocytes retrieved in ICSI cycles. This temporary induced
nuclear arrest was equally effective (.80%) at both concen-
trations of 1 and 10 mM cilostamide. The high efﬁciency of
speciﬁc PDE3-I’s to arrest meiosis has been previously demon-
strated in human and non-human primate oocytes (Nogueira
et al., 2003a, 2006; Jensen et al., 2002).
The period of inhibition proved to be completely revers-
ible. After removal of PDE3-I, GV oocytes were capable
of resuming meiosis at the same ﬁnal rate as non-arrested
oocytes. The overall maturation rate obtained in the present
study was comparable with those achieved by others
working with cumulus-free GV oocytes retrieved from stimu-
lated cycles and matured in TCM-199 (Goud et al., 1998;
Cekleniak et al., 2001; Chian and Tan, 2002; Roberts
et al., 2002).
Although the ﬁnal rate of nuclear maturation achieved in the
PDE3-I groups was similar to the control group, the time
course for PB extrusion after removal of PDE3-I was slowed
down. The reason for this event is at the moment unclear.
Resumption of meiosis requires PDE3A activity (Tsafriri
et al.,1996; Richard et al., 2001). It is possible that the delay
in meiotic progression observed in the PDE3-I group at 24 h
is a result of the time necessary for the reconstitution of
PDE3 activity and the breakdown of cAMP prior to GVBD.
However, since we did not evaluate the time-lapse between
the onset of meiosis and oocytes’ PB extrusion, it is still to
be evaluated if the lower rate of PB-extruded oocytes at 24 h
of IVM is a result of a later onset of GVBD in comparison to
the control group or if it is due to a longer gap between
GVBD and PB extrusion.
It is still debatable whether this delay in meiotic progression
after withdrawal of the inhibitor results in a positive outcome.
A study by Son et al. (2005) demonstrated that embryos
derived from late-maturing oocytes (48 h of IVM and
beyond) were of lower quality compared with oocytes maturing
between 24 and 30 h of IVM. This suggests that a retarded
meiotic progression results in a negative outcome. On the
other hand, different studies demonstrated that exposure of
oocytes to gonadotrophins (Gomez et al., 1993; Cha and
Chian, 1998) and absence of cumulus cells (Goud et al.,
1998; Kim et al., 2000) accelerates meiotic progression in
vitro, which is a non-physiological condition of oocyte matu-
ration. Both of these variables are relevant to the culture con-
ditions applied in the present study. Therefore, it is possible
that the initial delay in meiotic progression after removal of
inhibitor contributes to a better co-ordination of nuclear and
cytoplasmic maturation.
Figure 2. Different chromatin patterns in human germinal vesicle (GV) oocytes after staining with ethidium homodimer-2 and analysis with laser
scanning confocal microscopy. (A) Pattern ‘1’: partially surrounded nucleolus. Note the presence of ﬁbrillar chromatin distributed throughout the
nucleus; (B) Pattern ‘2’: identiﬁed by a rim of condensed chromatin surrounding the nucleolus and threads of chromatin dispersed in the nucleus;
(C) Pattern ‘3’: all chromatin surrounds the nucleolus and there is no chromatin staining present throughout the remainder of the nucleoplasm.
Scale bar ¼ 10 mm.
Figure 3. Chromatin conﬁguration of oocyte nuclei before and after
arrest by cilostamide (1 mM). Patterns 1, 2 and 3 refer to Figure 2.
*Signiﬁcant different from control (P , 0.05).
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It is difﬁcult to assess the degree of cytoplasmic maturation
of oocytes, apart from the ability to fertilize and support
embryonic development. A possible marker is the morphology
of the meiotic spindle, an essential component of the oocyte.
Disruption of microtubule organization might lead to failures
in chromosome segregation and organelle allocation during
later development (Van Blerkom et al., 1995;
Eichenlaub-Ritter et al., 2002). For that reason, spindle mor-
phology and associated chromosome conﬁgurations were
used in the present study as an index of the cytoplasmic integ-
rity of the oocytes.
LSCM observations revealed that a small proportion of in
vitro matured PB oocytes were at the telophase I stage at the
moment of ﬁxation. Polscope analysis showed that following
the extrusion of the ﬁrst PB, the human oocyte remains at the
telophase I stage for 75–90 min prior to formation of the
MII spindle (Montag et al., 2006). This could explain why
some of the PB oocytes in our study were still at the telophase
I stage. Another portion of oocytes examined showed chroma-
tin and microtubules distinctive of spontaneous activation,
which suggests the inability of the in vitro matured oocytes
to properly maintain M-phase characteristics. This has been
previously recognized as one of the deﬁciencies related to
IVM (Combelles et al., 2002). Balakier et al. (2004) demon-
strated that the highest fertilization rate of human in vitro
matured oocytes was obtained when ICSI was performed
between 3 and 6 h after extrusion of the PB. These observations
together led us to conclude that the exact time recording of PB
extrusion and fertilization is an essential factor in order to
enhance the outcome of IVM.
MII spindle morphology and chromosome organization
appeared to be suboptimal in in vitro matured control oocytes
compared to in vivo matured oocytes. This is in agreement
with a recent study by Li et al. (2006), comparing spindle mor-
phology and chromosome alignment of in vivo versus in vitro
matured oocytes from polycystic ovary syndrome patients.
An interesting observation in our study was the tendency to
obtain normal spindle/chromosome conﬁgurations when
oocytes were exposed to 1 mM cilostamide. This could indicate
that the period of PMC induced cytoplasmic changes in the
oocyte that are necessary for the construction of a normal
spindle and the maintenance of a well-aligned MII plate.
Microtubule reorganization and stability is inﬂuenced by
several factors, including protein kinase activity (e.g. mitogen-
activated protein kinase), centrosome-based microtubule
nucleation and post-translational modiﬁcations of tubulin
(Albertini, 1992). A PMC could have been attributed to the
synthesis, storage and modiﬁcations of some of these factors.
The beneﬁcial effect of PDE3-I on spindle/chromosome
conﬁguration was not clearly demonstrated when a concen-
tration of 10 mM cilostamide was used. This indicates that
the concentration of inhibitor is of importance when applying
such IVM systems. The precise reason for this observation is
unclear at this stage. Some disorganization of meiotic spindles,
abnormalities in microtubule organizing centres and damage to
kinetochores and microtubules have been observed in 6-
dimethylaminopurine (DMAP)-treated mouse oocytes (Rime
et al., 1989; Szo¨llo¨si et al., 1991). Whether similar effects
were, indirectly, induced by the effect of cilostamide at high
concentrations needs further research. However, it is also poss-
ible that the ﬁndings are inﬂuenced by the variability that might
exist between individual oocytes. The impact of patient age on
spindle morphology has been demonstrated previously
(Battaglia et al., 1996; Eichenlaub-Ritter, 1998). Inter-patient
variability might be eliminated if a larger number of oocytes
per patient could be available.
Another possible marker for oocyte developmental capacity
is the pattern of chromatin organization within the GV. The
results in this study demonstrate that human denuded GV
oocytes, isolated from pre-ovulatory follicles, present hetero-
geneity in the chromatin conﬁguration. This heterogeneity
was previously reported in human oocytes (Parfenov et al.,
1989; Combelles et al., 2002; Miyara et al., 2003).
After the 24 h period of meiotic arrest, we could observe an
increased proportion of oocytes that had acquired a nuclear
conﬁguration in which all of the highly condensed chromatin
surrounded the nucleolus (pattern ‘3’). This ﬁnding conﬁrms
that a PMC period with a PDE3-I contributes to the synchroni-
zation of the population of GV oocytes. Similar effects of the
PDE3-I Org9935 were found in mouse oocytes (Nogueira
et al., 2003b).
A transition from a decondensed ‘non-surrounded nucleolus’
to a condensed ‘surrounded nucleolus’ (SN) chromatin pattern
has been related to a transition from an active to an inactive
state of nuclear transcription in rodents (Mattson and Albertini,
1990; Zuccotti et al., 1998, De La Fuente, 2006). The presence
of a SN conﬁguration has been associated with a higher pro-
portion of oocytes reaching meiotic maturation, better embryo-
nic developmental quality and, hence, represents a more
advanced step in oocyte differentiation. In the present study,
the increase of the oocyte population in the arrested group
(1 mM cilostamide) with a pattern ‘3’ conﬁguration might
have contributed to the higher proportion of oocytes with
normal spindles and chromosome organization.
At present, it cannot be ruled out that an acceleration of the
transition from the active to the inactive state of transcription
may have also detrimental effects for some oocytes. Following
transcriptional silencing, the oocyte relies on maternal mRNA
stores to resume meiosis and sustain the ﬁrst cleavage divisions
after fertilization until activation of the embryonic genome.
Experimentally extending the period between transcriptional
inactivation in the GV and initiation of meiotic maturation
may reduce the competence of the oocytes to complete preim-
plantation embryonic development (De La Fuente and Eppig,
2001). This suggests that the period of temporary nuclear
arrest is crucial and may not be too extensive. Further systema-
tic analysis, e.g. through ﬂuorescent detection of transcriptional
activity, could reveal at which time point the transition from an
active to an inactive state took place during the PMC period
(Fair et al., 1996; Miyara et al., 2003).
An important aspect that deserves attentionwhen analysing the
present results is the source of oocytes used in this study. The GV
oocytes represent an already compromised group of oocytes
retrieved from follicles that failed to conclude maturation in
vivo in response to the hormonal stimulation. Moreover, the
oocytes were denuded of cumulus cells in preparation for ICSI
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before culture. Granulosa cells are the production site of steroids,
growth factors, proteins and other compounds that contribute to
cytoplasmic maturation of oocytes. Beneﬁcial effects of
cumulus cells on microtubule dynamics and/or chromatin stab-
ility, oocyte maturation and early embryonic development have
been reported in many species, including the human (Kennedy
and Donahue, 1969; Cha and Chian 1998; Goud et al., 1998;
Moor et al., 1998; Ueno et al., 2005). Therefore, these oocytes
should not be considered as a ﬁrst choice for the infertility treat-
ment of the patient. Nevertheless, in some patients with a low
number of mature oocytes at the day of retrieval, these GV
oocytes could be used in order to increase the number of fertiliz-
able oocytes.Oneway to approach amore physiological situation
for IVM of these spare GV oocytes is to restore the communi-
cation between the cumulus cells and the oocyte. A study by
Combelles et al. (2005) describes a novel co-culture system in
which cumulus cells were embedded into a 3D collagen gel
matrix and mixed together with individual oocytes. The authors
found that microtubule-rich processes, which resemble transzo-
nal projections, were visible at the oocyte–cumulus cell inter-
face. This indicates that the interaction between the isolated
cell populations was restored. The next step to improve the
outcome of denuded, otherwise clinically useless, human GV
oocytes might be the use of a similar co-culture system in combi-
nation with temporary nuclear arrest by PDE3-I.
In conclusion, temporary nuclear arrest by the speciﬁc PDE3-I
cilostamide (1 mM) proved to be beneﬁcial for spindle/chromo-
some conﬁgurations and allowed synchronization of the popu-
lation of immature oocytes. Modiﬁcation of the PMC to restore
and sustain oocyte-granulosa cell interactions during IVM
might be a feasible step to mirror the physiological situation.
Finally, before any clinical application, complete testing of poss-
ible increased risks of aneuploidy is necessary.
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background: During conventional in vitro maturation (IVM), oocytes undergo nuclear maturation but do not attain full cytoplasmic
maturity. The present study aimed to evaluate the quality of denuded in vitro matured human oocytes (¼ ‘rescue IVM’) following a prema-
turation culture (PMC) in a three-dimensional (3D) co-culture system with cumulus cells.
methods: Denuded, germinal vesicle (GV) oocytes retrieved from controlled ovarian hyperstimulation (COH) cycles were embedded in
collagen (Type I) gel containing dissociated cumulus cells and a speciﬁc phosphodiesterase 3-inhibitor (PDE3-I) for 24 h. Afterwards, oocytes
were removed from the gel and transferred to IVM inhibitor-free medium. The reversibility of PDE3 inhibition was assessed following IVM
culture for a maximum of 48 h. Cytoplasmic maturation was assessed by the oocytes’ capability to fertilize after ICSI and sustain further
embryonic development. Conventional microdroplet cultures of denuded oocytes, with and without PMC, served as controls.
results: Oocytes embedded in collagen gel and exposed to PDE3-I were efﬁciently arrested at the GV stage. After removal from col-
lagen and inhibitor, oocytes were capable of resuming meiosis: maturation rates (74.5%) were similar compared with non-prematured
(68.5%) and prematured oocytes (73.4%) in microdroplets. Fertilization rates after PMC in 3D co-culture were signiﬁcantly higher compared
with non-prematured oocytes (72.2% versus 54.0%; P, 0.05), but similar to oocytes prematured in microdroplets (63.8%). Compared with
both controls, the PMC in 3D co-culture improved the morphological quality and nuclear constitution of embryos on Day 3 post-ICSI.
conclusions: Three-dimensional PMC co-culture using a PDE3-I may enhance cytoplasmic maturation of denuded human GV oocytes
retrieved from COH cycles.
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Introduction
The major challenge in developing in vitro maturation (IVM) systems is
to create environmental conditions and to support oocyte develop-
ment, which approach the in vivo situation. Current IVM culture
systems are often unable to fulﬁl these criteria. This is clearly demon-
strated by the lower success rates in achieving pregnancy of embryos
derived from in vitro matured oocytes (for review, see Chian et al.,
2004; Mikkelsen, 2005; Jurema and Nogueira, 2006).
In vitro matured oocytes undergo maturation ‘precociously’ while
they are still in the process of acquiring the cytoplasmic machinery
needed to fully support preimplantation embryonic development
(Dieleman et al., 2002; Sirard et al., 2006; Gilchrist and Thompson,
2007). Therefore, several researchers have tried to improve the
oocytes’ developmental potential by temporarily inhibiting spon-
taneous meiotic maturation, in an attempt to arrest oocytes at the
germinal vesicle (GV) stage while cytoplasmic maturation takes
place. In this way, a two-step culture has been created consisting of
a prematuration culture (PMC) followed by IVM (Lonergan et al.,
1998; Anderiesz et al., 2000; Nogueira et al., 2003).
Spontaneous maturation can be prevented by exposing the oocytes
to compounds that inhibit meiosis. Oocyte-speciﬁc phosphodiesterase
type-3-inhibitors (PDE3-Is; e.g. cilostamide, milrinone, Org9935) are
potent candidates for this purpose. These agents keep intra-oocyte
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cAMP levels above a threshold that maintains the oocyte arrested at
the GV-stage in vitro (Tsafriri et al., 1996; Conti et al., 2002;
Thomas et al., 2002). Inclusion of PDE3-I in the culture medium
during a period of PMC is likely to improve quality and developmental
potential in mouse (Nogueira et al., 2003; Vanhoutte et al., 2008) and
bovine (Thomas et al., 2004b) oocytes. In addition, enhancement of
nuclear maturation rates occurs when human cumulus-enclosed
oocytes (CEOs) are prematured in the presence of PDE3-I (Nogueira
et al., 2006). Furthermore, combined exposure of human CEOs to
PDE3-I and forskolin, an adenylate cyclase activator, has a positive
effect on fertilization rates following IVM (Shu et al., 2008).
A similar approach has recently been tested by our group on
denuded GV-stage oocytes obtained after ovulation induction for
ICSI treatment (Vanhoutte et al., 2007). Although these oocytes are
of poor developmental quality compared with their in vivo matured
counterparts and, therefore, routinely considered as a side-product
of the IVF treatment, they may be valuable for studying new IVM pro-
tocols. Furthermore, these dysmature oocytes can be rescued by IVM
and could be a surplus material for ICSI patients when a low number
of mature oocytes are retrieved.
PMC of those denuded GV-stage oocytes with a PDE3-I contrib-
utes to a better coordination between nuclear and cytoplasmic matu-
ration (Vanhoutte et al., 2007). However, a clear drawback in this
experimental set-up remains the fact that cumulus cells are absent
during PMC. Owing to research conducted during the past decade,
it is now clear that the bidirectional communication between the
oocyte and its surrounding cumulus cells plays an important role in
the acquisition of oocyte developmental competence and in sub-
sequent embryogenesis (for review, see Albertini et al., 2001;
Eppig, 2001; Tanghe et al., 2002; Gilchrist et al., 2004). Removal of
the cumulus oophorus before IVM is detrimental to oocyte quality
(Kennedy and Donahue, 1969; Schroeder and Eppig, 1984; Hwang
et al., 2000; Ruppert-Lingham et al., 2003; Nogueira et al., 2006).
To circumvent this deﬁciency, some researchers have tried to estab-
lish co-culture systems of human denuded GV oocytes with disso-
ciated cumulus cells (Ha¨berle et al., 1999; Johnson et al., 2008;
Zhu et al., 2008). These studies, however, have been unable to
show a signiﬁcant improvement in IVM outcome. An attempt to
better mimic the physiological situation is to create a system that
permits a tight contact between the dissociated cumulus cells and
the oocyte in a three-dimensional (3D) structure, by making use of
an extra-cellular matrix (ECM) (Combelles et al., 2005; Torre
et al., 2006).
A superior culture condition for human denuded GV oocytes (¼
‘rescue IVM’) could be the combination of a similar 3D co-culture
system in a period of PMC. In this way, the unhealthy condition of pre-
cocious spontaneous maturation is circumvented by the addition of a
PDE3-I, while the surrounding somatic cells may produce a suitable
micro-environment to support prematuration events of the oocyte.
The current study was undertaken to test this hypothesis. Denuded
GV-stage oocytes, retrieved following controlled ovarian hyperstimula-
tion (COH), were prematured in a 3D co-culture with cumulus cells for
24 h. Nuclear maturation capability was assessed upon release from
artiﬁcial meiotic arrest. Embryonic developmental potential was evalu-
ated subsequently as a marker for oocyte cytoplasmic quality. Possible
adverse effects of collagen embedding on cell morphology and viability
were analysed under light, confocal and electron microscopy.
Materials and Methods
The study was undertaken after complete institutional review board
approval from the Ghent University Ethical Committee (Project no. EC
UZG 2006/168 and 2006/128). In addition, the study was ﬁled to the
Federal Ethical Committee on Embryos. Written informed consent was
obtained from each infertile couple before the use of their donated
gametes.
All products were purchased from Sigma-Aldrich (Bornem, Belgium),
unless otherwise indicated.
Source of oocytes
Oocytes that failed to mature in vivo were donated by women undergoing
IVF/ICSI treatment in our Department of Reproductive Medicine. All
patients underwent COH after cycle synchronization with a standard con-
traceptive pill for 2–6 weeks. A short gonadotrophin-releasing hormone
agonist protocol was used, consisting of 0.1 mg of triptorelin (Decapeptyl,
Ipsen, France) from Day 5 onwards after discontinuation of the oral con-
traceptive. This was followed by human menopausal gonadotrophin (hMG;
Menopur, Ferring, Germany) or follicle-stimulating hormone (FSH; either
Gonal-F, Serono, Geneva, Switzerland, or Puregon, Organon, Oss, The
Netherlands) from Day 7 after discontinuation of the pill onwards. The
starting dose was usually 150 IU, but this dose was adjusted after 7 days
of hMG or FSH administration, according to the individual response of
the patient. Known poor responders were started on 300 IU of hMG or
FSH daily. The follicular phase was monitored by means of transvaginal
ultrasound scanning of the ovaries and serum estradiol measurement if
judged necessary. An injection of 5000 or 10 000 IU human chorionic gon-
adotrophin (hCG; Pregnyl, Organon) was administered when half of all
mature follicles had reached a mean diameter of at least 20 mm, measured
in two planes. Oocyte retrieval was scheduled 34–36 h after hCG
administration.
Oocytes were denuded enzymatically by a brief exposure to 80 IU/ml
hyaluronidase (Type III), followed by mechanical denudation. In order to
perform a more controlled study, all oocytes were completely denuded
before starting PMC and IVM. The nuclear status of denuded oocytes
was recorded. Only morphologically normal appearing GV-stage oocytes
were used in the study.
Isolation and treatment of cumulus cells
Cumulus cells were collected after enzymatic and mechanical removal
from the oocytes at the time of oocyte preparation for ICSI. To obtain suf-
ﬁcient numbers, cumulus cells from different patients were pooled and
centrifuged for 5 min at 400g. The resulting pellet was resuspended and
exposed to a lysis buffer to remove red blood cells (8.29 g/L NH4Cl þ
1.0 g/L KHCO3 þ 0.58 g/L EDTA in embryo water, pH 7.2; 5 min at
378C). The cumulus cells were then pelleted down by centrifugation
and resuspended in 1 ml of warm Ca/Mg-free EBSS medium (Invitrogen,
Merelbeke, Belgium) supplemented with 5% human serum albumin
(HSA; Red Cross, Brussels, Belgium). This procedure was repeated at
least twice to remove all traces of hyaluronidase and cell debris. Cell clus-
ters were dispersed by repeated gentle pipetting. Finally, cells were resus-
pended in a small volume of PMC-medium (composition below) and
counted in a haemocytometer. Cell viability was estimated by Trypan
Blue exclusion and was found to be consistently higher than 80%.
Three-dimensional co-culture
The co-culture was prepared as described by Combelles et al. (2005) with
some modiﬁcations. An ECM solution composed of collagen (3.79 mg/ml
rat tail collagen Type I; BD Biosciences, Erembodegem, Belgium) was
brought to neutral ionic strength and pH (7.4) by quickly mixing eight
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volumes with one volume of 10 concentrated TCM-199 (Invitrogen) and
one volume of 0.05 N NaOH containing 22 mg/ml NaHCO3. This sol-
ution was kept on ice until usage. Collected and puriﬁed cumulus cells
were mixed with this neutralized collagen solution at a ﬁnal density of
2  106 cells/ml. Microdroplets (4 ml) of this cell suspension were
seeded in the wells of a 96-well plate (BD Biosciences), creating gels
that contained around 8000 cumulus cells each. A single immature
oocyte was added carefully to each droplet in a minimal volume of
medium, which was then allowed to polymerize at 378C for 10 min
before adding 80 ml of PMC-medium (composition below) to each well
(ﬁnal density of 1  105 cells/ml/well).
Culture medium for oocyte maturation
The basal culture medium was Tissue Culture Medium 199 (TCM 199)
supplemented with 5 mg/ml human transferrin, 5 ng/ml sodium selenite,
10 ng/ml human recombinant insulin, 100 ng/ml long R3 insulin-like
growth factor-I, 100 mM cysteamine hydrochloride, 10 mIU/ml FSH
(Puregon, Organon), 1 mM L-glutamine, 0.3 mM sodium pyruvate, 0.8%
HSA (Red Cross), 100 IU/ml penicillin G and 100 mg/ml streptomycin
sulphate.
The PMC-medium was composed of the basal medium plus 1 mM cilos-
tamide, a speciﬁc PDE3-I (Calbiochem, Bierges, Belgium; Stock 10 mM in
DMSO stored at 2208C) (Vanhoutte et al., 2007).
The IVM-medium was constituted by the basal medium supplemented
with 10 ng/ml epidermal growth factor, 1 mg/ml estradiol and 0.5 IU/
ml hCG (Pregnyl, Organon).
Experimental design for GV-stage
oocyte culture
A schematic presentation of the study design is shown in Fig. 1. Oocytes
from each patient were randomly allocated to three different culture
conditions:
(i) Conventional IVM: oocytes were cultured individually in 25 ml micro-
drops of IVM-medium. Evaluation during the IVM period was per-
formed at 24 h, up to 30 h (from 25 to 30 h) and up to 48 h (from
31 to 48 h) of culture. The nuclear maturational stage was classiﬁed
as GV, GV breakdown (GVBD) or polar body (PB) extrusion.
(ii) PMC in microdroplets þ IVM: oocytes were prematured singly in
25 ml microdrops of PMC-culture medium. The oocytes were main-
tained arrested for 24 h. PDE3-I withdrawal was carried out by
washing the oocytes three times in IVM-medium. IVM culture and
evaluation of nuclear stage were performed as described in group (i).
(iii) PMC in 3D co-culture þ IVM: oocytes were prematured in a 3D
co-culture system containing cumulus cells embedded in collagen.
The oocytes were prematured for 24 h and were subsequently
removed manually with a pulled Pasteur pipette from the gel.
Denuded oocytes were washed and placed in IVM-medium and eval-
uated as described in group (i).
All cultures were carried out in a humidiﬁed atmosphere of 5% CO2 in
air at 378C.
ICSI procedure and embryo culture
Oocytes matured under different culture conditions were fertilized by ICSI
between 1 and 4 h after the PB had been visualized. Sperm cells for ICSI
were obtained the previous day from several male patients with excellent
sperm characteristics (¼ number of sperm cells, motility and morphology)
and who consented to donate supernumerary sperm cells for scientiﬁc
research. After injection, oocytes were cultured individually in Sydney
IVF Cleavage Medium (Cook, Ltd, Limerick, Ireland) for 3 days.
Fertilization was evaluated 16–18 h post-injection and was considered
normal when two pronuclei were identiﬁed. Embryo morphology was
classiﬁed as ‘excellent’, ‘good’ or ‘poor’, based on morphological criteria.
Embryos with four or ﬁve blastomeres on Day 2 and a minimum of seven
blastomeres on Day 3, ,20% fragmentation and no visual signs of multi-
nucleation were scored as ‘excellent morphology’. Those with two or
three blastomeres on Day 2 and a minimum of six blastomeres on Day
3, ,20% fragmentation and no visual signs of multinucleation were
scored as ‘good morphology’.
Immunostaining and confocal imaging
of cumulus cells and embryos
Three-dimensional-cultured cumulus cells and embryos of excellent and
good morphology on Day 3 post-ICSI were evaluated for cytoskeleton
organization and/or nuclear anomalies. The samples were simultaneously
ﬁxed and extracted in a microtubule-stabilizing buffer, as described else-
where (Mattson and Albertini, 1990). To visualize microtubules, cells
were incubated in the presence of a mixture of mouse monoclonal
anti-a,b-tubulin (1:200) overnight at 48C, followed by Alexa Fluor 488
conjugated goat-anti-mouse IgG (1:200; Molecular Probes, Eugene,
Oregon) for 2 h at 378C. Chromatin was stained with Ethidium
Homodimer-2 (1:500; Molecular Probes) for 1 h at 378C. Labelled
samples were mounted on microscope slides in 90% glycerol–PBS sol-
ution containing 0.2% 1,4-diazabicyclo[2.2.2]octane as an antifading
reagent. Preparations were observed using a laser scanning confocal
microscope (Bio-Rad Radiance 2000 mounted on a Nikon inverted micro-
scope; Tokyo, Japan) equipped with an Argon-ion/HeliumNeon (488/
543) laser and selective ﬁlter sets for Alexa Fluor 488 and Ethidium
Homodimer-2. Images were obtained using a 60 plan oil immersion
objective (numerical aperture 1.2).
For evaluation of embryos, all interphase and metaphase stage nuclei
were carefully examined and counted in each blastomere. Interphase
nuclei were classiﬁed as mono-, bi-, multinucleated or fragmented.
Spindle morphology and chromosome alignment in metaphase nuclei
were classiﬁed as normal (i.e. barrel-shaped spindle and well-aligned
chromosomes at the equator) or abnormal.
Transmission electron microscopy
In order to explore morphological characteristics of the 3D-PMC
co-culture, a few samples (n ¼ 6) of collagen gels containing oocytes
and cumulus cells were ﬁxed at the end of PMC in 2.5% glutaraldehyde
in 0.1 M cacodylate buffer (pH 7.3). After post-ﬁxation with 1% osmium
tetroxide in cacodylate buffer and dehydration in graded series of
alcohol, cells were embedded in Epon. Serial semithin sections of 1 mm
were cut throughout the oocyte and stained with Toluidine Blue for
Figure 1 Schematic diagram of the study design.
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light microscopic guidance. Ultrathin sections (0.1 mm) for electron micro-
scopic evaluation were collected at the point where the nucleolus of the
oocyte was visible. The sections were transferred on wide single-slot
copper grids, coated with carbon ﬁlm and stained with uranyl acetate
and lead citrate. Evaluation was done with a Zeiss E900 transmission elec-
tron microscope (Oberkochen, Germany).
Measurement of steroids
At the end of PMC, conditioned media from 3D-cultured cumulus cells
with oocytes were collected and stored at 2208C. The media were
assayed for progesterone (P) and estradiol-17b (E2) to validate the func-
tionality of collagen-embedded cumulus cells during the PMC period.
PMC-medium placed over collagen with no cells served as the uncondi-
tioned medium control. Concentrations of steroid hormones were
measured by clinical routine immunoassays after an appropriate dilution
in steroid-free culture medium. Kits were obtained from Roche Diagnos-
tics GmbH (Mannheim, Germany; E2: analytical sensitivity: 5 pg/ml; intra-
and inter-assay coefﬁcients of variance: 5.7% and 6.2%; P: analytical
sensitivity: 0.03 ng/ml; intra- and inter-assay coefﬁcients of variance:
2.4% and 5.4%). Data are presented as means+ SD from ﬁve measure-
ments. For each measurement, the medium of six wells derived from
the same cumulus cell preparation was used.
Statistical analysis
The Fisher exact test or contingency x2 test was used to evaluate differ-
ences in maturation, fertilization, cleavage rate, embryo quality and
embryo nuclear status between conventionally in vitro matured oocytes
and the PMC groups. A Bonferroni correction for multiple testing was per-
formed. Differences in mean number of blastomeres were calculated using
one-way ANOVA, followed by Tukey post hoc test. A level of P, 0.05
was considered statistically signiﬁcant.
Results
Effect of PMC method on the maturation
capacity of oocytes
Table I shows the cumulative time course of meiotic progression
under different IVM conditions. There was no difference in the pro-
portion of oocytes maintained at the GV stage (.90%) in the two
PMC groups (microdroplet versus 3D co-culture).
Upon 24 h of IVM culture, the percentage of PB-extruded oocytes
in the conventional IVM group was signiﬁcantly higher compared with
the PMC groups (P, 0.05). However, no difference was observed
during the subsequent IVM culture (up to 30 h and up to 48 h).
Final maturation rates at the end of IVM were equal among the
three experimental groups.
Effect of PMC method on fertilization
and embryo development
The results regarding fertilization and embryo development are pre-
sented in Table II. The percentage of two pronuclear (PN) embryos
was higher in the 3D-PMC compared with the conventional IVM
group (P, 0.05) and was not different from the microdroplet-PMC
group. The majority of fertilized oocytes underwent cleavage on
Day 2. Embryo quality on Day 2 was similar among the three
groups. On the other hand, a signiﬁcantly higher number of good
.............................................................................................................................................
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Table I Meiotic progression of immature oocytes cultured under different conditions for up to 48 h
Culture conditions
Conventional IVM PMC in microdroplet culture 1 IVM PMC in 3D co-culture 1 IVM
No. (%) of GV after inhibition 94/102 (92.2) 106/117 (90.6)
No. of GV undergoing IVM 92 94 106*
Maturation at 24 h of IVM (%)
GV 26.1 25.5 32.1
GVBD 38.0a 57.4b 46.2a,b
PB 33.7a 17.0b 17.9b
Degenerated 2.2 0 3.8
Maturation up to 30 h of IVM (between 25 and 30 h) (%)
GV 22.8 22.3 22.6
GVBD 17.4 16.0 16.0
PB 54.3 61.7 57.5
Degenerated 5.4 0 3.8
Maturation up to 48 h of IVM (between 31 and 48 h) (%)
GV 13.0 18.1 11.3
GVBD 12.0 8.5 9.4
PB 68.5 73.4 74.5
Degenerated 6.5 0 4.7
a,bValues within the same row with different superscripts are statistically different (P, 0.05).
*Oocytes were removed from collagen prior to IVM.
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quality embryos and a signiﬁcantly lower number of bad quality
embryos were obtained on Day 3 in the 3D-PMC compared with
the other groups (P, 0.05). The mean number of blastomeres was
not statistically different between groups (P. 0.05).
Nuclear status of embryos
The double-labelling method allowed the co-observation and localiz-
ation of the nucleus (chromatin) and cytoskeleton (tubulin) of individ-
ual blastomeres in embryos on Day 3 post-ICSI (see Fig. 2 and
Table III).
The mean number of blastomeres analysed per embryo was not
different among the groups. The 3D-PMC group contained signiﬁcantly
more mononuclear blastomeres compared with the other groups
(63.3% versus 47.1% in microdroplet-PMC and 37.5% in conventional
IVM; P, 0.05). The percentage of multinucleated, fragmented and
anuclear blastomeres was lower in the 3D-PMC compared with the
conventional IVM (P, 0.05), but not different compared with the
microdroplet-PMC.
In addition to interphase nuclear abnormalities, we identiﬁed some
metaphase abnormalities in all groups. This included mostly the disa-
lignment of chromosomes (Fig. 2C). However, the number of blasto-
meres at metaphase was too low to identify any statistical difference
among the groups.
As a result of these observations, 60% (n ¼ 15) of the embryos in
the 3D-PMC group contained at least 50% blastomeres with normal
interphase and/or metaphase conﬁguration, while this was 16.7%
...................................................................................................................................
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Table II Fertilization and embryo development of PB oocytes following IVM under different culture conditions
Culture conditions
Conventional IVM PMC in microdroplet culture1 IVM PMC in 3D co-culture1 IVM
No. of injected PB oocytes 63 69 79
No. (%) of 2PN 34 (54.0)a 44 (63.8)a,b 57 (72.2)b
Cleaved/2PN (%) 82.4 79.5 82.5
Embryo quality Day 2 (%)
Excellent 23.5 27.3 29.8
Good 38.2 34.1 42.1
Poor 38.2 38.6 28.1
Embryo quality Day 3 (%)
Excellent 11.8 11.4 17.5
Good 5.9a 9.1a 26.3b
Poor 82.4a 79.5a 56.1b
Mean blastomere no./embryo+ SD Day 2 2.96+0.96 2.80+1.18 2.87+0.99
Mean blastomere no./embryo+ SD Day 3 4.68+2.00 4.26+2.21 5.17+1.95
a,bValues within the same row with different superscripts are statistically different (P, 0.05).
Figure 2 Representative confocal images of good quality embryos on Day 3 post-ICSI from oocytes prematured in 3D co-culture.
Embryos are stained to visualize microtubules (green) and chromatin (red). (A) Detailed section through ﬁve blastomeres of an 8-cell embryo. A single nucleus is visible in
four blastomeres and a dense network of microtubules is present throughout the cytoplasm. (B) 3D reconstruction of three multinucleate blastomeres from a 7-cell
embryo. (C) High-power confocal section of two blastomeres from a 6-cell embryo. One blastomere is at the metaphase stage, with several disaligned chromosomes
(arrow). In the other blastomere, multiple nuclei are present. Scale bar ¼ 20 mm.
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(n ¼ 1) in the conventional IVM group and 44.4% (n ¼ 4) in the group
of PMC in microdroplets (P . 0.05).
Morphological characteristics of the 3D-PMC
co-culture
Representative light microscopic and confocal images of the 3D-PMC
co-culture are shown in Fig. 3. At the end of PMC, the GV oocytes
were surrounded by multiple layers of cumulus cells which covered
the whole surface of the zona pellucida (Fig. 3A). Numerous cyto-
plasmic processes between neighbouring cumulus cells were noticed
(Fig. 3B and D). In addition, these processes appeared to have an
extension towards the oocyte (Fig. 3C).
Electron microscopy allowed a more accurate observation of the
oocyte, cumulus cells and possible interactions at the oocyte–
cumulus interface at the end of 3D-PMC (Fig. 4).
Oocytes
Collagen embedding seemed to have no deleterious effect on the
ultrastructural morphology of the GV-arrested oocyte. The general
nuclear and cytoplasmic organization did not present morphological
abnormalities (Fig. 4A). No signs of vacuolization were observed
in the cytoplasm. The nuclear membranes of all prematured
GV-arrested oocytes had remained intact. Cytoplasmic organelles
(e.g. mitochondria, Golgi complexes, elements of smooth endoplasmic
reticulum) were dispersed throughout the ooplasm. A few
cortical granules were found in the cytoplasm and beneath the
oolemma. Microvilli were uniformly distributed over the surface of
the oocyte.
Cumulus cells
Three-dimensional-cultured cumulus cells showed well-developed
mitochondria, lipid droplets and lysosomes all clustered in the
perinuclear region of the cells. The cytoplasm was ﬁlled with
polyribosomes. Numerous intercellular junctions were seen at the
area of contact between neighbouring cells (Fig. 4B). A network of
cytoplasmic processes was visible between intercellular spaces,
which were often connected with each other (Fig. 4C). Although a
few necrotic cells could be observed, their presence was only
sporadic.
Connections at the oocyte–cumulus interface were only rarely
seen. Flat layers of cumulus cells were visible in close proximity to
the zona pellucida, but they did not seem to be tightly connected
by transzonal projections (TZPs) (Fig. 4D). In most cases, the zona
pellucida had a homogeneous structure, without traces of TZPs.
In exceptional cases, some cumulus cell processes extended
towards the zona, but did not grow further towards the oocyte
(Fig. 4E and F).
Steroid production by cumulus
cells during PMC
Steroids were measured in conditioned medium to estimate any
adverse effects of collagen embedding and culture of cumulus cells
on cell function. The cultured cumulus cells were capable to secrete
estradiol (E2) with a concentration of 340.6+107.6 pg/ml. Progester-
one (P) concentration in cumulus-conditioned medium was 472.7+
133.1 ng/ml. In the control medium, in the absence of cumulus
cells, concentrations were signiﬁcantly lower (23.1+4.1 pg/ml for
E2 and below the detection limit for P).
Discussion
In the present study, we aimed to design an improved ‘rescue IVM’
system for human denuded GV-stage oocytes retrieved from COH
cycles. Although it is well known that leaving the cumulus oophorus
intact during IVM is a prerequisite to obtain satisfactory results, our
....................................................................................................................................
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Table III Nuclear status of embryos and individual blastomeres derived from different IVM groups
Culture conditions
Conventional IVM PMC in microdroplet culture1 IVM PMC in 3D co-culture 1 IVM
No. of embryos analysed* 6 9 25
No. of blastomeres analysed 45 65 168
Mean blastomere no./embryo+ SD 7.5+1.5 7.2+1.3 6.7+0.9
No. (%) of blastomeres at ‘interphase’ 32 (71.1)a 51 (78.5)a 150 (89.3)b
Mononuclearc 12 (37.5)a 24 (47.1)a 95 (63.3)b
Binuclearc 5 (15.6) 13 (25.5) 23 (15.3)
Multinuclear and/or fragmented nucleic 15 (46.9)a 14 (27.5)a,b 32 (21.3)b
No. (%) of blastomeres at ‘metaphase’ 8 (17.8)a 8 (12.3)a,b 12 (7.1)b
Normal spindle shaped 6 (75.0) 6 (75.0) 10 (83.3)
Aligned chromosomese 3 (37.5) 4 (50.0) 8 (66.7)
No. (%) of ‘anuclear’ blastomeres 5 (11.1)a 6 (9.2)a,b 6 (3.6)b
a,bValues within the same row with different superscripts are statistically different (P, 0.05).
cPercentages are calculated over the total no. of blastomeres at interphase.
dDeﬁned as a barrel-shaped spindle. Percentages are calculated over the total no. of blastomeres at metaphase.
eDeﬁned as condensed chromosomes arranged on a compact plate at the equator of the spindle. Percentages are calculated over the total no. of blastomeres at metaphase.
*Only embryos of excellent and good quality on Day 3 were ﬁxed.
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aim here was to apply a methodology which would better rescue
the ‘left-over’ GV-stage oocytes, i.e. those that are punctured in the
same follicular pool as the retrieved matured oocytes destined for
patients’ use.
The oocytes were prematured in a 3D co-culture with cumulus cells
embedded in an ECM prior to undergo ﬁnal nuclear maturation. The
rational for this two-step approach was based on the experience gath-
ered from previous publications. Temporary prevention of spon-
taneous nuclear maturation with an oocyte-speciﬁc PDE3-I may
allow better synchronization between cytoplasm and nuclear maturity
(Nogueira et al., 2003, 2006; Thomas et al., 2004b). In addition, to
overcome the lack of cumulus cells during PMC and to simulate
more accurately the naturally 3D-environment of the cumulus–
oocyte complex (COC), we opted for the use of an ECM (i.e. col-
lagen) loaded with dissociated cumulus cells (Combelles et al., 2005).
The principal ﬁndings from our study were a signiﬁcantly higher fer-
tilization rate of 3D-PMC oocytes compared with oocytes that under-
went conventional IVM. Although 3D-PMC did not augment the
fertilization capacity when compared with oocytes prematured in
microdroplets, embryos on Day 3 post-ICSI from the 3D-PMC
groups were of better quality and had fewer nuclear abnormalities
compared with the other groups. These results suggest that the
combination of a co-culture in the presence of an ECM may serve
as a physiological support during the last stages of oocyte
development.
The positive effect of the ECM on cellular behaviour in vitro, includ-
ing ovarian cells, has already been explored extensively in previous
studies. Human mural granulosa cells cultured on ECM, such as col-
lagen, maintain a more highly differentiated morphology, possess an
increased level of steroidogenic activity (Ben-Rafael et al., 1988;
Bussenot et al., 1993), produce signiﬁcantly higher levels of cAMP
(Furman et al., 1986) and induce de novo formation of gap junctions
(Amsterdam et al., 1989). It must be noticed, however, that the
cells in these experiments were grown on top of an ECM-layer in a
2D way. In the present study, cumulus cells and oocytes were
embedded within an ECM to create a 3D nature. Since the collagen
preparation needs to be chilled (08C) to prevent early polymerization,
the cells were submitted to an abrupt drop in temperature at the time
of loading of the gel. This could be detrimental, especially for oocytes
that are highly temperature sensitive (Wu et al., 1999; Vandevoort
et al., 2008). Therefore, one of the aims of the present study was
to analyse any adverse effect of collagen-embedding procedure on
cell viability and functionality. Although a larger sample would be
necessary for a more conclusive statement, the present transmission
electron microscopy (TEM) analysis could not reveal a negative
effect on cell morphology. Numerous junctional complexes were
Figure 3 Light microscopic and confocal images of the 3D-PMC co-culture.
(A) Representative light microscopic image of a human GV oocyte after 24 h of 3D co-culture PMC with cumulus cells. (B) Detail of 3D-cultured cumulus cells: note the
cytoplasmic, dendritic processes that interconnect different clumps of cumulus cells. (C) The dendritic processes extend from the cumulus cells towards the oocyte
(arrow). (D) Three-dimensional confocal reconstruction of 3D-cultured cumulus cells stained for anti-a,b-tubulin. Numerous microtubule-rich processes extend from
the cumulus cells, giving a web-like appearance. Original magniﬁcation: 400 (A–C) and 600 (D).
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formed between individual cumulus cells. In addition, cumulus cells
were capable of secreting estradiol and progesterone, which demon-
strates that the cells retained their steroidogenic activity. Furthermore,
the presence of the collagen matrix did not reduce the effectiveness of
the PDE3-I on keeping the oocytes arrested at the GV stage. Upon
release from meiotic arrest and ECM, oocytes were competent to
resume meiosis and progress to the metaphase II stage, which is an
important functional end-point of the culture system. The kinetics of
oocyte nuclear maturation was slowed down compared with the con-
ventionally IVM group. This phenomenon is likely a result of the
PDE3-I itself rather than the ECM, since a similar pattern of meiotic
progression was seen in the microdroplet-PMC group. Based on
these observations, we may conclude that cumulus cells and
oocytes were able to withstand the cooling–warming step during
Figure 4 TEM analysis of the 3D-PMC co-culture.
(A) Electron micrograph of a prematured 3D co-cultured GV oocyte. The cytoplasm is ﬁlled with evenly distributed organelles. The nucleus is spheroid with an intact
nuclear membrane. Some cortical granules are visible just below the oocyte plasma membrane (arrows) (3000). Inset: microvilli are projected from the oolemma to the
inner cortex of the zona pellucida (7000). (B) Junctional complex between neighbouring cumulus cells (arrow) (200 000). (C) Detailed image of a cellular process
making contact with the cytoplasm of an adjacent cumulus cell (arrowhead) and a junctional complex at the level of the cumulus cell membranes (arrow). Note the
accumulation of dense material at the regions of interactions. Many lipid droplets are present in the cytoplasm (120 000). Inset: dense network of long cellular processes
between cumulus cells (120 000). (D) A layer of cumulus cells in close approximation with the zona pellucida. The cell surfaces of the cumulus cells have a smooth
appearance. Lipid droplets are widely scattered throughout the cytoplasm. Although a small cell process is formed (arrow), it does not extend towards the zona (3000).
(E) Examples of cytoplasmic projections at the oocyte–cumulus interface (see arrows) (200 000; Inset: 120 000). (F) Detail of a long cytoplasmic process growing
around a degenerated cumulus cell and making contact with the zona pellucida. Some cytoplasmic organelles are present within the cell process (120 000). CC, cumulus
cell; LP, lipid droplet; MT, mitochondrion; MV, microvilli; N, nucleus; SER, smooth endoplasmic reticulum; ZP, zona pellucida.
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embedding and polymerization of the collagen matrix. Still, it must be
noted that there is a lack of information on cooling-induced changes at
the biochemical and molecular level. A recent study by Succu et al.
(2008) observed that vitrifying ovine oocytes negatively affects the
content of transcripts related to several cell functions. A similar analy-
sis of differences in gene expression might offer extra information on
the effect of cooling during the embedding procedure on oocytes and/
or cumulus cells.
In a pilot study, we aimed to re-embed the 3D-cultured oocytes
after the 24 h-PMC period in a new collagen gel in order to
perform the IVM in a similar 3D-conﬁguration. However, maturation
rates never exceeded 50%, which was signiﬁcantly lower compared
with conventional IVM (data not shown). We know from the study
of Combelles et al. (2005) that nuclear maturation within a collagen
gel is feasible, since embedded oocytes matured at similar rates com-
pared with non-embedded, conventionally matured oocytes. There-
fore, we may conclude that repeated cooling–warming during the
two-step culture should be avoided. Other types of ECMs, which
do not have to be chilled before usage, could be tested for the
present two-step culture. Such an example is the barium alginate
capsule, a synthetic ECM (Torre et al., 2006).
During the ﬁnal stages of oocyte development, prior to ovulation,
the oocyte undergoes a process of ‘capacitation’. This process
involves structural and biochemical changes within the cytoplasm
(e.g. transcription of mRNA, post-translational modiﬁcations of pro-
teins, relocations and modiﬁcations of organelles etc.) that are essen-
tial to sustain normal fertilization and further embryonic development
(Hyttel et al., 1997; Dieleman et al., 2002). Recently, Cavilla et al.
(2008) demonstrated that human GV oocytes from COH cycles
increase in size during a 48 h-IVM period, even in the total absence
of somatic cellular support. Extending the period of GV-arrest in
culture by blocking meiosis progression (i.e. PMC) might allow time
to complete this capacitating and growth process. Our results demon-
strate that 3D-PMC culture of GV oocytes increases fertilization rates
compared with conventional IVM, while the effect of PDE3-I alone
(microdroplet-PMC) had only a slight, non-signiﬁcant inﬂuence on
this parameter. Of interest is that embryo morphology on Day 3
and nuclear constitution were signiﬁcantly enhanced in the 3D-PMC
compared with the microdroplet-PMC. While the incidence of bi-
and multinucleated, fragmented or anuclear blastomeres was not
different between the two groups, a signiﬁcant greater percentage of
blastomeres in the 3D-PMC had a mononuclear nucleus compared
with their counterparts in the microdroplet-PMC. This suggests that
culture protocols for ‘rescue IVM’ requires a PMC in the presence
of an appropriate in vitro environment, as we could establish by
using the 3D co-culture approach. Future studies on chromosomal
analysis should determine whether these embryos are also genetically
normal (Nogueira et al., 2000; Emery et al., 2005).
This study focused on oocyte–cumulus cell interactions as well. In
the in vivo situation, cumulus cells possess highly specialized TZPs
which penetrate through the zona pellucida and form gap-junctions
at their tips with the oocyte. Via these gap-junctions, cumulus cells
deliver numerous substances (e.g. amino acids, energy substrates,
purines, cAMP etc.) to the oocyte (Albertini et al., 2001; Tanghe
et al., 2002; Gilchrist et al., 2008). There exist several ways to evaluate
whether these connections could be reconstituted during the period
of PMC (e.g. Lucifer Yellow microinjection; Luciano et al., 2004). In
the present study, we used electron microscopy to evaluate this par-
ameter. As expected, newly developed TZPs reaching the oolemma
could not be observed. Cytoplasmic processes extending from the
cumulus cells might be unable to enter the zona pellucida. It is also
possible that the development and outgrowth of TZPs towards the
oolemma requires more time, since oocytes and cumulus cells are
physically separated a considerable distance by the zona. Extending
the PMC, for example, by an additional 24 h, might solve this
problem. Another possible solution is the supplementation of the
culture medium with compounds that favour the establishment of cel-
lular contacts. An example of such a compound is cAMP. Intracellular
cAMP has been shown to be a principal regulator of gap-junctions in
various cell types and tissues (Cruciani and Mikalsen, 2002). Treat-
ment of bovine and human COCs with a combination of different
cAMP-modulating agents extends the gap-junctional communication
between the oocyte and the cumulus cells (Thomas et al., 2004a;
Shu et al., 2008). It would be interesting to explore if a similar treat-
ment during prematuration could inﬂuence the de novo formation of
TZPs in our 3D culture system.
On the other hand, details of the role and regulation of TZPs at this
ﬁnal stage of oocyte maturation are scarce. In vivo, the structure and
number of TZPs changes during the maturation process (Allworth
and Albertini, 1993; Motta et al., 1994). While there are numerous
junctions present between the oocyte and the cumulus cells at the
pre-antral stage, their frequency decreases progressively as ovulation
approaches (Gilula et al., 1978; Dekel et al., 1981). Reports on
whether junctional association between cumulus cells and oocytes is
essential for the beneﬁcial effect of co-culture are controversial (Ge
et al., 2008). Our results on embryonic developmental quality on
Day 3 indicate that cytoplasmic maturation was improved to some
extent without restoration of oocyte–cumulus cell contacts during
PMC. Therefore, intracellular communication via paracrine signalling
could have been compensated for the absence of oocyte–cumulus
cell contacts (Carabatsos et al., 1998; Albertini et al., 2001). The
identiﬁcation of these paracrine factors remains to be explored.
Another aspect that deserves attention is the source of cumulus
cells used. These cells were taken from the COCs retrieved after
exposure to hCG. This means that the cumulus cells were luteinized,
a process which is associated with a decline in proliferative capacity
and an increase in the expression of enzymes involved in the synthesis
of progesterone (Paton and Collins, 1992). It also leads to an
increased production of inhibin (Seifer et al., 1996). One may conclude
that this differentiated cell stage is not appropriate to promote prema-
turation events of the oocytes. A better solution could be the use of
granulosa cells which have not yet shifted to the luteinizing phase. Pre-
ferable sources to obtain these cells are follicular ﬂuid aspirates
retrieved from growing antral follicles during IVM cycles, in which
the patient did not receive hCG (Lindeberg et al., 2007). Neverthe-
less, our results on embryo quality on Day 3 post-ICSI suggest that
the presence of cumulus cells during PMC, even if in the luteinized
form, exerted a positive effect on oocytes’ cytoplasmic maturity.
The precise mechanisms causing this beneﬁcial effect are unclear. It
could be possible that the oocyte and the cumulus cells reciprocally
supported each others physiology during PMC. A study from
Nekola and Nalbandov (1971) demonstrated that granulosa cells cul-
tured in close proximity to oocytes appeared to be less luteinized than
those cultured without oocytes. A more recent study demonstrated
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that denuded bovine oocytes co-cultured with cumulus cells induce a
dose-dependent suppression of cumulus cell apoptosis (Hussein et al.,
2005). This illustrates that the oocyte is not just a passive recipient of
developmental signals from its associated somatic cells, but also plays
key regulatory roles on neighbouring cumulus cells. The oocyte
achieves this through the synthesis and secretion of oocyte-speciﬁc
factors, such as growth differentiation factor 9 and bone
morphogenetic protein 15, which act on cumulus cells to modify
their proliferation, function and differentiation (Hutt and Albertini,
2007; Gilchrist et al., 2008). Via this pathway, the oocyte is a principal
regulator of its own meiotic and developmental competence. In our
study, it might be possible that a similar bidirectional feedback loop
between the oocyte and the cumulus cells took place during the
PMC period, which resulted in the overall improved outcome follow-
ing IVM.
Another possibility to explain our results is the protective role that
cumulus cells may play by reducing cystine to cysteine and promoting
the uptake of cysteine in the oocyte (Takahashi et al., 1993). Via this
pathway, cumulus cells may neutralize the damaging processes that
reactive oxygen species may exert on oocytes during the course of
PMC (de Matos et al., 1997).
Finally, an important aspect that deserves attention when analysing
the present results is the source of oocytes used in this study. The GV
oocytes represent an already compromised group of oocytes
retrieved from follicles that failed to conclude maturation in vivo in
response to the hormonal stimulation. Therefore, these ‘rescue
IVM’ oocytes should not be considered as a ﬁrst choice for the infer-
tility treatment of the patient. Nevertheless, in some patients with a
low number of mature oocytes at the day of retrieval, these
oocytes could be used in order to increase the number of fertilizable
oocytes.
Conclusion
In conclusion, the present results provide a proof of concept for a
novel and efﬁcient culture approach for human ‘rescue IVM’. Before
any clinical application in human IVF, complete testing of possible
increased risks of aneuploidy is necessary. In addition, further
studies involving embryo transfer in large mammals might reveal the
level of epigenetic risks that this technique could bring.
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Abstract
Background: Controlling nuclear maturation during oocyte culture might improve nuclear-
cytoplasmic maturation synchrony. In the present study, the quality of mouse and human 
cumulus-enclosed oocytes (CEOs) was examined after a two-step culture consisting of a 
three-dimensional prematuration culture (3D-PMC), followed by in vitro maturation (IVM).  
Methods: Mouse and human CEOs were embedded in an extra-cellular matrix (Collagen gel 
Type I). The gels containing the CEOs were cultured in medium with a phosphodiesterase 3-
inhibitor (PDE3-I; cilostamide 1 µM) for 24 h. Afterwards, CEOs were removed from the gel, 
washed away from inhibitor and underwent IVM. The optimal concentration of collagen 
(diluted 1:2 versus undiluted) was first determined in a mouse model. Cytoplasmic maturation 
after IVM of human and mouse oocytes was assessed in relation to fertilization and 
embryonic developmental capacity. 
Results: The diluted form of collagen supported better the structure of the expanding CEOs 
and meiotic competence of the oocytes. Electron microscopy in combination with Lucifer 
Yellow dye coupling assay revealed that oocyte-cumulus cell connections could be preserved 
during 3D-PMC. Percentages of mouse 2-cell embryos upon IVF were higher in the 3D-PMC 
group compared to in vitro controls and 2D-PMC oocytes, but lower compared to in vivo 
controls. In the human model, percentages of polar body-extruded oocytes were significantly 
higher in the 3D-PMC group compared to conventionally matured oocytes. Three-
dimensional PMC had also a beneficial effect on embryonic development on day 3 post-ICSI. 
Conclusions: Applying a 3D-PMC in the presence of a PDE3-I preserve oocyte-cumulus cell 
connections and influences oocyte developmental capacity.
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Introduction
The availability of viable oocytes is the limiting factor in the development of new assisted 
reproductive techniques. Oocyte in vitro maturation (IVM) is an important technology, as it 
bears the prospect of reducing/avoiding ovarian hyperstimulation. However, IVM outcomes 
remain significantly below the success rates obtained using in vivo matured oocytes (Chian et 
al., 2004; Jurema and Nogueira, 2006). Part of this deficiency is due to the fact that this 
technology must deal with a mixed population of oocytes collected from follicles at varying 
stages of development, both dominant and atretic (Stouffer and Zelinski-Wooten, 2004). In 
addition, IVM oocytes undergo nuclear maturation prematurely. Removing oocytes from mid-
sized antral follicles interrupts the process of oocyte capacitation, a phase during oogenesis in 
which the oocyte acquires the cytoplasmic machinery to support preimplantation development 
(Dieleman et al., 2002; Hyttel et al., 1997; Gilchrist and Thompson, 2007).
These observations have encouraged researchers to seek alternative strategies for the culture 
of immature oocytes. One approach to optimize developmental potential post-IVM is by 
temporarily inhibiting spontaneous meiotic maturation in vitro (Lonergan et al., 1998; 
Anderiesz et al., 2000). In this way, a two-step in vitro culture system is created. In the first 
step, called the ‘prematuration culture (PMC)’, oocytes are exposed to a meiosis-inhibiting 
compound to allow time for promoting cytoplasmic maturation. After the PMC period, 
oocytes are transferred to the classical maturation medium for IVM. The philosophy behind 
this strategy is to permit i) synchronization within the mixed population of immature oocytes 
and ii) synchronization between cytoplasmic and nuclear maturity within each individual 
oocyte.
Oocyte-specific phosphodiesterase type 3-inhibitors (PDE3-Is) are potent meiotic arresters. 
These agents keep intra-oocyte cAMP levels above a threshold that maintains the oocyte 
arrested at the GV-stage in vitro (Tsafriri et al., 1996; Conti et al., 2002; Thomas et al., 2002). 
In an attempt to improve oocyte developmental competence, temporary exposure to a PDE3-I 
during a period of PMC has been tested in several mammals with limited success. Exposure 
of mouse cumulus-enclosed oocytes (CEOs) to the PDE3-I Org9935 (Nogueira et al., 2003b) 
or cilostamide (Vanhoutte et al., 2008) improves their quality and developmental potential. A 
similar observation is found when bovine CEOs are exposed to the PDE3-I milrinone 
(Thomas et al., 2004b). In addition, enhancement of nuclear maturation rates occurs when 
human CEOs are prematured in the presence of the PDE3-I Org9935 (Nogueira et al., 2006a). 
Furthermore, combined exposure of human CEOs to a PDE3-I (i.e. cilostamide) and an 
adenylate cyclase activator (i.e. forskolin) has a positive effect on fertilization rates following 
IVM (Shu et al., 2008). Yet, the results are still suboptimal compared to the in vivo situation. 
This indicates that IVM techniques require a more robust scientific validation or refining for 
improved efficiency and acceptability. 
The difference between the in vitro situation and the in vivo environment may originate from 
the extent of the communication between somatic cells and the oocyte. It was observed that 
during the process of PMC, loss of association between the oocyte and cumulus cells occurred 
(Nogueira et al., 2003a and b, 2006a; Vanhoutte et al., 2008). The CEOs attach to the two-
dimensional (2D) culture surface of the petri-dish and the somatic cells spread out and 
migrate away from the oocyte. In other cases, the cumulus cells loosen completely from the 
oocyte in form of clumps. This spreading or loosening alters the three-dimensional (3D) 
structure of the CEOs, thereby disrupting the cell-cell interactions. The interruption of normal 
oocyte-somatic cell interactions during the final hours of oocyte maturation may preclude the 
establishment of full developmental competence (Eppig, 2001; Albertini et al., 2001; Tanghe 
et al., 2002; Gilchrist et al., 2004).
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In accordance with the above observations, the aim of the present study was to establish an 
optimized 2-step culture system which could maintain the bi-directional gap-junctional and/or 
paracrine communication between the oocyte and the cumulus cells during the period of 
PMC. One way to preserve 3D structures in vitro and, consequently, to mimic more faithfully 
the in vivo environment is to embed tissues within an extra-cellular matrix (ECM). This 
approach has been tested already on ovarian follicles of different mammalian species, mainly 
of the mouse (Torrance et al., 1989; Carroll et al., 1991; Gomes et al., 1999; Pangas et al.,
2003; Kreeger et al., 2006; Xu et al., 2006). The ECM-embedding method has also been 
shown to preserve the integrity of bovine (Yamamoto et al., 1999; Alm et al., 2006) and 
canine (Otoi et al., 2006) CEOs. Many of these studies used collagen-gel as ECM (Torrance 
et al., 1989; Carroll et al., 1991; Gomes et al., 1999; Yamamoto et al., 1999; Abir et al.,
2001; Itoh et al., 2002; Alm et al., 2006; Otoi et al., 2006).
In the present study, we have employed collagen-gel (Type I) as a 3D matrix for the 
encapsulation of CEOs during the first step (i.e. the PMC) of our 2-step culture. A similar 
approach has recently been tested by our group on denuded GV-stage oocytes obtained after 
ovulation induction for ICSI treatment (= ‘rescue IVM’) (Vanhoutte et al., 2009). Denuded 
oocytes were encapsulated in collagen containing dissociated cumulus cells and prematured. 
This co-culture system had a positive effect on the oocytes’ developmental capacity following 
IVM and IVF. However, if we want to extrapolate a similar 2-step culture system to a clinical 
IVM treatment it is imperative to use CEOs. Therefore, in the present study, intact CEOs were 
embedded in collagen matrix. After PMC, CEOs were released from the gel, washed away 
from PDE3-I and subjected to IVM. This so-called ‘3D-PMC’ system was initially tested and 
optimized in a mouse model. In addition, we evaluated this culture system on human CEOs 
derived from small antral follicles after controlled ovarian stimulation (COH) of patients 
undergoing IVF/ICSI treatment. Outcome parameters were CEO morphology, oocyte-
cumulus cell connections, maturation rates, fertilization and embryonic development. 
Material and methods 
The study was undertaken after complete institutional review board approval from the Ghent 
University Ethical Committee (Project N° EC UZG 2007/142), the Animal Ethical Committee 
(Project N° ECD 06/05) and the Federal Ethical Committee on Embryos (Belgian Registration 
N° B67020072076).
Unless otherwise indicated, all chemicals were purchased from Sigma Chemical Co. 
(Bornem, Belgium). 
Collection of mouse cumulus-enclosed oocyte (CEOs)
Mice used in this study were 7 to 8 week-old F1 hybrids (B6D2; Iffa Credo, Brussels, 
Belgium), housed and bred according to national legislation for animal care. Immature CEOs 
were collected from small antral follicles, 24 h following intraperitoneal injection of 5 IU/ml 
eCG (Folligon; Intervet, Mechelen, Belgium). Ovaries were dissected and collected in 
Leibovitz-glutamax medium (Invitrogen, Merelbeke, Belgium), supplemented with 10% heat-
inactivated fetal calf serum (Invitrogen), 100µg/ml streptomycin, 100 U/ml penicillin. To 
prevent spontaneous resumption of meiosis, Cilostamide (1 µM) was added to this medium. 
CEOs were freed mechanically by puncturing antral follicles with fine insulin needles (26
1/2
-
G; Becton Dickinson, Erembodegem, Belgium). Only CEOs that consisted of an oocyte 
surrounded by a compact cumulus-cell mass were selected for the experiments.  
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As in vivo controls, oocytes were obtained by priming mice with 5 IU/ml eCG followed by 5 
IU/ml hCG (Chorulon; Intervet) 48 h later. Mature CEOs were recovered from the ampullae 
16-18 h post-hCG. 
Collection of human cumulus-enclosed oocyte (CEOs)
Only consenting patients who had undergone routine controlled ovarian stimulation (COH) 
for IVF/ICSI treatment were included in the study.
All patients underwent COH after cycle synchronization with a standard contraceptive pill for 
2-6 weeks. A short gonadotrophin-releasing hormone (GnRH) agonist protocol was used, 
consisting of 0.1 mg of triptorelin (Decapeptyl, Ipsen, France) from day 5 onwards after 
discontinuation of the oral contraceptive. This was followed by human menopausal 
gonadotrophin (hMG; Menopur, Ferring, Germany) or follicle stimulating hormone (FSH; 
either Gonal-F, Serono, Switzerland or Puregon, Organon, The Netherlands) from day 7 after 
discontinuation of the pill onwards. The starting dose of hMG or FSH was 150 IU, which was 
adjusted on day 8 of stimulation according to the individual response of the patient. An 
injection of 5000 IU human chorionic gonadotrophin (hCG; Pregnyl, Organon, The 
Netherlands) was administered when at least  2 follicles reached a diameter of 20 mm.  
To minimize confounding factors, only patients with a good prognosis in terms of ovarian 
response (e.g. at least 7 follicles of  12 mm on ultrasound before oocyte retrieval) were 
included in the study. Oocyte retrieval was scheduled 34 to 36 h post-hCG, using a 17G 
aspiration needle. First, follicles larger than 10 mm were aspirated and the retrieved oocytes 
were used for the IVF/ICSI treatment of the patient. The needle attached to the test tube was 
washed with HEPES-containing media, and a new tube was attached to the needle for 
aspiration of smaller follicles measuring 5-10 mm. Only aspirates from these follicles were 
used for our study. The pressure to aspirate the smaller follicles was set to 140-150 mm Hg.  
After collection, oocyte maturity was evaluated under the microscope with high magnification 
using the ‘spreading’ method (Veeck, 1988). This procedure consists of placing the CEO in a 
small droplet of culture medium on the flat surface of a sterile Petri dish and, by jarring the 
dish, spreading the medium and flattening the cumulus mass. The oocyte is then examined 
under the inverted microscope for the presence of a germinal vesicle (GV). When a well 
defined nuclear membrane could not been observed, the oocyte was denuded by chemical (80 
IU/ml hyaluronidase type VIII) and mechanical means. Polar body (PB)-extruded oocytes 
were included as in vivo controls, since they were retrieved from small follicles of the same 
patients. 
Culture medium for mouse oocyte maturation 
The basal culture medium consisted of alfa-Minimal Essential Medium with glutamax (α-
MEM; Invitrogen) supplemented with 5% FCS, 5 µg/ml insulin, 5 µg/ml transferrin, 5ng/ml 
selenium, 100 µM cysteamine, 100 IU/ml penicillin G, 100 µg/ml streptomycin sulphate and 
10 mIU/ml FSH (Puregon; Organon).  
The PMC-medium was composed of the basal medium plus 1µM cilostamide, a specific 
PDE3-I (Calbiochem, Bierges, Belgium; Stock 10 mM in DMSO stored at –20°C).  This 
concentration was used because previous studies have shown that 1 µM was the lowest 
effective dose for maximum level of inhibition and reversibility of meiosis inhibition in 
mouse oocytes (Vanhoutte et al., 2008). In the human, a concentration of 1 µM cilostamide 
was more likely to preserve meiotic spindle morphology and chromosome alignment after 
IVM compared to 10 µM cilostamide (Vanhoutte et al., 2007). 
The IVM-medium was constituted by the basal medium supplemented with 5 ng/ml epidermal 
growth factor (EGF) and 1.5 IU/ml hCG (Pregnyl, Organon). 
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Culture medium for human oocyte maturation 
The basal medium was Tissue Culture Medium 199 (TCM 199; Invitrogen) supplemented 
with 0.8 % human serum albumin (HSA; Red Cross, Brussels, Belgium), 10 ng/ml human 
recombinant insulin, 5 µg/ml human transferrin, 5 ng/ml sodium selenite, 100 ng/ml long R3 
insulin-like growth factor-I (IGF-I), 100 µM cysteamine, 1 mM L-glutamine, 0.3 mM sodium 
pyruvate, 100 IU/ml penicillin G, 100 µg/ml streptomycin sulphate and 10 mIU/ml FSH.  
The PMC-medium was composed of the basal medium plus 1µM cilostamide. 
The IVM-medium was constituted by the basal medium supplemented with 10 ng/ml 
epidermal growth factor (EGF), 1 µg/ml estradiol and 0.5 IU/ml hCG.
Three-dimensional prematuration culture (3D-PMC) 
An extra-cellular matrix (ECM) solution composed of collagen (3.79 mg/ml rat tail collagen 
Type I; BD Biosciences, Erembodegem, Belgium) was brought to neutral ionic strength and 
pH (7.4) by quickly mixing eight volumes with one volume of 0.05 N NaOH containing 22 
mg/ml NaHCO3 and one volume of 10x concentrated α-MEM (Invitrogen; for mouse oocytes) 
or 10x concentrated TCM-199 (Invitrogen; for human oocytes). To obtain a 1:2 diluted 
collagen-gel matrix (see Experiment 1), one volume of the neutralized solution was mixed 
with one volume of PBS. The collagen mixtures were prepared immediately prior to PMC and 
kept on ice until usage.  
For mouse 3D-PMC, 200 µl of the collagen mixture was placed in the bottom of a 4-well dish 
(BD Biosciences) and allowed to polymerize at 37°C. Thirty to forty CEOs were placed on 
top of this layer with a small volume of PMC-medium. A second layer of 150 µl collagen was 
put onto the CEOs. The gels containing the CEOs were then placed in an incubator at 37°C 
for 30 min to polymerize. After gelatinization, 400 µl of PMC-medium was poured onto the 
gels containing the CEOs. At this time the gels were made floating by a gentle rimming of the 
wells with a 25-G needle.  
For human 3D-PMC, microdroplets (4 µl) of the collagen solution were seeded in the wells of 
a 96-well plate (BD Biosciences). A single CEO was added carefully to each droplet, which 
was then allowed to polymerize at 37°C for 10 min before adding 80 µl of PMC-medium to 
each well. 
The PMC for both human and mouse CEOs took 24 h under standard conditions (37°C in a 
humidified atmosphere of 5% CO2 in air).  
Removal of CEOs from the 3D-PMC and IVM culture 
At the end of PMC, mouse and human CEOs embedded in collagen were incubated with type 
I collagenase (0.1 mg/ml) for 10 min at 37°C. After this treatment, the CEOs were subjected 
to gentle and repetitive pipetting with a pulled Pasteur pipette of which the internal diameter 
was selected to be slightly larger than the complexes. This combined digestion/mechanical 
treatment caused the release of CEOs from the gel, yielding oocytes still surrounded by 
several layers of cumulus cells. The PDE3-I was subsequently removed by washing the 
oocytes several times in fresh IVM-medium. 
For mouse IVM, CEOs (groups of 15-20) were transferred to microdroplets (30 µl) of IVM-
medium under oil and cultured for 16-18 h under standard conditions. The nuclear 
maturational stage was classified as GV, GV breakdown (GVBD) or polar body (PB) 
extrusion.
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For human IVM, CEOs were cultured individually in 25 µl microdrops of IVM-medium 
under oil, after confirming the nuclear maturation stage using the spreading method. 
Mechanical denudation of the oocytes and evaluation of maturation stages (GV, GVBD or 
PB) was performed at 24 h of IVM. Immature oocytes remaining at GV or GVBD-stage were 
further cultured in the same medium and re-examined up to 30 h (from 25 to 30 h) and up to 
48 h (from 31 to 48 h).  
Evalution of CEO morphology 
Mouse CEOs were embedded in collagen-gel solutions at two different concentrations (not-
diluted or diluted 1:2; see description above). The morphology of the CEOs was evaluated at 
the end of PMC by light microscopy in relation to the pattern of cumulus cell-oocyte 
connections: (i) C+ if oocytes were completely surrounded with multiple layers of cumulus 
cells; (ii) C- if the connections between the two cell types were disturbed (i.e. partially 
denuded oocytes or presence of gaps between the oocyte and the cumulus cell layers.) 
The optimal collagen concentration was subsequently tested for the 3D-PMC of human 
CEOs. The cumulus layers around the oocytes were scored at the beginning of 3D-PMC, the 
end of 3D-PMC and after 24 h of IVM as follows: Type I: compacted (when one or more 
compact layers of cumulus cells were present); Type II: moderately expanded (expanded 
distal layers of cumulus cells but a compact proximal cell layer); Type III: fully expanded or 
Type IV: partially denuded (Nogueira et al., 2003a).
Transmission electron microscopy (TEM) 
In order to verify more accurately the presence of cumulus-oocyte connections after 3D-PMC, 
mouse CEOs were fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.3). After 
postfixation with 1% osmium tetroxide in cacodylate buffer and dehydration in graded series 
of alcohol, CEOs were embedded in Epon. Serial semithin sections of 1 µm were cut 
throughout the CEO and stained with toluidine blue for light microscopic guidance. Ultrathin 
sections (0.1 µm) for electron microscopic evaluation were collected at the point where the 
nucleolus of the oocyte was visible. The sections were transferred on wide single-slot copper 
grids, coated with carbon film and stained with uranyl acetate and lead citrate. Evaluation was 
done with a Zeiss E900 electron microscope (Oberkochen, Germany). 
Dye coupling assay 
To assess the functionality of oocyte-cumulus connections, a 3% solution of Lucifer Yellow 
(LY) dye in 5mM lithium chloride was injected into mouse oocytes and the spread of dye into 
surrounding cumulus cells was monitored with an inverted fluorescence microscope 
(Olympus IX70; Aartselaar, Belgium). To reduce the incidence of damaging oocytes during 
injection, the temperature of the microscope stage was kept at room temperature. The analysis 
of gap junction functionality was performed within 10 min of the injection by observation of 
LY spreading from the oocyte to the cumulus cells. This was analysed at the start (0 h; 
positive control) and the end (24 h) of the PMC period. To be certain that the spread of dye 
observed reflected transfer from the oocyte to the cumulus cells via gap junctions, we also 
examined a group of CEOs exposed to carbenoxelone (CBX; 500 µM; 20 min), a known gap-
junction inhibitor (negative control). Oocyte-cumulus cell communications were classified as 
open (diffusion in the entire cumulus), partially open (only dye diffusion in a limited number 
of cells between ooplasm and corona radiata cells) or closed (no dye diffusion) (Luciano et
al., 2004).
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In vitro fertilization and embryo culture 
In the mouse model, the caudae epididymidis were removed from adult males. Epididymal 
contents were carefully squeezed out and the residual caudal tissue was discarded. Sperm 
suspensions were preincubated for 2.5 h to ensure capacitation in KSOM supplemented with 
3% BSA (fraction V). CEOs were inseminated into 40 µl droplets and sperm was added at a 
final dilution of 2 x 10
6
/ml and incubated in a humidified atmosphere of 37°C, 5% CO2 in air 
for 3 h. At the end of this period, inseminated oocytes were washed to remove sperm and 
cumulus cells by gently pipetting and were then cultured in 40 µl microdroplets of KSOM 
supplemented with 0.5% crystalline BSA (Calbiochem) for 4 days in a humidified atmosphere 
of 37°C, 5% CO2, 5% O2 and 90% N2. The percentage of developing embryos to the 2-cell 
and blastocysts stages was determined. 
In the human model, PB-extruded oocytes were fertilized by ICSI between 1 and 4 h after the 
PB had been visualized. Sperm cells for ICSI were obtained the previous day from several 
male patients with excellent sperm characteristics (= number of sperm cells, motility and 
morphology above WHO minima) and who consented to donate supernumerary sperm cells 
for scientific research. After injection, oocytes were cultured individually in Sydney IVF 
Cleavage Medium (Cook, Ltd., Limerick, Ireland) for 3 days in a humidified atmosphere of 
37°C and 5% CO2 in air.
Fertilization was evaluated 16-18 h post-injection and was considered normal when two 
pronuclei were identified. Embryos were scored on day 2 and day 3 post-ICSI and were 
classified as having a ‘good’ morphology when there were at least two cells on day 2 and six 
cells on day 3, less than 20% anucleate fragments and no apparent morphological 
abnormalities. 
Experimental groups 
A schematic diagram of the different experimental groups in the mouse and human 
experiments is shown in Figure 1. 
Statistical analysis 
The experiments on mouse CEOs were repeated at least three times. Variations between 
replicates are indicated with the standard deviation (± SD in tables and error bars on graphs). 
For evaluation of oocyte-cumulus cell morphology and communication (LY injection), 
maturation rates, fertilization and embryonic development, data were analyzed with one-way 
ANOVA and Tukey-post test. As data were proportions, they were subjected to arcsine 
square-root transformation before ANOVA to normalize their distribution. 
For the experiments on human CEOs, Fisher’s exact test or chi-square test was used to 
evaluate differences in oocyte-cumulus cell morphology, maturation, fertilization and embryo 
morphological quality. Differences in mean number of blastomeres were calculated using 
one-way ANOVA, followed by “Tukey post-hoc test”.
The threshold for significant difference was set at P<0.05. 
Results
Experiment 1: Effect of different collagen concentrations on mouse CEO morphology and 
maturation capacity 
Mouse CEOs morphology was investigated in collagen-gel preparations of two different 
concentrations (not-diluted versus diluted 1:2) and compared to a group of CEOs prematured 
in conventional microdroplet cultures (= 2-dimensional PMC; 2D-PMC; Fig 1A). 
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CEOs could maintain their 3D structures in the two collagen concentrations tested. In diluted 
collagen, increase of the cumulus mass could be observed. The cumulus cells stayed in close 
contact with each other and with the oocyte (Fig 2A). In the non-diluted gel, although the 
oocyte was still surrounded by cumulus cells, a gap between the oocyte and the somatic cells 
was often observed and the oocyte had a shrunken appearance (Fig 2B). In the 2D-PMC 
condition, cumulus cells started to spread away from the oocyte and attached to the bottom of 
the culture dish, leaving the oocyte almost denuded at the end of culture (Fig 2C). In order to 
quantify these results, the CEOs in the different groups were classified according to the 
appearance of their cumulus (C+ or C-). A significant higher proportion of CEOs with a C+ 
pattern could be recovered after 3D-PMC in diluted collagen (80.7 ± 2.8 %) compared to 
undiluted collagen (31.9 ± 2.3 %) and 2D-PMC (15.2 ± 1.9 %; P<0.05).
After removal from collagen, half of the oocytes were denuded to assess the efficiency of the 
PDE3-I to maintain mouse oocytes under nuclear arrest in a 3D-environment. More than 90% 
of oocytes exposed to PDE3-I were efficiently arrested at the GV-stage, either in the 2D- or 
the 3D-PMC (Fig 3A). These results were compared to a group of non-arrested oocytes (in 
vitro control; Fig 1A). More than > 80% of these oocytes matured spontaneously after 
isolation.
The remaining CEOs were washed out of PDE3-I and transferred to IVM medium. At the end 
of IVM, CEOs with a C+ pattern acquired an expanded cumulus layer, while CEOs with a C- 
cumulus were partially or completely denuded (data not shown). Maturation stages were 
analyzed at the end of IVM to evaluate the reversibility of the PDE3-I and compared to 2D-
PMC cultured oocytes and spontaneously matured oocytes (in vitro control) (Fig 1A). 
Oocytes cultured in non-diluted collagen demonstrated the highest rate of GV-arrest at the 
end of IVM compared to the other groups (P>0.05; Fig 3B). Based on these observations, the 
diluted form of collagen-gel was applied in all further experiments on mouse and human 
oocytes.
Experiment 2: Evaluation of mouse cumulus-oocyte connections by transmission electron 
microscopy (TEM) and dye coupling assay 
The optimal concentration of collagen solution, as assessed in Experiment 1, was used to test 
the integrity and functionality of cumulus-oocyte connections at the end of PMC. The 
presence of transzonal projections (TZPs) in 2D versus 3D cultured CEOs was first explored 
by TEM (n = 30 in each group; Fig 4).  In 3D-PMC cultured CEOs, variously shaped 
transzonal projections (TZPs) from surrounding cumulus cells were observed within the zona 
pellucida (Fig 4A, B). In the 2D-PMC group, on the other hand, big gaps between the oocyte 
and the cumulus cells were frequently visible (Fig 4C).  
After having confirmed the presence of oocyte-cumulus connections, their functionality was 
assessed by Lucifer Yellow dye (LY) microinjection (Fig 5). The gap junctional statuses in 
the different treatment groups are shown in Table I. Injection of LY in the oocytes 
immediately after collection of CEOs (0 h; positive control) resulted in an immediate spread 
of the dye into neighbouring corona radiata cells in >80% of CEOs analyzed. A dramatic drop 
in oocyte-cumulus cell coupling occurred in the 2D-PMC group compared to the positive 
control, where the majority of CEOs exhibited partially open or closed intercellular junctions 
(P<0.05). In the 3D-PMC group, the presence of functional gap junction-mediate 
communications between oocytes and surrounding cumulus cells were observed in a 
significantly higher proportion compared to the 2D-PMC group, although this percentage was 
lower than for the positive control (P<0.05). In the CEOs exposed to the gap junction 
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inhibitor CBX (negative control), no dye diffusion was observed between oocyte and cumulus 
cells. 
Experiment 3: Effect of 3D-PMC on human CEO morphology and maturation capacity 
A total of 196 human CEOs out of small antral follicles were retrieved from 57 patients. The 
mean age of the patients was 31.4 ± 4.52 years (range 23-40). Microscopical evaluation using 
the spreading method revealed that 60% (n = 118) of the oocytes were at the GV-stage at the 
time of oocyte retrieval. These oocytes were distributed among the two IVM conditions (3D-
PMC and in vitro control; Fig 1B). Fifty six (29 %) oocytes were at the PB-stage at retrieval 
and were regarded as the in vivo controls (Fig 1B).
At the start of 3D-PMC, the pattern of CEO was classified as Type I, II or III (Fig 6A). A 
clear modification of the cumulus expansion pattern could be observed during the inhibition 
period. A significantly higher proportion of CEOs acquired a type II (moderately expanded) 
or type III (fully expanded) configuration at the end of 3D-PMC compared to the start, while 
the percentage of CEOs with a type I (compact) configuration was significantly reduced 
(P<0.05).
A second evaluation of the cumulus layers was performed after 24 h of IVM culture and the 
results of the 3D-PMC group were compared to conventionally matured oocytes (= in vitro 
control; Fig 6B). Of interest was the fact that a significantly higher proportion of CEOs in the 
control group were partially denuded (Type IV) compared to the 3D-PMC group (P<0.05). 
Table II summarizes the nuclear maturation rates in the 3D-PMC versus the in vitro control. 
Oocytes embedded in collagen and prematured in PDE3-I-containing medium were efficiently 
arrested at the GV-stage (>90%). After removal from collagen and inhibitor, oocytes were 
capable of resuming meiosis. At 24 h of IVM, when all CEOs in the two experimental groups 
were denuded of surrounding cumulus cells, the proportions of GV, GVBD and PB stages did 
not differ significantly between the in vitro control and the 3D-PMC group.  At 30 h of IVM, 
a significantly higher proportion of oocytes in the in vitro control were still arrested at the GV 
stage compared to the 3D-PMC. Of oocytes evaluated 48 h after IVM, those in the 3D-PMC 
group acquired significantly higher maturation rates compared to the in vitro controls 
(P<0.05).
Experiment 4: Effect of 3D-PMC on fertilization and embryonic development of mouse and 
human oocytes
Mouse and human oocytes that matured under different culture conditions were fertilized in 
vitro at the end of IVM.
In the mouse model, four different experimental groups were evaluated: 3D-PMC, 2D-PMC, 
in vitro control and in vivo control (Fig 1A). The results on fertilization and embryonic 
development are represented in Fig 7. The percentage of 2-cell embryos on day 1 was higher 
in the 3D-PMC group compared to the 2D-PMC and the in vitro control, but lower compared 
to the in vivo group (P<0.05; Fig 7A). The proportion of blastocysts on day 4 was similar 
between the 3D- and the 2D-PMC group (P>0.05), but higher than in the in vitro control and 
lower compared to the in vivo control group (P<0.05; Fig 7B). The percentages of developing 
embryos to the 2-cell and blastocysts stages of 2D-PMC oocytes were higher compared to the 
in vitro control (P<0.05). 
In the human model, fertilization and embryonic development post-ICSI were assessed in 
three experimental groups: 3D-PMC, in vitro control and in vivo control (Fig 1B and Table 
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III). Fertilization rates were significantly higher in the in vivo controls compared to the in 
vitro controls (P<0.05), but similar to the 3D-PMC (P>0.05; Table III). The majority of 
fertilized oocytes underwent cleavage on day 2. Embryo quality on day 2 was similar among 
the three groups. On day 3 post-ICSI, however, a significantly higher proportion of good- 
morphology embryos were obtained in the in vivo and 3D-PMC groups compared to the in 
vitro control group (P<0.05). The mean number of blastomeres on day 2 post-ICSI did not 
differ between groups. On day 3, a significantly higher number of blastomeres was observed 
in the in vivo control and 3D-PMC group compared to the in vitro control (P<0.05; Table III). 
Discussion
Oocyte maturation is a complex process involving the interaction of local regulatory factors 
and endocrine signals. Studies from Nogueira et al. (2003b) and Thomas et al. (2004b) were 
the first to demonstrate that a 2-step culture with cAMP-modulating agents (i.e. PDE3-I alone 
or in combination with an adenylate cyclase activator) exert a significant positive effect on the 
IVM-outcome of, respectively, mouse and cattle oocytes. Later, similar experiments on 
human CEOs confirmed that this approach improves meiotic competence (Nogueira et al.,
2006a) and fertilization rates (Shu et al., 2008). Although the rational behind this strategy is 
to prolong oocyte-cumulus cell gap-junctional communication and to allow for continued 
mRNA and protein accumulation within the ooplasm (Thomas et al., 2004a; Luciano et al.,
2004; Gilchrist and Thompson, 2007), the 2D nature of this culture system alters the 3D 
architecture of the CEOs. 
In the present study, we tried to overcome this deficit by performing the PMC-step in a 3D-
environment. The feasibility of working with a collagen matrix to create a 3D-PMC was 
explored for the co-culture of human denuded GV-stage oocytes with dissociated cumulus 
cells (Vanhoutte et al., 2009). Hence, we applied the same collagen matrix for the first time to 
encapsulate intact CEOs during PMC, which better approaches the clinical situation of IVM 
cycles.
The results of the present study demonstrated that embedding mouse and human CEOs in 
collagen-gel not only maintained their spherical architecture, but also resulted in meiotically 
competent oocytes. In addition, mature oocytes obtained after 3D-PMC and IVM could be 
fertilized and sustained preimplantation development in vitro. In the mouse model, an 
increase in oocyte competence was reflected in higher cleavage rates compared to the 2D-
PMC and the in vitro control group. In the human model, the 2-step 3D-PMC culture had a 
beneficial effect on oocyte developmental capacity, resulting in an increased yield of matured 
oocytes and an improved embryonic developmental quality on day 3 post-ICSI compared to 
spontaneously matured oocytes. 
Providing an appropriate environment to culture CEOs in three dimensions is not easy. The 
density and mechanical properties of the ECM may influence cellular behaviour in vitro 
(Cukierman et al., 2002; Berkholtz et al., 2006; West et al., 2007). Therefore, the first 
experiment in our study was designed to define the optimal concentration of collagen in order 
to preserve CEO integrity without affecting subsequent meiotic competence. Two collagen-
gel preparations varying in matrix stiffness and density were formed by changing the collagen 
concentration (diluted 1:2 versus not diluted). Preliminary experiments showed that further 
dilutions (e.g. 1:3 and beyond) affected the rigidity of the gel and hampered a proper 
encapsulation of CEOs within the gel (data not shown).
Our results demonstrate that collagen in undiluted form limits the outgrowth of the cumulus 
cell-layers and influences optimal oocyte maturation. In diluted collagen, on the other hand, 
CEOs preserved their in vivo-like morphology, with a centrally located oocyte and 
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surrounding layers of cumulus cells. In addition, increase of the cumulus mass could be 
observed.
A plausible explanation for this difference is that less rigid gels deform more readily, which 
creates space as the cumulus mass increases around the oocyte (Xu et al., 2006; West et al.,
2007). In addition, oocytes enclosed in undiluted collagen and surrounded by multiple layers 
of cumulus cells may have experienced hypoxic conditions, which may explain the observed 
shrunken appearance of the ooplasm. This preliminary experiment illustrates that the ECM 
density is an important aspect to take into account when dealing with a 3D culture in order to 
obtain satisfactory results. 
The next step was to investigate if the intercellular communication between the two different 
cell types, cumulus cells and oocytes, were preserved at the end of 3D-PMC. Evaluation of 
the physical integrity of the connections was initially performed using transmission electron 
microscopy (TEM). Although this type of analysis provides us with a topographically selected 
kind of information, it showed clearly that big gaps were present between the oocyte and the 
cumulus cells in 2D cultured CEOs, while numerous transzonal projections (TZPs) could still 
be observed at the end of 3D-PMC.
To examine the functionality of these connections, a LY dye coupling assay was performed 
subsequently. We found that the presence of functional gap-junctions between oocytes and 
surrounding cumulus cells was significantly higher at the end of 3D-PMC compared to the 
2D-PMC group, where an interruption of communication was observed. These results suggest 
that the presence of the ECM act as a scaffold which preserves the 3D morphology and, as a 
result, the functional integrity of the CEOs. This is in agreement with findings from Webb et
al. (2002), who demonstrate that an intact CEO is required for normal gap-junctional 
communication between the oocyte and the cumulus cells during IVM.  
Our results show also that the culture conditions were not sufficient to maintain functional 
communication during the entire period of PMC, since the percentage of CEOs with open 
communications was significantly lower at the end of 3D-PMC compared to the start. This 
indicates that further fine-tuning of the current culture system may be required. In this respect, 
the composition of the ECM may be subject of investigation. Collagen-gel, although being 
used widely for 3D culture of cells, has some disadvantages as cell scaffold. The composition 
is very simple, not standardized (it may vary from batch to batch) and removal of the CEO 
after PMC requires some technical skills and precise adjustment of the enzymatic and 
mechanical treatment. Since the collagen preparation needs to be chilled to prevent early 
polymerization, the cells are submitted to an abrupt drop in temperature at the time of loading 
of the gel. Alternative substrates, such as an alginate hydrogel, may be more appropriate. 
Alginate exhibits minimal cellular interactions with mammalian cells, which makes it easier 
to remove the cells from their 3D environment. This substrate has proven to be successful for 
the culture of mouse preantral follicles (Pangas et al., 2003; Kreeger et al., 2003, 2005). More 
sophisticated and tailor-made matrices could be created by the supplementation of certain 
growth factors, enzymes and other molecules (Abbott, 2003; Kreeger et al., 2006). In this 
way, the ECM composition could be adapted more closely to the natural in vivo situation of 
the CEOs.
Another possible approach to better preserve gap-junctional communication during the course 
of PMC is to manipulate cAMP levels within the CEO in a different way. We know from 
previous reports that exposure of CEOs to PDE3-I results in the increase of intra-oocyte 
cAMP concentration (Tsafriri et al., 1996, Thomas et al., 2002). Elegant studies from Thomas 
et al. (2004a + b), Luciano et al. (2004) and Shu et al. (2008) demonstrated that elevated 
intra-cellular cAMP levels promotes the gap-junctional cross-talk between the germinal and 
somatic compartment. Of interest was the fact that this effect was augmented when an 
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adenylate cyclase activator was added in combination with PDE3-I (Thomas et al., 2004; Shu 
et al., 2008). A similar analysis on mouse CEOs has so far not been performed, but in light of 
these observations, it might be favourable to enrich our 3D-PMC medium with an adenylate 
cyclase stimulator, such as forskolin or FSH (at a higher concentration). In this way, cAMP 
production within the cumulus cells might contribute to the total cAMP content of the oocyte 
and may enhance gap-junctional communication accordingly. The confirmation of this 
hypothesis needs further experiments. 
After exploring the effect of 3D-PMC on mouse oocytes in detail, we tested our 2-step culture 
in a human model. A valuable source of oocytes for this purpose are the immature oocytes 
retrieved from small antral follicles (5-10 mm in diameter) after COH for IVF/ICSI treatment. 
These oocytes are still acquiring cytoplasmic competence and are therefore not routinely 
punctured for the infertility treatment of the patient (Nogueira et al., 2006b; Son et al., 2008).
This part of the study focused first of all on oocyte-cumulus morphology. During the 
prematuration step, human CEOs maintained an in vivo-like morphology with a centrally 
located oocyte and surrounding layers of cumulus cells. A significantly higher proportion of 
CEOs acquired a moderate or fully expanded cumulus configuration at the end of PMC 
compared to the start. This may indicate that the presence of collagen did not disturb the 
ability of the cumulus to expand and develop normally during the prematuration period.  
A previous study of Nogueira et al. (2003a) performed on the same type of human CEOs 
demonstrated that around 65% of oocytes became partially denuded within 24-48 h of culture. 
This figure corresponds with that observed in our in vitro control group (62% of CEOs 
partially denuded). In the 3D-PMC group, however, less than 40% of oocytes became 
spontaneously denuded after removal from collagen and subsequent IVM culture for 24 h. 
This illustrates that a 3D environment may preserve oocyte-cumulus cell connections during 
PMC, leading to a slower breakdown of connections during the second step of our culture 
system. This effect may also explain the improved maturation rates we obtained in the 3D-
PMC group compared to the in vitro control, since several studies showed that removal of the 
cumulus oophorus before IVM is detrimental to oocyte meiotic capacity (Kennedy and 
Donahue, 1969; Schroeder and Eppig, 1984; Ruppert-Lingham et al., 2003; Nogueira et al.,
2006a).
In the last part of our study, we tested the effect of a 2-step culture on the cytoplasmic quality 
of mouse and human oocytes. In order to characterize this parameter, in vitro matured oocytes 
were fertilized and the potential for embryonic development was evaluated.  
In the mouse model, an increase in oocyte competence after 3D-PMC was reflected in higher 
cleavage rates compared to the 2D-PMC and the in vitro control. The proportion of 
blastocysts, on the other hand, was similar between 3D- and 2D-PMC oocytes, but higher 
than in the in vitro control.  
It has been demonstrated earlier that mouse oocyte developmental competence can be 
promoted during meiotic arrest using PDE3-Is (Nogueira et al., 2003b; Vanhoutte et al.,
2008), which has now been confirmed in the present report. The additional positive effect we 
obtained after 3D-PMC, although only observed at the level of cleavage rates, might be 
explained by a better preservation of cellular connections within the CEO. This hypothesis is 
supported by previous studies demonstrating that there is a direct correlation between the 
duration of junctional coupling along IVM and the oocytes’ developmental potential after 
fertilization (Luciano et al., 1999; Guixue et al., 2001). Elimination of cumulus cells from 
CEOs prior to IVM decreases sperm penetration rates in mice (Schroeder and Eppig, 1984), 
rats (Vanderhyden and Armstrong, 1989) and cattle (Zhang et al., 1995). Since most of the 
oocytes in the 2D-PMC group were partially denuded at the end of PMC, the lower 2-cell rate 
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in this group might be explained by poor sperm penetration and/or a deficient interaction
between the spermatozoa and the cumulus oophorus matrix during fertilization (Zhuo and 
Kimata, 2001). Why this positive effect of 3D-PMC was not visible at the level of blastocyst 
rates is unclear at the moment.  
In the human model, 3D-PMC did not affect fertilization, cleavage rates or day 2 embryonic 
quality. On day 3, however, 3D-PMC resulted in a significantly higher proportion of embryos 
with less fragmentation and more blastomeres, similar to the in vivo matured group and 
superior to the in vitro control. This indicates that improvement of the PMC conditions holds 
promise, since a previous report on the effect of a PDE3-I alone (in a 2D setting and on the 
same type of human oocytes) could not show an effect on embryo morphology and 
blastomere number compared to conventionally matured CEOs (Nogueira et al., 2006a).
An aspect that deserves attention when analysing the present results is the source of in vivo 
control oocytes used in this study. Several studies indicate that a correlation exists between 
oocyte developmental competence and follicular size (Triwitayakorn et al., 2003; Nogueira et 
al., 2006b). Therefore, it must be taken into account that these oocytes come from small 
follicles and may differ qualitatively from their counterparts derived from larger follicles. 
However, since there quality is superior compared to in vitro matured oocytes (Nogueira et
al., 2006a), they offer an extra source of mature oocytes for research purposes. 
In conclusion, the present study demonstrates that preservation of the 3D-morphology of the 
CEO during a PMC is possible through the use of appropriate collagen gel culture 
environments. This approach represents a promising system to optimize PMC.  
Our data also indicate that the system can be adapted to support IVM from different species. 
Production of normal offspring might justify the application of this system for clinical 
settings. 
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Figure legends 
Figure 1: Schematic diagram of the different experimental groups in mouse (A) and human 
(B) experiments.
(A) Immature mouse CEOs were collected from small antral follicles and allocated to two 
different groups: 3D-PMC or 2D-PMC. In the 3D-PMC, CEOs were prematured in collagen. 
In the 2D-PMC, CEOs were prematured in conventional microdroplet culture. After PMC, 
CEOs in both groups were in vitro matured. According to the type of experiment, the results 
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were compared to a group of in vitro controls (non-arrested, spontaneously matured oocytes) 
or in vivo controls (in vivo matured oocytes retrieved upon priming mice with eCG and hCG). 
(B) Immature human CEOs were collected from small antral follicles and allocated to two 
different groups: 3D-PMC or in vitro control. In the 3D-PMC, CEOs were prematured in 
collagen and subsequently in vitro matured. In the in vitro control, oocytes were immediately 
in vitro matured. According to the type of experiment, the results were compared to a group 
of in vivo controls (PB-extruded oocytes retrieved from small follicles). 
Figure 2: Effect of collagen concentration on mouse CEO pattern.  
Mouse CEOs were embedded in collagen-gel solutions prepared at two different 
concentrations (not diluted versus diluted 1:2). The morphology of the CEOs was evaluated at 
the end of PMC by light microscopy in relation to the pattern of cumulus cell-oocyte 
connections and compared to 2D-cultured CEOs. (A) C+: the oocyte is completely 
surrounded by multiple layers of cumulus cells (CEO cultured in diluted 3D-PMC); (B) C-: a 
gap is present between the oocyte and the cumulus cell layers and the oocyte is shrunken 
(CEO cultured in non-diluted 3D-PMC); (C) C-:  the oocyte is partially denuded (CEO 
cultured in 2D-PMC). Original magnification x 400.  
Figure 3: Effect of PMC on (A) nuclear arrest and (B) reversibility of nuclear arrest in mouse 
oocytes.
CEOs were 3D prematured in diluted versus non-diluted collagen for 24 hrs. Afterwards, CEOs 
were removed from collagen, washed out of PDE3-I and in vitro matured. Maturation rates 
after PMC (A) and after IVM (B) were compared with a group of CEOs prematured in 
conventional microdroplet cultures (= 2D-PMC) and non-arrested, spontaneously matured 
oocytes (= in vitro control). Values are expressed as mean % ± SD (error bars) of four 
independent replicates. Different letters within the same maturation classes represent significant 
differences (P<0.05). PB = polar body extrusion; GVBD = germinal vesicle breakdown; GV = 
germinal vesicle. 
Figure 4: Representative electron microscopic section of 3D-PMC (A, B) and 2D-PMC (C)
cultured mouse CEOs.  
(A) After PMC for 24 h in collagen, cumulus cells were still in close approximation with the 
oocyte and several transzonal projections were visible in the zona pellucida (arrow). 
Junctional complexes between neighboring cumulus cells could be observed as well 
(arrowhead). Note the presence of numerous fibrillar lattices in the oocytes’ cytoplasm, which 
is characteristic for mouse oocytes; (B) Detailed image of a long cumulus cell process 
crossing the zona pellucida (arrow); (C) A big gap is visible between the oocyte and the 
cumulus cells of a 2D-PMC CEO. Although remnants of TZPs could be observed within the 
zona (arrow), they were disconnected from the cumulus cells.  
CC = cumulus cell; FL =  fibrillar lattices; MV = microvilli; N = nucleus; O = oocyte; ZP =  
zona pellucida. Original magnification: x 12 000 (A, B) and x 7000 (C). 
Figure 5: LY diffusion in mouse CEOs cultured for 24 h in 3D-PMC.  
A solution of LY dye was injected into mouse oocytes and the spread of dye into surrounding 
cumulus cells was monitored with an inverted fluorescence microscope to assess the 
functionality of gap junctions. This was analysed at the start and the end of the PMC period. 
Fluorescence and bright field, respectively, of open (A and B), partially open (C and D) and 
closed (E and F) gap junction-mediated oocyte-cumulus cell communications. Original 
magnification x 200.  
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Figure 6: Effect of 3D-PMC and IVM on human CEO morphology.  
CEO’s were 3D prematured for 24 hrs. Afterwards, CEOs were removed from collagen, 
washed out of PDE3-I and in vitro matured. Enclosed figures show representative examples 
of different cumulus configurations: Type I: compact; Type II: moderately expanded; Type 
III: fully expanded or Type IV: partially denuded. Original magnification: x 400 (Type I, II 
and IV) and x 200 (Type III). 
Evaluation was performed at the beginning of 3D-PMC, the end of 3D-PMC and after 24 h of 
IVM. (A) Graph illustrating the % of CEOs according to the morphological pattern of their 
cumulus at the start and the end of 3D-PMC; (B) Graph illustrating the % of CEOs according 
to the morphological pattern of their cumulus in the 3D-PMC group versus the in vitro control 
at 24 h of IVM. * = P<0.05.
Figure 7: Effect of PMC condition on fertilization and embryonic developmental rates in a 
mouse model.  
Oocytes that matured under different conditions were fertilized in vitro at the end of IVM. 
The results were compared with oocytes from 2D-PMC (PMC in microdroplets), in vitro 
control (no PMC) and in vivo control (in vivo matured oocytes). (A) Two-cell stage 1 day 
after IVF; (B) Blastocyst stage 4 days after IVF. Values represent the mean % ± SD (error 
bars) of five independent replicates. Different letter superscripts denote significant differences 
(P<0.05).
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Figure 7:
Table I. Functional coupling between cumulus cells and oocytes in mouse CEOs at the start 
of PMC (0 h; positive control), at the end of 2D- and 3D-PMC (24 h) and after exposure to 
CBX (negative control) 
Treatments 
N° of 
CEOs
analyzed 
CEOs with open
gap junctions 
CEOs with partially
open
gap junctions 
CEOs with closed
gap junctions 
Positive
control
102 82.9 ± 3.1
a
15.2 ± 4.0
a
  1.9 ± 1.8
a
2D-PMC 101 5.4 ± 5.8
b
52.8 ±  10.1
b
41.8 ± 4.3
b
3D-PMC 115 64.6 ± 2.0
c
29.1 ± 2.6
a
6.3 ± 3.2
a
Negative
control
45 0
b
14.4 ± 5.1
a
85.6 ± 5.1
c
Results are presented as % ± SD 
a,b,c
Different superscripts within columns indicate statistical differences (P<0.05).
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Table II. Meiotic progression of human oocytes following 3D-PMC and/or IVM for up to 48 
h.
Culture conditions 
In vitro control 3D- PMC  
N° (%) of GV after inhibition  49/52 (94.2) 
N° of GV undergoing IVM 66 49 
Maturation at 24 h of IVM (%)   
      GV 37.9 36.7 
      GVBD 43.9 46.9 
       PB 18.2 16.3 
       Degenerated 0 0 
Maturation up to 30 h of IVM 
(between 25 and 30 h) (%)
      GV 30.3
a
12.2
b
      GVBD 10.6 22.4 
       PB 57.6 65.3 
       Degenerated 1.5 0 
Maturation up to 48 h of IVM 
(between 31 and 48 h) (%)
      GV 27.3
a
12.2
b
      GVBD 10.6 6.1 
       PB 60.6
a
81.6
b
       Degenerated 1.5 0 
a,b
Values within the same row with different superscripts are statistically different (P<0.05).
Table III. ICSI-outcome of human PB oocytes following 3D-PMC and/or IVM.
Culture conditions 
In vivo control In vitro control  3D-PMC  
N° of injected PB oocytes  56 40 40 
N° (%) of 2PN  43 (76.8)
a
22 (55.0)
b
27 (67.5)
ab
Cleaved/2PN (%) 88.4 81.8 77.8 
Good embryo quality on day 
2 (%)
69.8 68.2 70.4 
Good embryo quality on day 
3 (%)
55.8
a
27.3
b
55.6
a
Mean blastomere N°/embryo 
± SD day 2
3.3 ± 1.02 2.9 ± 0.88  3.2 ± 1.08  
Mean blastomere N°/embryo 
± SD day 3 
5.8 ± 1.61
a
4.4 ± 1.66
b
5.7 ± 2.03
a
a,b
Values within the same row with different superscripts are statistically different (P<0.05). 
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4. General discussion 
In vitro maturation (IVM) holds great promise as a potential alternative to classical ART. This 
technology may even become the procedure of choice, not only for infertile patients but also 
for obtaining oocytes for donation and preservation of fertility. With the assistance of the 
cloning technology, in vitro matured oocytes could generate embryos for derivation of stem 
cell lines. However, IVM is still premature and needs to be further developed in order to be as 
efficient as the routinely used IVF technology.
A major difficulty in developing the technique into a safe and reproducible procedure is the 
lack of human experimental material. The strategies to be further applied in the human could 
therefore benefit from experiences obtained in animal studies. In the present research project, 
results acquired from mouse experiments were translated to humans.  
Our main findings include that a 2-step culture composed of (1) a PMC with PDE3-I to 
induce temporarily nuclear arrest, followed by (2) conventional IVM is a reliable method to 
improve the quality of mouse cumulus-oocyte complexes (COCs) post-IVM. A similar 
approach proved to be beneficial for the IVM of human cumulus-free oocytes in relation to 
stability of spindle morphology and chromosome alignment.  
Furthermore, our results indicate that 3D co-culture of human cumulus-free oocytes with 
dissociated cumulus cells during PMC positively influenced the morphological quality and 
nuclear constitution of the resulting embryos. 
Finally, 3D-PMC followed by IVM of mouse and human COCs, both retrieved from small 
antral follicles, preserves intra-cellular connections and influences developmental 
competence. Hence, this innovative 2-step approach with PDE3-I may be an interesting 
advancement to simulate more precisely the in vivo preovulatory maturation conditions. 
4.1. Clinical outcome of conventional in vitro maturation  
(= ‘rescue IVM’) 
Around 15 to 20% of human oocytes collected from large ( 15 mm) antral follicles following 
COH for IVF/ICSI treatment are meiotically immature, either at the GV or MI stage (Cha and 
Chian 1998; Smitz et al., 2004). These oocytes are generally considered to be a side-product 
of the infertility treatment.  
Partially mature MI oocytes have already undergone the process of GVBD and may progress 
spontaneously to the MII stage within a few hours of in vitro culture. This allows them to be 
submitted to ICSI at the same time as their sibling mature MII oocytes and the same day of 
sperm collection. As such, IVM might allow these oocytes to be “rescued” and be destined for 
patients use, which may be particular interesting when a low number of mature oocytes are 
retrieved. This hypothesis was tested in the first study of our research project. To achieve this 
goal, we selected ICSI cycles in which a maximum of 6 mature oocytes and at least one MI 
oocyte were obtained at oocyte retrieval. 
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In our laboratory, MI oocytes cultured in vitro for different periods (2-26 hrs) had the ability 
to resume meiosis, but the fertilizability and developmental competence was significantly 
reduced compared to in vivo matured sibling oocytes (Vanhoutte et al., 2005). These results 
confirmed the findings of previous studies on this subject (De Vos et al., 1999; Chen et al.,
2000; Balakier et al., 2004; Strassburger et al., 2004). Nevertheless, the percentage of 
embryos transferred or cryopreserved per fertilized oocyte appeared to be relatively high in 
our study (76% = total MI utilization rate). One pregnancy and live birth was obtained out 
of 13 transfers of embryos exclusively derived from IVM oocytes (Vanhoutte et al., 2005).
In view of the results obtained, we concluded that clinical applications of ‘rescue IVM’ 
should be recommended exclusively for selected patient populations, such as women with few 
mature oocytes (e.g. ‘poor responders’). Furthermore, the oocytes’ reduced developmental 
capacity confirmed that IVM culture conditions must be refined to support maturation in vitro
properly.
4.2. Effect of prematuration culture in the presence of a 
phosphodiesterase type 3 inhibitor 
Isolation of fully-grown GV oocytes out of small or medium-sized follicles truncates the 
cytoplasmic maturation process by the spontaneous resumption of meiosis. In addition, GV-
stage oocytes isolated from follicles stimulated by exogenous gonadotrophins are 
heterogeneous in size, cytoplasmic microtubule organization, chromatin and nucleolar 
configuration (Mattson and Albertini, 1990; Zuccotti et al., 1998; Combelles et al., 2002; De 
La Fuente, 2006).
Applying a 2-step culture might synchronise nuclear and cytoplasmic maturation and may 
reflect more closely the physiological situation. Recent results offer perspectives for the 
application of ‘second-generation’ specific PDE-Is to extend the developmental period of the 
immature oocyte (i.e. PMC) before final IVM (Nogueira et al., 2003b, 2006; Thomas et al.,
2004). Hence, our laboratory has taken the approach to set-up a 2-step culture with PDE3-I in 
order to improve the IVM-outcome of human and mouse oocytes. Since MI oocytes (as used 
in Article I) are already in the process of nuclear maturation, we continued our experiments 
with germinal vesicle (GV)-stage oocytes in order to test the above described hypothesis.
4.2.1. Effect of prematuration culture on mouse cumulus-oocyte complexes
In our study on mouse COCs retrieved from immature antral follicles, we first identified the 
lowest effective concentration of the PDE3-I cilostamide (i.e. 1 µM) for maximum level of 
inhibition and reversibility of meiotic arrest. Thereafter, we aimed to clarify precisely the 
effect of PDE3-I on the maturation process itself, which is currently largely unknown 
(Vanhoutte et al., 2008).
One method to observe possible underlying cell cycle aberrations during IVM is to explore 
the kinetics of meiotic progression upon removal from the inducer of nuclear arrest. We 
found a higher synchrony in meiotic progression after PMC compared to spontaneously 
matured oocytes. This might be attributed to a better synchronisation of the starting 
population of GV oocytes. A synchronous pattern of meiotic progression was previously 
found to be a specific characteristic of oocytes that have been matured in vivo compared to in 
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vitro matured oocytes (Sanfins et al., 2004). We also observed that the timing of meiotic 
progression in previously arrested oocytes was initially more rapid compared to in vitro non-
arrested and in vivo control oocytes. The reasons for this acceleration are unclear, but it has 
been suggested that during the block of meiosis the oocyte might have extra time for the 
accumulation of factors related to cell cycle progression (Anderiesz et al., 2000). 
Alternatively, rapid meiotic progression may also be explained by a precocious migration of 
factors from the oocyte cortex (centrosomes, cytoplasmic microtubules, MPF), leading to 
uncontrolled G2 to M cell cycle transition (Sanfins et al., 2004). 
A potential biomarker of oocyte cytoplasmic quality is the normalcy of the MII spindle 
structure and the integrity of their chromosome constituents. The oocyte spindle is crucial 
for maintaining the fidelity of chromosome segregation at meiotic divisions. Alterations in 
spindle morphology are therefore indicators of adverse conditions during oocyte development 
that may result in meiotic aneuploidy (Eichenlaub-Ritter, 2002; Shen et al., 2007). Several 
studies on mouse oocytes confirmed that IVM conditions can have deleterious effects on the 
microtubular organization of the spindle (Sanfins et al., 2003; Moon et al., 2005; Roberts et
al., 2005; Rossi et al., 2006; Barrett and Albertini, 2007). It was therefore interesting to 
observe that a 2-step culture significantly improved the number of oocytes with normal MII 
spindle morphology. This might be a result of higher nucleation capacity of the centrosomes, 
tubulin assembly competence or microtubule stability. A quantitative analysis was performed 
as well by measuring spindle length and width. Spindles of in vivo matured oocytes were 
clearly shorter and smaller compared to 2-step cultured oocytes. It has been shown earlier that 
large, barrel-shaped spindles are formed during IVM as a result of the recruitment of massive 
amounts of centrosomal material during spindle assembly. In vitro matured oocytes also 
exhibit a lower number of cytoplasmic microtubule organizing centres (MTOCs) and present 
increased polar body size (Sanfins et al., 2003). This reduces the stores of available 
cytoplasmic gamma-tubulin necessary for early cleavage events during embryogenesis 
(Combelles and Albertini, 2001; Sanfins et al., 2003, 2004; Barrett and Albertini, 2007). 
Hence, although a 2-step culture improved spindle morphology, the presence of enlarged 
spindles reflects a not yet fully optimized spindle assembly mechanism.  
In addition, we investigated the possible risk of aneuploidy during MI by investigating 
chromosome preparations of 2-step cultured and PB extruded oocytes. Our analysis revealed 
that a 2-step culture with PDE3-I did not increase aneuploidy rates after IVM. Other structural 
aberrations, such as the presence of single chromatids, were not observed. 
Finally, our results demonstrated that developmental competence upon IVF was increased 
in 2-step cultured oocytes compared to the control group. Not only the fertilization, but also 
the blastocyst formation rate was significantly increased in arrested oocytes. In a similar study 
of Nogueira et al. (2003b) beneficial effects on fertilization and blastocyst rates were 
observed, but only the results on fertilization rates were significantly improved using the 
PDE3-I Org 9935 (10 µM). This might indicate that the type of PDE3-inhibitor and the 
working concentration can exert different effects on IVM outcome.   
All together, this study demonstrates that a PMC in the presence of PDE3-I alters the 
cytoplasmic quality into a direction more closely related to the in vivo situation. Nevertheless, 
it was noticed that cumulus cells started to lose the contact with the oocyte during PMC, a 
process that is associated with loss of gap junctional communication. Modifications of the 
current culture conditions, aiming for a better oocyte-cumulus contact during the 2-step 
culture, may result in a better outcome (see article V – Vanhoutte et al., 2009b). 
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4.2.2. Effect of prematuration culture on human cumulus-free oocytes 
Because of the promising results on mouse oocytes (Vanhoutte et al., 2008), we applied a 
similar 2-step culture with PDE3-I on human oocytes. Since human oocytes for research 
purposes is difficult to obtain, we used spare cumulus-free germinal vesicle (GV)-stage 
oocytes retrieved from superovulated women undergoing a regular ICSI attempt (Vanhoutte 
et al., 2007).
Supplementation of the PMC medium with PDE3-I resulted in efficient meiotic arrest of the 
GV oocytes. The inhibitory activity was reversible, and oocytes underwent GVBD and 
extruded the first PB to the same extent as non-arrested oocytes. In contrast to the results 
obtained in the mouse (Vanhoutte et al., 2008), the time course for PB extrusion was slowed 
down after PMC. This might be a result of the time necessary for the reconstitution of the 
PDE3 activity and the breakdown of cAMP prior to GVBD. 
Cytoplasmic integrity of the 2-step cultured oocytes was judged by the morphology of the 
second meiotic spindle and the associated chromosome configurations. It has been 
demonstrated before that human oocytes matured in vitro have an increased incidence of 
spindle abnormalities and chromosomal misalignments compared with human oocytes 
matured in vivo, regardless of whether the immature oocytes are recovered from unstimulated 
(Racowsky and Kaufman, 1992; Li et al., 2006) or hormonally stimulated ovaries (Cekleniak 
et al., 2001; Wang and Keefe, 2002). In our study, we observed a tendency to obtain normal 
spindle/chromosome configurations when oocytes were prematured with PDE3-I at a 
concentration of 1 µM cilostamide.  
The effect of a PMC period on nuclear configuration within the GV was analyzed as well. 
At the end of the PMC, most oocytes had acquired a nucleolus completely surrounded by a 
rim of highly condensed chromatin, while at the start of PMC heterogeneity in chromatin 
pattern was present. This illustrates that a synchronization within the mixed population of GV 
oocytes occurred during the course of prematuration. The presence of a surrounded nucleolus 
(SN) chromatin pattern has been associated with a higher proportion of oocytes reaching 
meiotic maturation, better embryonic development and, hence, represents a more advanced 
step in oocyte differentiation (Mattson and Albertini, 1990; Zuccotti et al., 1998; De La 
Fuente, 2006).
The results in this section illustrate that applying a 2-step culture with PDE3-I can affect the 
quality of human oocyte. It should be stressed, however that our first study with PDE3-I in the 
human was performed using spare GV oocytes, which failed to mature in vivo. These oocytes 
had been disconnected from surrounding granulosa cells to score the oocyte maturation stage. 
It is questionable whether making use of these GV oocytes for IVM studies is a good choice. 
One way to approach a more physiological situation for IVM of these ‘left over’ GV oocytes 
is to restore the communication between the cumulus cells and the oocyte (see article IV – 
Vanhoutte et al., 2009a).
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4.3. Effect of three-dimensional prematuration culture in the 
presence of a phosphodiesterase type 3 inhibitor
Many of the practices commonly used in human ART lead to alterations in cumulus cell 
and/or zona integrity and therefore modify the immediate microenvironment of the oocyte. In 
this context, maintaining and/or re-establishing this microenvironment will be essential in the 
design and implementation of IVM systems.  
4.3.1. Effect of three-dimensional prematuration culture on human 
cumulus-free oocytes
In the next study, we aimed to further optimize the 2-step ‘rescue IVM’ for human cumulus-
free oocytes (see Article III - Vanhoutte et al., 2007). To overcome the lack of cumulus cells 
during PMC and to simulate more accurately the natural 3D-environment of the COC, the 
oocytes were prematured in a 3D co-culture with cumulus cells embedded in an extra-
cellular matrix (ECM; collagen) (= 3D-PMC) (Vanhoutte et al., 2009a). Parameters to asses 
oocyte quality were nuclear maturation, fertilization and pre-implantation embryonic 
development. 
The principal findings from this study were a significantly higher fertilization rate of 3D-
PMC oocytes compared to oocytes that underwent spontaneous maturation (= in vitro 
control). Although 3D-PMC did not augment the fertilization capacity when compared to 
oocytes prematured without cumulus cells and ECM (= 2D-PMC), embryos on day 3 post-
ICSI from the 3D-PMC groups were of better quality and had fewer nuclear abnormalities 
compared to the in vitro control and 2D-PMC group. These results suggest that the 
combination of a co-culture in the presence of an ECM may serve as a physiological support 
during the last stages of oocyte development.  
One of the objectives of this study was to analyze any probable adverse effects of collagen-
embedding procedure on cell viability and functionality. Transmission electron microscopy 
(TEM) analysis could not reveal a negative effect on cell morphology in cumulus cells and 
the oocyte. Cumulus cells were capable of secreting estradiol and progesterone, which 
demonstrates that the cells retained their steroidogenic activity. The presence of the collagen-
matrix did not reduce the effectiveness of the PDE3-I on keeping the oocytes arrested at the 
GV-stage. Upon release from meiotic arrest and ECM, oocytes were competent to resume 
meiosis and progress to the MII stage, which is an important functional end point of the 
culture system. Based on these observations we may conclude that cumulus cells and oocytes 
were able to withstand the cooling-warming step during embedding and polymerization of the 
collagen matrix.
Furthermore, we evaluated oocyte-cumulus cell interactions. A study by Veitch et al. (2004) 
demonstrated that denuded mouse oocyte/granulosa cell co-cultures can re-establish 
heterocellular coupling, reproducing the intercellular gap-junctional communication that 
exists in vivo. In our study, newly developed TZPs reaching the oolemma could not be 
observed. The reason for our improved results might, therefore, be explained by the existence 
of paracrine intracellular communication signalling, which could have compensate the 
absence of oocyte-cumulus cell contacts (Carabatsos et al., 1998; Albertini et al., 2001; Ge et
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al., 2008). Another possibility to clarify our improved results on embryo quality post-IVM is 
the protective role that cumulus cells may play by reducing cystine to cysteine and promoting 
the uptake of cysteine in the oocyte (Takahashi et al., 1993; de Matos et al., 1997). Via this 
pathway, cumulus cells may neutralize the damaging processes that reactive oxygen species 
may exert on oocytes. 
In summary, this study illustrates that culture protocols for ‘rescue IVM’ requires a PMC in 
the presence of an appropriate in vitro environment, as we could establish by the 3D co-
culture approach (Vanhoutte et al., 2009a). 
4.3.2. Effect of three-dimensional prematuration culture on mouse 
cumulus-oocyte complexes 
In our study on mouse COCs, we observed that a proportion of the oocytes had clearly lost 
cumulus-oocyte contact by the end of the PMC (see Article II - Vanhoutte et al., 2008). We 
thus tried to overcome this deficit by performing the first step of our 2-step culture (i.e. the 
PMC) in a 3D-environment. This was realized by embedding COCs in an ECM, the same 
collagen matrix as was used in the previous study on human cumulus-free oocytes (see Article 
IV - Vanhoutte et al., 2009a). 
This 3D-PMC system was initially tested and optimized in a mouse model. The first 
experiment was designed to define the optimal concentration of collagen in order to 
preserve COC integrity without affecting subsequent meiotic competence. Collagen in 
undiluted form limited the expansion of the cumulus cell-layers and affected oocyte 
maturation. In diluted collagen (1:2), on the other hand, COCs preserved their in vivo-like 
morphology and a general growth of the cumulus cell layers due to cell proliferation was 
observed. This preliminary experiment illustrates that ECM density is an important aspect to 
take into account when dealing with a 3D culture in order to obtain satisfactory results. 
The next step was to investigate if the intra-cellular communication between the two 
different cell types, cumulus cells and oocytes, were preserved at the end of 3D-PMC. To 
examine this, a Lucifer Yellow (LY) dye coupling assay was performed. The presence of 
functional gap-junctions between oocytes and surrounding cumulus cells was significantly 
higher at the end of 3D-PMC compared to the 2D-PMC group. This suggests that the ECM 
act as a scaffold to preserve 3D morphology and, as a result, the functional integrity of the 
COCs. Our results showed also that the culture conditions were not sufficient to maintain 
functional communication during the entire period of PMC, since the percentage of COCs 
with open communications was significantly lower at the end of 3D-PMC compared to the 
start. Hence, further fine-tuning of the current culture system may be required. In this respect, 
the composition of the ECM may be subject of investigation. Another possibility is to 
manipulate cAMP levels in a different way, for example by the addition of an adenylate 
cyclase activator in combination with PDE3-I. This approach has previously shown to 
promote the gap-junctional cross-talk between the germinal and somatic compartment 
(Thomas et al. 2004, Luciano et al., 2004; Shu et al., 2008). 
Mature mouse oocytes obtained after 3D-PMC and IVM could be fertilized and sustained 
preimplantation development in vitro. An increase in oocyte competence was reflected in 
higher cleavage rates compared to non-arrested spontaneously matured oocytes and 2D-PMC 
cultured oocytes. Elimination of cumulus cells from COCs prior to IVM has previously 
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shown to decrease sperm penetration rates in mice (Schroeder and Eppig, 1984). Since most 
of the oocytes in the 2D-PMC group were partially denuded at the end of PMC, the lower 2-
cell rate in this group might be explained by poor sperm penetration and/or a deficient 
interaction between the spermatozoa and the cumulus oophorus matrix during fertilization 
(Zhuo and Kimata, 2001). 
4.3.3. Effect of three-dimensional prematuration culture on human 
cumulus-oocyte complexes 
Thereafter, we translated the work we had performed in mice to human COCs. Since ‘true 
IVM’ is not performed on a routine basis in our Department of Reproductive Medicine, we 
asked patients to donate immature COCs from small antral follicles (5-10 mm in diameter) 
after COH for IVF/ICSI treatment. These oocytes are still acquiring cytoplasmic competence 
and are therefore not routinely aspirated for the infertility treatment. Nevertheless, they are a 
valuable source of research material to study different IVM culture conditions (Nogueira et
al., 2006). 
Results from 3D-PMC cultured COCs were compared with a group of non-arrested, 
conventionally matured oocytes (in vitro control). Polar body-extruded oocytes, retrieved 
from small follicles of the same patients, were included as in vivo controls. 
This part of the study focused first of all on oocyte-cumulus morphology. A previous study 
of Nogueira et al. (2003a) performed on the same type of human COCs demonstrated that 
around 65% of oocytes became partially denuded within 24-48 h of IVM culture. This figure 
corresponds with what we observed in our in vitro control group. In the 3D-PMC group, 
however, less than 40% of oocytes became spontaneously denuded after removal from 
collagen and subsequent IVM culture for 24 h. This illustrates that a 3D environment may 
preserve oocyte-cumulus cell connections during PMC, leading to a slower breakdown of 
connections during the second step of our culture system.  
The 2-step 3D-PMC culture had a beneficial effect on human oocyte developmental capacity. 
This was visible by an increased nuclear maturation rate in 3D-PMC cultured oocytes 
versus spontaneously matured ones.  
Finally, an improvement in embryonic developmental quality was obtained as well. The 2-
step culture did not affect fertilization, cleavage rates or embryonic quality on day 2 post-
ICSI. On day 3, however, 3D-PMC resulted in a significantly higher proportion of embryos 
with less fragmentation and more blastomeres, similar to the in vivo matured group and 
superior to the in vitro control.
This indicates that systems involving PMC with a PDE3-I using culture methods that preserve 
the 3D architecture of the COC holds promise. This is possible through the use of appropriate 
collagen gel culture environments. The system can be adapted to support IVM from different 
species (Vanhoutte et al., 2009b).
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5. Perspectives for future research 
“Research is what I’m doing when I don’t know what I’m doing” 
Wernher von Braun
Our understanding of the factors regulating oocyte developmental competence is gradually 
improving and these insights are slowly translating into progressive enhancement of IVM 
efficiency. The work presented in this thesis is only one more step on a long road. Many 
pieces from the puzzle are still missing and substantial adaptations are needed before the ‘2-
step culture’ principle can be considered as a valuable strategy in human IVM.  
There are several points that remain to be investigated in the near future.  
Though our work has contributed towards gaining more insight into the influence of the 
PDE3-I and 3D culture on oocyte development, mechanisms of PDE3 activation itself and 
signalling pathways of the oocyte-cumulus cell communication axis remain unknown. 
Measurement of cAMP concentration could reveal if the positive effects we observed can be 
explained by a rise in intra-oocyte cAMP concentration. Therefore, a lot of research remains 
to be done at the molecular level. One of the challenges is the integration of this information 
into coherent physiological theories on the mechanisms governing oocyte developmental 
competence.  
Also the questions regarding the effect of our newly developed 2-step culture on blastocyst 
formation and normal fetal development to term remain unanswered. The ability to resume 
meiosis, to fertilize and to develop into a blastocyst, to induce pregnancy and to generate 
healthy offspring are all separate events and succeeding in the first event does not ensure the 
success of subsequent ones (Sirard et al., 2006). It is obvious that, before any clinical 
application, complete testing of possible increased risks of aneuploidy is necessary. In 
addition, further studies in large mammals involving embryo transfer might reveal possible 
epigenetic risks that this technique could induce.
Another consideration that was left unhandled is the choice of culture medium. It is still 
unknown what constitutes an ideal nurturing medium for oocyte maturation. Although a 
variety of culture media have been described in the literature, no single system has been 
shown to be clearly superior (Trounson et al., 2001). Oocyte maturation media are usually 
formulations designed many years ago for culture of non-ovarian somatic cells. This is the 
case for the most widely employed oocyte IVM media used today, Tissue Culture Medium-
199 and Minimal Essential Medium. There are no studies that directly correlate the metabolic 
needs of the complex and dynamic requirements of the maturing COC with developmental 
outcomes (Sutton et al., 2003). Therefore, extensive studies on the effects of different types of 
basal media will be necessary. In this respect, it is possible that the medium composition 
during the arrest period (i.e. PMC) needs further specific supplements, which may be distinct 
from supplements needed during the nuclear maturation process (i.e. IVM).  
Recent findings on bovine and mouse showed that IVM oocytes benefit from the exposure to 
exogenous oocyte-secreted factors (OSFs), resulting in improved embryo quality and better 
fetal survival post-transfer (Hussein et al., 2006; Yeo et al., 2008). These data generate 
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enthusiasm in the field of IVM, albeit that they are derived from animal models. 
Supplementing the PMC- and/or IVM-medium with exogenous OSFs (e.g. GDF-9 and BMP-
15) may have a major impact on the results of IVM in both animal models and the human.  
Further fine-tuning of the ECM composition for culturing the COCs is another subject of 
investigation. Collagen-gel, although being used widely for 3D culture of cells, has some 
disadvantages as cell scaffold. The composition is very simple, not standardized (it may vary 
from batch to batch) and removal of the COC after PMC is not easy. Alternative substrates, 
such as the synthetic alginate hydrogel, may be more appropriate. Alginate exhibits minimal 
cellular interactions with mammalian cells, which makes it easier to remove the cells from 
their 3D environment. More sophisticated and tailor-made matrices could be created by the 
supplementation of certain growth factors, enzymes and other molecules (Abbott, 2003; 
Kreeger et al., 2006). Finally, the concept of using matrix components normally found in the 
cell system of interest in the body is gaining interest in other fields. A diversity of ECM 
molecules is present in ovarian follicles (Rodgers et al., 2003) and proteoglycans, laminin, 
collagen IV and fibronectin are all present in the hyaluronan-rich matrix of the COC (Zhuo 
and Kimata, 2001). In this way, the ECM composition could be adapted more closely to the 
natural intra-follicular in vivo situation of the COCs.
Finally, defining objective and non-invasive parameters to predict oocyte quality is of critical 
importance for future research on IVM. Morphological parameters such as polar body 
extrusion, spindle morphology, fertilization rate and embryo quality are routinely used, but 
are often subjective and controversial. Gene expression profiling of cumulus cells may 
indirectly provide novel and reliable parameters to assess oocyte competence. These cells are 
easily accessible and their capacity to predict oocyte quality is now emerging (Assidi et al.,
2008; Bettegowda et al., 2008). With the advent of the functional genomics and metabolomics 
era, it has become possible to identify the transcriptome of granulosa cells using throughput 
technology such as the micro-array. Future efforts should focus on integrating these genetic 
markers as parameters for oocyte/embryo selection, not only in the field of IVM but also for 
routine IVF/ICSI applications at large. However, consistent molecular markers predictive of 
oocyte competence are often lacking. Therefore, more comprehensive studies are needed in 
clinical settings to establish and standardize objective molecular markers.   
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